Comparative pathogenesis of Yersinia enterocolitica biotypes by Alenezi, D
  
 
 
 
 
 
 
 
 
  Comparative Pathogenesis of Yersinia enterocolitica Biotypes 
 
 
 
Dhahi Alenezi 
 
 
 
A thesis submitted in partial fulfilment of the requirements of 
Nottingham Trent University for the degree of Doctor of Philosophy 
 
March 2015 
i 
 
DECLARATION 
 
This work is the intellectual property of the author. You may copy up to 5% of this work for 
private study, or personal, non-commercial research. Any re-use of the information contained 
within this document should be fully referenced, quoting the author, title, university, degree 
level and pagination. Queries or requests of any other use, or if a more substantial copy is 
required, should be directed in the first instance to the owner(s) of the Intellectual Property 
Rights. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ii 
 
Abstract  
 
           Yersinia enterocolitica is a well known food-borne bacterium which belongs to the 
Enterobacteriaceae family. Y. enterocolitica is pathogenic for humans and it causes a wide 
spectrum of diseases ranging from self-limiting gastrointestinal diseases to fatal sepsis 
depending on the age and the immunity of the infected person. Oral ingestion of undercooked 
raw meat products, unpasteurised milk and contaminated water are the main sources of 
acquisition of this bacterium.  Y. enterocolitica strains are categorized into six biotypes (1A, 
1B, 2, 3, 4 &5).   These six biotypes are further classified into high pathogenic, low 
pathogenic and non-pathogenic biotypes depending on their pathogenicity in the mouse 
infection model. This project compared the pathogenic potential of Yersinia enterocolitica 
high pathogenic, low pathogenic and non-pathogenic biotypes. The HEp-2 laryngitic human 
epithelial cell line and the alternative infection model Galleria mellonella greater wax moth 
larvae are the main infection models used to investigate the pathogenic potential of Y. 
enterocolitica biotypes. A diverse collection of Y. enterocolitica strains was used by which 
this strains collection is encompassing all six biotypes and all major serotypes.  These strains 
were isolated from human and animal origins.  Here novel results are presented showing new 
infection phenotypes of the Y. enterocolitica strains. All Y. enterocolitica biotypes strains 
were invasive to the HEp-2 epithelial cell line and pathogenic to the Galleria insect model.  
The non-pathogenic biotype was the most lethal in the Galleria model while the high 
pathogenic biotype shows little to no pathogenicity.  The low pathogenic biotypes were 
moderately pathogenic to the Galleria insect model.  The pYV plasmid showed a minor role 
in modulating the virulence in the Y. enterocolitica pathogenic biotypes. Investigating the in 
vivo Y. enterocolitica-Galleria interaction showed that Y. enterocolitica pathogenic biotypes 
bacterial cells were growing inside the Galleria larvae while the non-pathogenic biotype 
bacterial cells were dying.  The heat-killed Y. enterocolitica strains were completely avirulent 
to the Galleria larvae. 
 
 
 
 
 
iii 
 
Contents  
 
Declaration……………………………………………………...……………….................i  
Abstract………………………………………………………...………………………….ii    
Contents………………………………………………...…………………………..….…iii   
Acknowledgments………………………………………………………………….……. ix    
Abbreviations………………………………………………...…………………………....x   
List of figures…………………………………………………………………………....xiv     
List of tables……………………………………………………………..…………….…xx       
Chapter1 Introduction……………………………………………………………………1 
1.1 The Genus Yersinia Classification and Characteristics………………………………..2 
1.2 Y. enterocolitica Biotypes..............................................................................................3 
1.3 Y. enterocolitica Serotypes.............................................................................................5 
1.4 Y. enterocolitica virulence factors…………...……………………………………..….6 
1.4.1 pYV plasmid encoded virulence factors………………………...…………….…… 6 
1.4.1.1 The Ysc Type Three Secretion System Injectisome……...…………………….....6 
1.4.1.2 The Secreted Yop proteins……………………………...…………………………7 
1.4.1.3 Syc Chaperones ………………………………...…………………………………8 
1.4.1.4 Yersinia adhesin A (YadA)…………...…………………………………………...8 
1.4.2 Y. enterocolitica chromosomally encoded virulence factor………………...……….9 
1.4.2.1 Yersinia secretion apparatus (Ysa)………………………………………………...9 
1.4.2.2 Y. enterocolitica Type 2 Secretion System (T2SS)……...……………………….10 
1.4.2.3 Y. enterocolitica Flagella and motility…………...…...………………………….10 
1.4.2.4 Lipopolysaccharides (LPS) O-antigen of Y. enterocolitica ………………...……11 
1.4.2.5 Y. enterocolitica HPI..............................................................................................12 
1.4.2.6 Invasin protein (Inv)...............................................................................................12 
1.4.2.7 Ail protein………………………………………………………………………...13 
1.4.3 Auxiliary Y. enterocolitica virulence factors………………...……………….....…13  
1.4.3.1 Mucoid Yersinia factor (Myf)…………………………………...……..……….. 13 
1.4.3.2 YST (Yersinia stable toxins)………………………………...…………………...14 
1.4.4 Y. enterocolitica Route of Infection…………………......…………………………14 
iv 
 
1.4.5 Y. enterocolitica clinical manifestations………………..………………………….15 
1.4.5.1 Y. enterocolitica gastrointestinal infections………...…………...……………….15 
1.4.5.2  Y. enterocolitica extra intestinal infections………………...…………...……….15 
1.4.6  Project Background……………………………………………...………………...16   
1.4.7  Project General Aims……………………………………………………...………17 
Chapter 2: Materials & Methods………………………………………………………18 
2.1 Materials and Reagents…………………...………………………………………….19  
2.1.1 Bacterial strains and growth conditions……………………………………………19 
2.1.2 Luria-Bertani Agar (LB) agar....................................................................................20 
2.1.3 Luria-Bertani Broth (LB) Broth……………………………...………………….…21 
2.1.4 Yersinia Selective Agar (CIN) (Schiemann's CIN agar) Formula and Preparation..21 
2.1.5 CRMOX Agar Preparation…………………………………………………………22 
2.1.6 Tryptone Soy Agar (TSA).........................................................................................23 
2.1.7 1X TAE buffer preparation…………………………………………...……………23 
2.1.8 Agarose Powder…………………..…………………………………...………...…23 
2.1.9 Phosphate Buffered Saline (PBS)………………………………………………….23 
2.1.10 Glycerol freezing medium preparation………………………………………...….23 
2.1.11 Trimethoprim antibiotic preparation………………………...………………...….24 
2.1.12 TrypLE Express Enzyme (1X) + phenol red………………………………...……24 
2.1.13 Dulbecco‟s Phosphate Buffered Saline (DPBS)……………………………...…..24 
2.1.14 Minimum Essential Medium Eagle (MEM)………………………………………25 
2.1.15 Penicillin-Streptomycin Antibiotics (Pen-Strep)………………………………….25 
2.1.16 Gentamicin Antibiotic Solution………………………………………….………..25 
2.1.17 Triton X………………………………………………………...……………...….25 
2.1.18 HEp-2 cell line……………………………………………………………….……26 
2.1.19 Hamilton Syringe Preparation…………………………………………………….26 
2.1.20 Galleria mellonella larvae storage and usage.........................................................26 
2.1.21 Genomic DNA extraction………………………………………………………....27 
2.1.22 1kbp ladder………………………………………………………………………...77 
2.1.23 QIAprep Spin Miniprep Kit (50)…………………………………………………77 
2.1.24 SOC Medium……………………………………………………………………..77 
v 
 
2.1.75 pAJD434………………………………………………………………………….77 
2.1.26 GenePulser Xcell electroporator system………………………………………….77 
2.1.77 Electroporation cuvette (2ml)…………………………………………………….77   
2.2 Methods and Procedures ………………………………………………...……….….28 
2.2.1 Inoculum (Initial dose) and dose Preparation using the plate count technique….…28 
2.2.2 Cell Line Growth and Maintenance……………………...……………………..….28 
2.2.3 Association and Invasion assays………………………………...…………………29 
2.2.4 Galleria infection assay……………………………………………………,,.…….33 
2.2.5 Monitoring of infected Galleria larvae………………...…………………....……..30 
2.2.6 Calculating the LD50………………………………………………………………..31 
2.2.7 Time To Death (Survival Curves)…………………………….…………….……...31 
2.2.8 PCR Reaction Preparation ………………………………………………….………31 
2.2.9 PCR Reaction……………………………………………………..……….………..37  
2.2.10  Amplified DNA analysis using agarose gel electrophoresis…………..………….32 
Chapter 3: Studying the Pathogenic Potential of Y. enterocolitica Biotypes in HEp-2 Cell 
Line and G. mellonella Insect Model…………………………………………………..33 
3.1 Introduction……………………………….……………..….………………………..34  
3.1.1 In vitro infection models for Y. enterocolitica Pathogenesis…………….…..….…34  
3.1.2 Mammalian Infection Models……………………………………………..……….35 
3.1.3 Insect Infection Model……………………………………………………….……..37 
3.2 Aim and Objectives……………………………...……………………………...……40  
3.2.1 Aim…………………………………………………………………………………40 
3.2.2 Objectives ………………………………………………………………….………40 
3.3 Materials & Methods…………………………………………………………………41 
3.3.1 Y. enterocolitica strains growth conditions…………………………………...……41 
3.3.2 Statistical analysis……………………………………………...…………………..41  
3.4 Results……………………………………………………………………….……….42 
3.4.1 Association and Invasion Results…………………………………………….…….42 
3.4.1.1 Association and Invasion results of the HEp-2 cell line infected with                                 
Y. enterocolitica strains pre-grown at 25°C……………………………….………..…….42 
3.4.1.2 Association and Invasion results of the HEp-2 cell line infected with                                  
Y. enterocolitica strains pre-grown at 37°C……………………………………...….……44 
vi 
 
3.4.2 Galleria mellonella Alternative Infection Model Results.........................................46  
3.4.2.1 Median Lethal Dose (LD50) Results………………………………..…………….46 
3.4.2.1.1 LD50 results of Y. enterocolitica strains pre-grown at 25°C…………...….……46 
3.4.2.1.2  LD50 results of Y. enterocolitica strains pre-grown at 37°C……………...…....48 
3.4.2.2 Survival Curves ………………...………………………………..………………50 
3.4.2.2.1 Survival curves of Galleria infected with strain YE5303………..………...…..50 
3.4.2.2.2 Survival curves of Galleria infected with strain YE8081 ……………………..53 
3.4.2.2.3 Survival curves of Galleria infected with strain YE14902 …………………....56  
3.4.2.2.4 Survival Curves of Galleria infected with strain Strain YE5603 ……………..59 
3.4.2.2.5 Survival curves of Galleria infected with strain YE21202………………….…62 
3.4.2.2.6 Survival curves of Galleria infected with strain YE1203…………...…………65 
3.2.2.2.7 Survival curves of Galleria infected with strain YE3094/96.………………….68 
3.5 Discussion…………………………...…………………………………….…………72 
3.6 Conclusion………………………………………………………………..…………..80 
Chapter 4:  Diverse Pathogenic Potential and in vivo Interaction of Y. enterocolitica 
Biotypes in Galleria……………………………………………………………………..81 
4.1 Introduction……………………...……………….…………………………………..82 
4.2 Aims………………………………...………………………………………………..83 
4.3 Materials and Methods…………………………………...…………………………..84 
4.3.1 Y. enterocolitica strains growth and Galleria infection procedures…….......….…..84 
4.3.2  Heat Killed Y. enterocolitica (HKY)…………………...………………………….85 
4.3.3 Infection Dynamics Work……………………………....……………………..……86 
4.3.3.1  Preparation of Y. enterocolitica electro-competent cells………………………....86 
4.3.3.2  Transformation  of Y. enterocolitica electro-competent cells…………………....86 
4.3.3.3  pAJD434 plasmid extraction………….…………………………………………..87 
4.3.3.4  PCR procedure……………………………………………………………...….…87 
4.3.3.5  Strains preparation and growth conditions……………….………………...……..88 
4.3.3.6  Infection and Bacterial Cells Recovery Procedures………………….……….…..88 
4.3.3.7 Statistical analysis………………………………………………………………….90 
4.4 Results………………………...………………………………………………...…..….90 
4.4.1 Results of the pathogenic effect of the Y. enterocolitica diverse trains………...……90 
4.4.1.1 Median Lethal Dose (LD50) Results……………………………...……………...…90 
vii 
 
4.4.1.2 Survival Curves………………………………...……………………..………….94  
4.4.1.2.1 Survival curves of Galleria infected with Bioserotype 4/O:3 Strains…..……...94 
A) Strains of Human Origin………………………………………...……………………94 
B) Non-Human Origin 4/O:3 Strains…………………………………………...………..97 
4.4.1.2.2 Survival curves of Galleria infected with biotype 1A strains……….…...……100 
4.4.1.2.3 Survival curves of Galleria infected with Serotype O:9 strains………………103 
4.4.1.2.4 Survival curves of Galleria infected with Serotype 3/O:5,27 strains…………106 
4.4.2 Heat Killed Y. enterocolitica (HKY)………………...…………………….……..109 
4.4.3 Electroporation  results……………………………………………………………109 
4.4.4 Infection Dynamics Results………………………………………………...……..111  
4.4.4.1 Infection dynamics of the low pathogenic biotypes Y. enterocolitica strains…..111 
4.4.4.2 Infection dynamics results of the high pathogenic strain 8081 (Bioserotype 
1B/O:8)………………………………………………………………………………….116 
4.4.4.3 Infection dynamics of the non-pathogenic strain 5303 (Bioserotype 1A/O:5)…118 
4.5 Discussion…………………………….…………..…………………………..…….120  
4.6 Conclusion……………………………….……………...………………..…………126  
Chapter 5: Investigating the pYV role in modulating the lack of virulence of the pathogenic 
biotypes in Galleria host model………………………………………………….……127 
5.1 Introduction……..…………………………………………………………………..128 
5.2 Aim……………………………………………………………………………….…130 
5.3 Objectives………………………………………………………………………...…130 
5.4 Materials and Methods……………………………………...…………………...….131 
5.4.1 Bacterial strains list……………………………………………...………………..131  
5.4.2 Primers list………………………………………………………………………...131 
5.4.3 pYV Plasmid curing procedure…………………………………………...……....132 
5.4.4 pYV plasmid Stability…………………………………………………………….132 
5.4.5 Statistical analysis………………………………………………………………...133 
5.5 Results………………………………………………………...………………….…134 
5.5.1 pYV curing………………………………………………………………………..134  
5.5.1.1 Gel electrophoresis image of pYV curing results…………………………........135 
5.5.1.2 The LD50 values of Y. enterocolitica pYV-cured strains…………..………..….136  
5.5.1.3 Survival Curves………………………...………………………………...……..138  
viii 
 
5.5.1.3.1 Survival curves of Galleria infected with the derivative strain 8081c……….139 
5.5.1.3.2 Survival curves of Galleria infected with the derivative strain 1203c…….…141 
5.5.1.3.3 Survival curves of Galleria infected with the derivative strain 14902c…........144 
5.5.2 Stability of  pYV dynamics during Galleria infection…………………………....147  
5.5.2.1 Gel electrophoresis results of checking the stability of the pYV plasmid……...148 
5.5.2.2 Gel electrophoresis results for detecting the 16S rDNA gene………………..…149 
5.7 Discussion……………………………………………...……………………….…..150  
5.8 Conclusion……………………………………………………………..……………153  
Chapter 6: Project Final Conclusion………………………………………………....154 
6.1 Project Final Conclusion……………………………………...………...…………..155 
6.2 Future Work…………………………………………...……...…………………….157 
Chapter 7: References…………………………………………………....…………....159 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
ACKNOWLEDGMENTS  
I would like to thank my leader of study Doctor Alan McNally for giving me the opportunity 
to carry out this PhD project under his supervision and for his excellent support, kind 
guidance and encouragement throughout the duration of my studies at NTU.  
Many thanks to my second supervisor Professor Graham Balls for his helpful guidance, 
assistance and support during this project.  Many thanks to Doctor Georgina Manning and I 
am very grateful for her assistance during my project approval period  and  her advice during 
the lab meetings.   
I am thankful and very grateful for the lab help and assistance provided by the great staff of 
School of Science and Technology namely Pam, Mike, Barbara, Andy, Nick, Steven, Iain, 
Aaron and all the rest of staff who provided their kind help behind the scenes.  
My sincere thanks to my fantastic colleagues in the pathogen group Fahad Alhashash, 
Abdulaziz Alqasim, Hall Miquette and Alya Redwan who I am so proud of their friendship 
and very grateful for their help and assistance.  
My thanks are extended to my friends and laboratory fellows Faisal Almajed, Jade Gouriet, 
Sandra, Abiyad, Gemma, Aldukali and Naqash for their nice company.   
A special thanks to my family. Words cannot express how grateful I am to them.  Without 
their kind support, patience and encouragement I wouldn‟t  be able to finish this work.  Many 
thanks to my sweet little daughter Rahaf and I wish her the best future.   
 
 
 
 
x 
 
Abbreviations 
 
Abbreviation Description  
Ail attachment-invasion locus 
Bla-A β-lactamase A enzyme  
Bla-B β-lactamase B enzyme 
BT Biotype 
C.F.U. colony forming unit formula  
CaCl2 Calcium Chloride  
CDs Coding Sequences  
CHO Chinese Hamster Ovary cell line 
CIN Cefsulodin  irgasan novobiocin agar 
cm centimetre  
CO2 Carbon dioxide  
CRMOX agar congo red-magnesium oxalate agar medium 
DAG diacylglycerol 
DMSO Dimethyl Sulfoxide solvent 
DNA Deoxyribonucleic acid 
dNTPs Deoxyribonucleotide triphosphate 
DPBS Dulbecco‟s Phosphate Buffered Saline  
FAE Follicle associated epithelium 
Fops flagellar outer proteins 
F-Primer Forward primer 
g gram 
HeLa human epithelial cell line  
HEp-2 human laryngitic epithelial cell line  
HKY heat killed Y. enterocolitica  
HPI High Pathogenicity Island  
inv gene encoding for Invasin protein  
Inv Invasin protein  
Kbp Kilo base pair  
kDa Kilo Dalton  
xi 
 
L Litre   
LB Agar Luria-Bertani Agar 
LB Broth Luria-Bertani Broth 
Lcr low calcium response  
LD50 The median lethal doses 
Log Logarithm  
LPS Lipopolysaccharides  
M Molar 
M.O.I. Multiplicity of infection 
Mb Mega base  
M-cells Microfold cell 
MEM Minimum Essential Medium Eagle  
Mg
2+
 Magnesium Cation 
MgCl2 Magnesium Chloride  
ml millilitre  
mm millimetre   
mm millimetre  
mM millimolar  
Myf Mucoid Yersinia factor  
Na2C2O4 Sodium Oxalate 
NaCl Sodium chloride  
ng nanogram  
nm nanometre  
O-antigen Outer antigen  
OD optical density  
p.i. post infection 
PAI Pathogenicity islands  
PBS Phosphate Buffered Saline  
PCR Polymerase Chain Reaction  
PG phylogroups  
PLCs Phospholipases  
PMNs polymorphonuclear leukocytes 
Pmol picomole  
xii 
 
PP Peyer‟s Patches  
pYV Plasmid of Yersinia Virulence    
rpm rounds per minute  
R-Primer Reverse Primer 
rRNA ribosomal ribonucleic acid 
SC species complexes 
sdH2O sterile distilled water 
sec seconds 
Subsp subspecies 
Syc Specific yop chaperone 
T2SS type II secretion system 
T3SS type III secretion system 
tc Insecticidal toxin genes 
Tc Toxin complex 
tc-PAI
Ye
 tc pathogenicity island of Y. enterocolitica 
TSA Tryptone Soy Agar 
UV light ultraviolet light 
VirF Virulence regulon transcriptional activator   
YadA Yersinia adhesin A     
Ybt Yersiniabactin 
YGT Yersinia genus type three secretion system  
Yop Yersinia outer membrane proteins 
YplA The phospholipase protein 
Ysa Yersinia secretion apparatus                                            
YSA PI Yersinia secretion apparatus pathogenicity island 
Ysc Yop secretion 
Ysps Yersinia secreted proteins 
YST Yersinia stable toxins 
Yts1 Yersinia type II secretion 1 
Yts2 Yersinia type II secretion 2 
α alpha  
β beta 
γ-proteobacteria Gammaproteobacteria 
xiii 
 
λ lambda 
μg microgram  
μl microliter  
μM micromolar  
–ve control negative control 
+ve control positive control                                              
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiv 
 
List of figures 
Chapter 3  
Fig 3.1: Association and Invasion results of the HEp-2 cell line infected with Y. enterocolitica 
strains pre-grown at 25°C……………………………………………………………….……43 
Figure 3.2: Association and Invasion results of the HEp-2 cell line infected with                    
Y. enterocolitica strains pre-grown at 37°C...………………………………………………..45 
Figure 3.3: LD50 results of Y. enterocolitica strains pre-grown at 25°C…………….……….47  
Figure 3.4: LD50 results of Y. enterocolitica strains pre-grown at 37°C…………….…….…49   
Figure 3.5: Survival curves of Galleria infected with strain YE5303 (BT 1A/O:5)………...51 
Figure 3.5a: Survival curve of Galleria incubated at 37°C and infected with strain YE5303 
(BT 1A/O:5) pre-grown at 25°C  …………………………………………………....………51  
Figure 3.5b: Survival curve of Galleria incubated at 25°C and infected with  strain YE5303 
(BT 1A/O:5) pre-grown at 25°C ………………………….…………..…………………..…51  
Figure 3.5c: Survival curve of Galleria incubated at 37°C and infected with strain YE5303 
(BT 1A/O:5) pre-grown at 37°C …………………………………….…………..….……….52 
Figure 3.5d: Survival curve of Galleria incubated at 25°C and infected with strain YE5303 
(BT 1A/O:5) pre-grown at 37°C ……………………………………….……………………52 
Figure 3.6: Survival curves of Galleria infected with strain YE8081 (BT 1B/O:8)………...54 
Figure 3.6a: Survival curve of Galleria incubated at 37°C and infected with strain YE8081 
(BT 1B/O:8) pre-grown at 25°C …………………..………….……………………………...54 
Figure 3.6b: Survival curve of Galleria incubated at 25°C and infected with strain YE8081 
(BT 1B/O:8) pre-grown of 25°C …………………………………….…………….….……..54 
Figure 3.6c: Survival curve of Galleria incubated at 37°C and infected with strain YE8081 
(BT 1B/O:8) pre-grown at 37°C ……………………………….……..……………………...55 
Figure 3.6d: Survival curve of Galleria incubated at 25°C and infected with strain YE8081 
(BT 1B/O:8) pre-grown at 37°C ………….………..……………………………………...…55 
Figure 3.7: Survival curves of Galleria infected with strain YE14902 (BT 3/O:5,27)……...57 
Figure 3.7a: Survival curve of Galleria incubated at 37°C and infected with strain YE14902 
(BT 3/O:5,27) pre-grown at 25°C …………………………………………………………...57 
Figure 3.7b: Survival curve of Galleria incubated at 25°C and infected with strain YE14902 
(BT 3/O:5,27) pre-grown at 25°C…………………………………………….…………...…57 
Figure 3.7c: Survival curve of Galleria incubated at 37°C and infected with strain YE14902 
(BT 3/O:5,27) pre-grown at 37°C ………………………………………………………...…58 
Figure 3.7d: Survival curve of Galleria incubated at 25°C and infected with strain YE14902 
(BT 3/O:5,27) pre-grown at 37°C..........................................................................................58 
xv 
 
Figure 3.8: Survival curves of Galleria infected with strain YE5603 (BT 3/O:9)…..………60  
Figure 3.8a: Survival curve of Galleria incubated at 37°C and infected with strain YE5603 
(BT 3/O:9) pre-grown at 25°C …………………………………………………….………...60 
Figure 3.8b: Survival curve of Galleria incubated at 25°C and infected with strain YE5603 
(BT 3/O:9) pre-grown at 25°C ……………………………………………….………….…..60 
Figure 3.8c: Survival curve of Galleria incubated at 37°C and infected with strain YE5603 
(BT 3/O:9) pre-grown at 37°C …………………………………….………………………...61 
Figure 3.8d: Survival curve of Galleria incubated at 25°C and infected with strain YE5603 
(BT 3/O:9) pre-grown at 37°C ………………………………………………….…...………61 
Figure 3.9: Survival curves of Galleria infected with strain YE21202 (BT 2/O:9)….……..63 
Figure 3.9a: Survival curve of Galleria incubated at 37°C and infected with strain YE21202 
(BT 2/O:9) pre-grown at 25°C …………………………………….………………………...63 
Figure 3.9b: Survival curve of Galleria incubated at 25°C and infected with strain YE21202 
(BT 2/O:9) pre-grown at 25°C …………………………….………………………………...63 
Figure 3.9c: Survival curve of Galleria incubated at 37°C and infected with strain YE21202 
(BT 2/O:9) pre-grown at 37°C ………………………….…………………………………...64 
Figure 3.9d: Survival curve of Galleria incubated at 25°C and infected with strain YE21202 
(BT 2/O:9) pre-grown at 37°C …………………………………….………………………...64 
Figure 3.10: Survival curves of Galleria infected with strain 1203 (BT 4/O:3)………..…...66 
Figure 3.10a: Survival curve of Galleria incubated at 37°C and infected with strain YE1203 
(BT 4/O:3) pre-grown at 25°C ………………………………………….…………………...66 
Figure 3.10b: Survival curve of Galleria incubated at 25°C and infected with strain YE1203 
(BT 4/O:3) pre-grown at 25°C …………………………….………………………………...66 
Figure 3.10c: Survival curve of Galleria incubated at 37°C and infected with strain YE1203 
(BT 4/O:3) pre-grown 37°C….……………………….……………………………………...67 
Figure 3.10d: Survival curve of Galleria incubated at 25°C and infected with strain YE1203 
(BT 4/O:3) pre-grown at 37°C ……………….……………………………………………...67 
Figure 3.11: Survival curves of Galleria infected with strain YE3094/96 (BT 5/O:2a)…….69 
Figure 3.11a: Survival curve of Galleria incubated at 37°C and infected with strain 
YE3094/96 (BT 5/O:2a) pre-grown at 25°C ……………….…………………………..……69 
Figure 3.11b: Survival curve of Galleria incubated at 25°C and infected with strain 
YE3094/96 (BT 5/O:2a) pre-grown at 25°C …….………………………………………..…69 
Figure 3.11c: Survival curve of Galleria incubated at 37°C and infected with strain 
YE3094/96 (BT 5/O:2a) pre-grown at 37°C..…………………………………..……………70 
Figure 3.11d: Survival curve of Galleria incubated at 25°C and infected with strain 
YE3094/96 (BT 5/O:2a) pre-grown at 37°C ……………………..………………………….70 
xvi 
 
Chapter 4  
Figure 4.1: LD50 results of infecting Galleria mellonella larvae with 23 Y. enterocolitica 
diverse strains pre-grown at 25°..…………………………………..…………………….…..93 
Figure 4.2: Survival curves of Galleria infected with BT 4/O:3 human origin strains ……..95 
Figure 4.2a: Survival curve of Galleria infected with the human origin strain Y1 (BT 4/O:3) 
………………………...………………………………………………………….…………..95 
Figure 4.2b: Survival curve of Galleria infected with the human origin strain YE0303 (BT 
4/O:3) ……………………………….……………………………………………...…….….95 
Figure 4.2c: Survival curve of Galleria infected with the human origin strain YE01/2012 (BT 
4/O:3) …………………………….…………………………….………………………...….96 
Figure 4.2d: Survival curve of Galleria infected with the human origin strain YE02/2012 (BT 
4/O:3) …………………………….……………………………………………...…………..96 
Figure 4.3: Survival curves of Galleria infected with BT 4/O:3 human origin strains …..…98 
Figure 4.3a: Survival curve of Galleria infected with the non-human origin strain YE204/02 
(BT 4/O:3) …………………………..…………….……………………………...………….98 
Figure 4.3b: Survival curve of Galleria infected with the non-human origin strain NZ15 (BT 
4/O:3) …………………………….……………………………………...………………..…98 
Figure 4.3c: Survival curve of Galleria infected with the non-human origin strain YE213/02 
(BT 4/O:3)……………………………………...………………………….……..…………..99 
Figure 4.3d: Survival curve of Galleria infected with the non-human origin strain YE201/02 
(BT 4/O:3) ……………………………..……………….……………………...………….…99 
Figure 4.4: Survival curves of Galleria infected with BT 1A strains …….……………..…101   
Figure 4.4a: Survival curve of Galleria infected with the strain YE3403 (BT 1A/O:5)…...101 
Figure 4.4b: Survival curve of Galleria infected with strain YE0903 (BT 1A/O:6,30)....…101 
Figure 4.4c: Survival curve of Galleria infected with strain YE3503 (BT 1A/O?).....……101 
Figure 4.4d: Survival curve of Galleria infected with strain NZ3 (BT 1A/O?)...…………102 
Figure 4.4e: Survival curve of Galleria infected with strain YE0902 (BT 1A/O?)...…..…102 
Figure 4.5: Survival curves of Galleria infected with Serotype O:9 strains.………………104   
Figure 4.5a: Survival curve of Galleria infected with the strain YE5803 (BT 3/O:9).……104 
Figure 4.5b: Survival curve of Galleria infected with strain YE2403 (BT 3/O:9).………..104 
Figure 4.5c: Survival curve of Galleria infected with strain YE119/02 (BT 2/O:9).…......104 
Figure 4.5d: Survival curve Galleria infected with strain NZ3 (BT 3/O:9)……….……….105 
Figure 4.5e: Survival curve of Galleria infected with strain YE218/02 (BT 3/O:9)……….105 
Figure 4.6: Survival curves of Galleria infected with BT 3/O:5,27 strains ………………..107   
xvii 
 
Figure 4.6a: Survival curve of Galleria infected with the strain YE232/02 (BT 3/O:5,27)..107  
 Figure 4.6b: Survival curve of  Galleria infected with strain YE231/02 (BT 3/O:5,27).....107 
Figure 4.6c: Survival curve of Galleria infected with strain YE111/02 (BT 3/O:5,27).…...107 
Figure 4.6d: Survival curve Galleria infected with strain YE153/02  (BT 3/O:5,27)….…..108 
Figure 4.6e: Survival curve of Galleria infected with strain YE226/02 (BT 3/O:5,27)……108 
Fig 7.4 Gel electrophoresis results of checking the pAJD434 plasmid transformation…….110   
Figure 4.7a:  Gel image of extracting the pAJD434 plasmid from the electro-transformed      
Y. enterocolitica strains and from the control strain E. coli DH5α………………………....110 
Figure 4.7b: Gel image of detecting the trimethoprim gene located on the pAJD434 plasmid 
by PCR amplification……………………………………………………………………….110  
Figure 4.8: Infection dynamics results of Y. enterocolitica low pathogenic biotypes 
strains……………………………………………………………………………...………..114 
Figure 4.8a: Infection dynamics results of the low pathogenic 1203 strain of bioserotype 
4/O:3……………………………………………………………………….………………..114 
Figure 4.8b: Infection dynamics results of the low pathogenic 14902 strain of bioserotype 
3/O:5,27……………………………………………………………………………………..114 
Figure 4.8c: Infection dynamics results of the low pathogenic strain 21202 of bioserotype 
2/O:9…………………………………………………………………………………..…….115 
Figure 4.9: Infection dynamics results of the high pathogenic 8081 strain of bioserotype 
1B/O:8………………………………………………………………………………………117 
Figure 4.10: Infection dynamics results of the non-pathogenic 5303 strain of bioserotype 
1A/O:5………………………………………………………………………………………119 
 
Chapter 5  
 
Figure 5.1: Gel electrophoresis images of pYV curing results…………….………..…..….135  
Figure 5.1a: Gel image of checking the pYV plasmid curing by detecting the Y. enterocolitica 
yscP gene of the 3 pYV-cured Y. enterocolitica strains YE8081c, YE1203c and 
YE14902c………………………………………………………………………………...…135 
Figure 5.1b: Gel image of detecting the Y. enterocolitica 16S rDNA gene of the 3 pYV-cured 
Y. enterocolitica strains YE8081c, YE1203c and YE14902c………………………....……135 
Figure 5.2: LD50 values of pYV-cured strains…………………….………………….…….137 
Figure 5.3: Survival curves of Galleria infected with the derivative strain 8081c & the wild 
type 8081 strain ………………………….……………………………………...……….…138 
xviii 
 
Figure 5.3a: Survival curve of Galleria incubated at 37°C and infected with the pYV-cured 
derivative strain 8081c…………...………….………………..…………………………….139 
Figure 5.3b: Survival curve of Galleria incubated at 37°C and infected with the pYV
+
 wild 
type  strain 8081...……………………….………………………………………………….139 
Figure 5.3c: Survival curve of Galleria incubated at 25°C and infected with of the pYV-cured 
derivative strain 8081c ………………………………………………………………….….140 
Figure 5.3d: Survival curve of Galleria incubated at 25°C and infected with of the pYV
+
 wild 
type strain 8081………………………………………………………………………….….140 
Figure 5.4: Survival curves of Galleria infected with the derivative strain  1203c & the wild 
type 1203 strain …………………………..………………………………………..….……142 
Figure 5.4a: Survival curve of Galleria incubated at 37°C and infected with of the pYV-cured 
derivative strain 1203c ……………………………………………….……………….……142 
Figure 5.4b: Survival curve of Galleria incubated at 37°C and infected with the pYV
+
 wild 
type strain 1203……………………………………………………….……………….……142 
Figure 5.4c: Survival curve of Galleria incubated at 25°C and infected with the pYV-cured 
derivative strain 1203c…………….………………….…………………….………………143 
Figure 5.4d: Survival curve of Galleria incubated at 25°C and infected with of the pYV
+
 wild 
type strain 1203 ………………………...…………….…………………….………………143 
Figure 5.5: Survival curves of Galleria infected with the derivative strain 14902c & the wild 
type 14902 strain ……………...……..……………………………………………..………145 
Figure 5.5a: Survival curve of Galleria incubated at 37°C and infected with the pYV-cured 
derivative strain 14902c………...…………………….…………………………….………145 
Figure 5.5b: Survival curve of Galleria incubated at 37°C and infected with the pYV
+
 wild 
type strain 14902..………………………….……………………………………….………145 
Figure 5.5c: Survival curve of  Galleria incubated at 25°C and infected with the pYV-cured 
derivative strain 14902c………...…………………….…………………………….………146 
Figure 5.5d: Survival curve of Galleria incubated at 25°C and infected with the pYV
+
 wild 
type strain 14902..………………………….……………………………………….………146 
Figure 5.6: Gel electrophoresis results of checking the stability of the pYV 
plasmid…………………………………………………………………………….………..148   
Figure 5.6a: Gel image of detecting the yscP gene of the tested Y. enterocolitica strains at 24h 
post infection…………………………………………………………………….....……….148 
Figure 5.6b: Gel image of detecting the yscP gene of the tested Y. enterocolitica strains at 7h 
post infection……………………………………………………………………..…..……..148 
Figure 5.6c: Gel image of detecting the yscP gene of the tested Y. enterocolitica strains at 
120h post infection…………………………………………………………...………….….148 
Figure 5.7: Gel electrophoresis results for detecting the 16S rDNA gene………………….149 
xix 
 
Figure 5.7a: Gel image of detecting the 16S rDNA gene of the tested Y. enterocolitica strains 
at 24h post infection………………………………………………………………………...149 
Figure 5.7b: Gel image of detecting the 16S rDNA gene of the tested Y. enterocolitica strains 
at 72h post infection…………………...………………………………………………..…..149 
Figure 5.7c: Gel image of detecting the 16S rDNA gene of the tested Y. enterocolitica strains 
at 120h post infection…………………………..……………………………..…………….149   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xx 
 
List of Tables 
Chapter 1  
Table 1.1: Table from Białas et al.,( 2012) of biotyping scheme for Y. enterocolitica 
(modified from Bottone (1999))…………………….…………………………………………4 
Table 1.2: Table adapted from Tennant et al., (2003). Table shows relationship between 
biotype, O serotype, and pYV carriage of Y. enterocolitica……………..……………………5 
Chapter 2 
Table 2.1: Bacterial strains used in this study...………………..…………………………….19 
Table 2.2: CRMOX reagents and preparation procedure……………………...………..……22 
Table 2.3:  PCR reagents and their volumes and concentrations……………………..…..….31 
Chapter 3  
Table 3.1: Bacterial strains used in chapter 3………..……………………………....……….41 
Chapter 4 
Table 4.1: Bacterial strains used in chapter 4.…………………………………………………..…84 
Table 4.2: PCR primers…………………….………..……...………..…………..……………88 
Chapter 5 
Table 5.1: Bacterial strains tested in chapter 5……………..…………..……………..…….131 
Table 5.2: PCR Primers……………………………………………………………….…….131 
 
 
 
 
 
1 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
Introduction  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
1.1 The Genus Yersinia Classification and Characteristics: 
       
The genus Yersinia belongs to the family Enterobacteriaceae and includes Gram-negative, 
rod shaped bacteria (Carniel  et al., 2006).  Species of the genus Yersinia are non spore-
forming bacteria with a shape ranging from rod to coccobacilli (Fredriksson-Ahomaa, 
2007a). Biochemical identification tests and DNA-DNA hybridization are the main 
techniques used to subtype within the Yersinia genus species (Sulakvelidze et al., 2000).   All 
the Yersinia species are oxidase-negative, catalase-positive and facultative anaerobic bacteria 
(Fredriksson-Ahomaa, 2007a).  Currently, the Yersinia genus includes 17 species (Savin et 
al., 2012) of which only three species are pathogenic to humans and animals, Y. pestis, Y. 
pseudotuberculosis and Y. enterocolitica (Fuchs et al., 2011).  Y. pestis is the aetiological 
agent of bubonic and pneumonic plague (or the Black Death) which is transmitted by flea 
vectors (Perry et al., 1997), while Y. pseudotuberculosis and Y. enterocolitica are 
enteropathogens acquired by the consumption of spoiled food and contaminated water 
(Zhang et al., 2008). The remaining 14 species are considered avirulent to humans and these 
species are Y. aldovae, Y. bercovieri, Y. frederiksenii, Y. intermedia, Y. kristensenii, Y. rohdei, 
Y. mollaretii, Y. ruckeri, Y. aleksiciae, Y. entomophaga, Y. massiliensis, Y. nurmii, Y. 
pekkanenii and Y. similis (Fuchs et al., 2011). The final six species were recently added to the 
genus Yersinia (Fernandez et al., 2007).  The species Y. ruckeri is characterised as a fish 
pathogen causing enteric red mouth disease (Fernandez et al., 2007) and the species Y. 
entomophaga is an insect pathogen (von Tils et al.,2012).   
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1.2 Y. enterocolitica Biotypes:          
Y. enterocolitica is a zoonotic pathogen that has been identified as a major cause of bacterial 
gastrointestinal disease in many developed and developing countries around the world 
(Rahman et al., 2011) and is the third most common cause of food-borne gastrointestinal 
disease in Europe (Fredriksson-Ahomaa et al.,2007b). Y. enterocolitica is a well known food- 
borne pathogen (Fredriksson-Ahomaa and Korkeala,2003) and is ubiquitous in domestic and 
wild animals (Kot et al.,2005).  Pigs are considered to be the major source of                         
Y. enterocolitica human infections (Laukkanen-Ninios et al.,2014).  Y. enterocolitica is a 
gram-negative, short rod or coccobacilli bacteria with a length of 0.5–1-2μm.                           
Y. enterocolitica are non-spore forming, facultative anaerobes which can survive in a wide 
range of temperatures from 0°C to 45°C.  The optimal growth temperature is from 22 to 29°C  
(Zadernowska et al., 2013).  Y. enterocolitica is a highly heterogeneous species (Tennant et 
al., 2003; Virdi & Sachdeva, 2005) and is classified into six biotypes on the basis of 
biochemical characteristics (Singhal et al., 2014) described in table 1.1. These biotypes are 
1A, 1B, 2, 3, 4 & 5.  These six biotypes are further classified into three groups (non-
pathogenic biotype 1A, the high pathogenic biotype 1B and the low pathogenic biotypes 2, 3, 
4 and 5) depending on their pathogenicity towards the mouse animal infection model 
(Bottone, 1999; Lepka and Wilharm, 2010).  Recent phylogenomic analysis of                      
Y. enterocolitica revealed that species is also genetically heterogeneous and diverse (Reuter 
et al., 2014).  Y. enterocolitica biotypes were phylogenetically classified into two species 
complexes (SC) according to a phylogenetic tree that was constructed depending on core 
genes common to the whole Yersinia genus. This approach classified the Y. enterocolitica 
biotypes into two separate SCs which are SC6 and SC7.  SC6 complex contains the high 
pathogenic biotype 1B and the non-pathogenic biotype 1A, while the SC7 complex includes 
the four low pathogenic biotypes 2, 3, 4 & 5.  Another phylogenetic tree based on core 
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genome SNPs of the Y. enterocolitica species revealed that Y. enterocolitica forms six 
distinctive lineages called phylogroups (PG) 1-6. PG1 contains biotype 1A, PG2 contains 
biotype 1B, PG3 contains bioserotype 4/O:3, PG4 includes bioserotypes 2/O:5,27 and 
3/O:5,27, PG5 includes bioserotypes 2/O:9 and 3/O:9 while PG6 contains biotype 5 (Reuter 
et al., 2014).  The first complete Y .enterocolitica genome was published in 2006 of the high 
pathogenic biotype 1B/O:8 strain 8081 (Thomson et al., 2006). Later, other genome drafts 
were sequenced from other strains representing a number of Y. enterocolitica low pathogenic 
biotypes (Batzilla et al., 2011a; Fuchs et al., 2011; Wang et al., 2011).  The genome size of  
Y. enterocolitica biotypes ranges from 4.5Mb to 4.9Mb.  The genome size of all low 
pathogenic biotypes is   4.5Mb and  4.6Mb for the high-pathogenic biotype while the genome 
size of the non-pathogenic biotype is around 4.9Mb.  The low pathogenic biotype 4 genome 
has the lowest number of coding sequences (CDSs) while the non-pathogenic biotype 1A 
include the largest number of CDSs (Reuter et al., 2012). Y. enterocolitica pathogenicity is 
strongly related to the bioserotypes of this bacterium (Rahman et al., 2011).   
Table 1.1: Table from Białas et al.( 2012) of biotyping scheme for Y. enterocolitica (modified from Bottone, 1999) 
Biochemical 
Reaction 
           Reactions in different Y. enterocolitica biotypes 
     1A      1B       2        3       4       5 
Inositol 
fermentation 
+        +        +        +        +        + 
Salicin 
fermentation 
       +        -        -        -        -        - 
Sorbose 
fermentation 
       +        +        +        +        +        - 
Trehalose 
fermentation 
       +        +        +        +        +        - 
Ornithine 
decarboxylase 
activity 
       +        +        +        +        +        + 
Lipase activity 
 
       +        +        -        -        -        - 
Pyrazinamidase 
activity 
       +        -        -        -        -        - 
Nitrate reduction        +        +        +        +        +        - 
Esculin 
hydrolysis 
     +/-         -        -        -       -        - 
+: (activity present) ; -: (activity absent) 
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1.3 Y. enterocolitica Serotypes: 
The Y. enterocolitica species includes about 70 serotypes (Garzetti et al., 2012; Pajunen et 
al., 2001).  The serotypes are characterised  according to the variable structure of the outer 
membrane O-antigen (Simonova et al., 2007) using serological tests )Saleh et al., 2012).   
Among those 70 serotypes, only serotypes O:3, O:9 , O:8 and O:5,27 are found to be 
pathogenic to humans (Chart & Cheasty, 2006; Saleh et al., 2012).  However, the precise 
detection of pathogenic Y. enterocolitica isolates requires the characterization of both the 
biotype and serotype of the isolated strain.  Most Y. enterocolitica strains found in human 
clinical cases belong to 4/O:3, 1B/O:8, 2/O:5,27, 2/O:9 and 3/O:3 (Rahman et al., 2011; 
Schaake et al., 2013).  Serotypes O:3, O:9 and O:5,27 were found to be the most dominant  in 
Europe (Chart & Cheasty, 2006) while serotype O:8 is the most predominant in North 
America (Schaake et al., 2013).  Table 1.2 illustrates major serotypes of Y. enterocolitica.  
 
Table 1.2 Adapted from Tennant et al. (2003) Table shows relationship between biotype, O serotype, and 
pYV carriage of Y. enterocolitica 
Biotype                                                  Serotypes  
   1A O:4; O:5; O:6,30; O6,31; O:7,8; O:7,13; O:10; O:14; O:16; O:21; O:22; 
O:25; O:37; O:41,42; O:46; O:47; O:57; NT
a 
   1B O:4,32
b
 ; O:8
b
 ; O:13a,13b
b
 ; O:16; O:18
b
 ; O:20
b
 ; O:21
b
 ; O:25; O:41,42; 
NT
a
 
    2 O:5,27
b
 ; O:9
b
 ; O:27 
    3 O:1,2,3
b
 ; O:3
b
 ; O:5,27
b
 
    4 O:3
b
 
    5 O:2,3
b
  
a
NT: not typable.        
b
Serotypes which include strains that carry pYV.    
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1.4 Y. enterocolitica virulence factors 
Y. enterocolitica virulence factors are encoded by both the chromosome and the pYV plasmid 
(Paixão et al., 2013).  The pathogenic biotypes (1B, 2, 3, 4 and 5) are considered to be 
pathogenic due to their acquisition of major virulence factors such as the Yersinia virulence 
70kb sized pYV plasmid (Cornelis et al., 1998) which is completely absent from the non-
pathogenic biotype 1A strains (Sabina et al., 2011). The pYV plasmid encodes for major 
virulence factors such as the Yersinia type three secretion system (Ysc), the Yersinia outer 
proteins (Yops) and the Yersinia adhesion protein A (YadA).  Y. enterocolitica high 
pathogenic biotype 1B strains exclusively harbour additional chromosomally encoded 
virulence determinants such as the High Pathogenicity Island (HPI) and the Ysa T3SS 
(Bhagat & Virdi, 2007; Sabina et al., 2011). These are discussed in more details below:  
 
1.4.1 pYV plasmid encoded virulence factors  
1.4.1.1 The Ysc Type Three Secretion System Injectisome:  
The Ysc (for Yop secretion) is a type three secretion system (T3SS) found in all human 
Yersinia species and encoded by the Yersinia virulence pYV plasmid (Cornelis et al., 1998).  
Ysc is considered the major virulence factor responsible for Y. enterocolitica pathogenesis. 
The Ysc injectisome is a bacterial organelle which is synthesised and assembled when Y. 
enterocolitica encounters temperatures of 37°C. The Ysc secretion system is composed of 
two main parts which are the basal body, spanning both the inner and outer bacterial 
membranes in addition to the periplasmic peptidoglycan layer, and the needle-like structure 
located on the top of the basal body and extends to outside of the cell.  (Broz et al., 2007; 
Mueller et al., 2008).  These parts of the Ysc injectisome are made from number of structural 
proteins encoded by the pYV plasmid. Proteins YscC, YscD, YscJ YscI YscN, YscK, YscL, 
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YscQ, YscR, YscS, YscT, YscU and YscV form the basal body part while  proteins YscF, 
YscO, YscP, YscU, YscV, YscX, YscY and YopR build up the injectisome needle (Dewoody 
et al., 2013; Cornelis, 2010).  
 
1.4.1.2 The Secreted Yop proteins:  
The Ysc injectisome acts as a protein pump to secrete a number of proteins called Yop 
proteins (for Yersinia outer proteins) (Cornelis, 2002).  At least six of the secreted Yops 
called effector Yop proteins which are YopH, YopE (Grosdent et al., 2002; Trosky et al., 
2008), YopM (Viboud and Bliska, 2005), YopT (Trulzsch et al., 2004), YopO (also called 
YpkA in Y .pestis and Y. pseudotuberculosis) (Grosdent et al., 2002; Juris et al., 2000)  and 
YopP (also called YopJ in Y. pseudotuberculosis and Y. pestis); (Denecker et al., 2002).  
These effector Yop proteins are toxic proteins injected into the cytosol of the target 
eukaryotic cell causing the disruption of signal transduction pathways (Lee et al., 2000) and 
actin cytoskeleton dynamics (Cornelis, 2002) leading to cellular apoptosis (Lee et al., 2000).  
These cellular alterations inhibit the phagocytosis ability of many phagocytes including 
macrophages, polymorphonuclear leukocytes (Cornelis, 2002) and dendritic cells (Koberle et 
al., 2009). This enables the Y. enterocolitica pathogenic strains to escape killing by the 
immune system (Koberle et al., 2009). The secretion of the Yop proteins to the external 
milieu is controlled by a protein complex called the “Calcium Block” made of the proteins 
YopN-TyeA-YscB-SycN.  This YopN-TyeA-YscB-SycN plug blocks the passage of the 
synthesized Yop proteins through the injectisome secretion channel in the presence of a high 
Calcium (Ca
2+
) concentration and the absence of contact with the eukaryotic cells. Yop 
secretion occurs once the Y. enterocolitica cells induce contact with eukaryotic cells and Ca
2+
 
levels drop (Dewoody et al., 2013).  The Ysc injectisome secretes the pore forming 
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translocator proteins YopB, YopD and LcrV which are required to translocate the secreted 
effector proteins into the cytosol of the target eukaryotic cell by forming a pore on the target 
host cell (Broz et al., 2007; Mueller et al., 2008).   
 
1.4.1.3 Syc Chaperones  
Yop protein secretion is assisted by another group of proteins called Syc chaperones (Syc for 
Specific yop chaperone); (Schmid et al., 2006). These chaperones are classified into Class I 
chaperones, class II chaperones and class III chaperones.   Chaperones of Class I interact with 
the effector proteins, chaperones in class II interact with the translocator proteins and 
chaperones of class III interact with T3SS needle constituents (Schreiner and Niemann, 
2012).  Each chaperone interacts with its specific partner of the Yop proteins (Fàbrega and 
Vila, 2012).  The Syc proteins discovered up to date are SycD chaperone which binds to both 
of the YopB and YopD translocator proteins, SycE chaperone which binds to the YopE 
effector protein, SycH chaperone binds to the YopH effector protein, the SycT chaperone 
which is specific for the YopT protein and the SycN chaperone which specifically bind to the 
YopN protein (Cornelis et al., 1998; Fàbrega and Vila., 2012).   
 
1.4.1.4 Yersinia adhesin A (YadA) 
The yadA gene is located on the pYV plasmid of the pathogenic species Y. pestis,                  
Y.  pseudotuberculosis and Y. enterocolitica and it encodes the Yersinia adhesin A (YadA) 
protein. YadA is an adhesion protein and it is characterised as a significant virulence factor of 
Y. enterocolitica (Schutz et al., 2010) while in Y. pseudotuberculosis YadA protein is not 
essential in virulence. YadA is not expressed in Y. pestis due to a frameshift mutation 
9 
 
silencing the yadA gene (El Tahir and Skurnik, 2001; Mikula et al., 2013) turning it into a 
pseudogene (Mikula et al., 2013). YadA protein is expressed at 37°C via the action of the 
transcription regulator protein VirF (Biedzka-Sarek et al., 2008; El Tahir and Skurnik, 2001).  
The main function of YadA is to bind to extracellular matrix molecules such as collagen, 
laminin and fibronectin.  YadA binds very efficiently to collagen but with less affinity to 
laminin and fibronectin (El Tahir and Skurnik, 2001).   YadA possess other functions like 
mediating autoagglutination (Mikula et al., 2013) and serum resistance (Mikula et al., 2013; 
Schutz  et al., 2010). 
1.4.2 Y. enterocolitica chromosomally encoded virulence factor 
1.4.2.1 Yersinia secretion apparatus (Ysa)   
The Y. enterocolitica high pathogenic 1B/O:8 strains exclusively possess an extra secretion 
system called the Yersinia secretion apparatus (Ysa); (Venecia and Young, 2005). Ysa 
secretion system is a type three secretion system (T3SS); (Young and Young, 2002a) which 
is distinct from the well-studied Ysc T3SS and works independently from it, but the role of 
the Ysa T3SS in pathogenesis is still ambiguous (Venecia and Young, 2005).  The Ysa T3SS 
system is encoded by a unique chromosomal locus called the Yersinia secretion apparatus 
pathogenicity island (YSA PI) which is only present in the chromosome of the high 
pathogenic biotype 1B Y. enterocolitica strains. The Ysa T3SS secretes extracellular effector 
proteins called Yersinia secreted proteins (for Ysps) into the cytosol of eukaryotic cells 
encoded by the ysa locus genes (Walker and Miller, 2009).  The Ysa secretion apparatus have 
been found, so far, to secrete about 16 Ysp proteins which are  YspB, YspC, YspD, YspG, 
YspH, YspJ, YspA, YspE, YspF, YspI, YspK, YspL, YspM, YspN, YspP and YspY 
(Fàbrega and Vila, 2012).  Part of these proteins build up the tranlocon apparatus and the 
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others act as effectors in the host cells (Fàbrega and Vila, 2012; Matsumoto and Young, 
2005).  
 
1.4.2.2 Y. enterocolitica Type 2 Secretion System (T2SS) 
The T2SS is not a very well characterized secretion system in the Genus Yersinia, compared 
to the well-studied Yersinia type three secretion systems (von Tils et al., 2012).  Two distinct 
types of T2SS have been so far identified in Yersinia species which are Yts1 (for Yersinia 
type II secretion 1) and Yts2 (for Yersinia type II secretion 1) (Iwobi et al., 2003).  Yts1 is 
found in the Y. enterocolitica high pathogenic biotype 1B/O:8 strains and Yts2 is present in 
all Y. enterocolitica biotypes (Shutinoski et al., 2010).  In Y. enterocolitica, the Yts1 and Yts2 
T2SSs are encoded on the chromosome and their genes occur in clusters.  Yts1 was the first 
characterised T2SS by Iwobi et al. (2003) in the high pathogenic biotype 1B/O:8 strain WA-
314 (von Tils et al., 2012)  and  located in the chromosomal plasticity zone (Iwobi et al., 
2003; von Tils et al., 2012) while the structure and function of Yst2 T2SS is still not very 
well characterized (von Tils et al., 2012).   
 
 
 
1.4.2.3 Y. enterocolitica Flagella and motility 
Y. enterocolitica is a motile bacterium which exhibits peritrichously distributed flagella for 
swimming and swarming motility (Young et al., 1999). Y. enterocolitica, along with Y. 
pseudotuberculosis, are the only human pathogenic motile members of the Genus Yersinia by 
which Y. pestis is non-motile due to a frameshift mutation in the flhD master regulator protein 
(Kim et al., 2008). Y. enterocolitica is only motile at temperatures below 30°C (Young et al., 
1999).  Like some other Enterobacteriaceae members, the Y. enterocolitica flagella 
biosynthesis is controlled by chromosomally encoded genes expressed in a complex 
hierarchy order (Atkinson et al., 2006; Bleves et al., 2002). Besides motility, the                   
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Y. enterocolitica flagella works as a secretion apparatus that secretes a non-flagellar proteins 
called „Fops‟.  Fops stand for flagellar outer proteins (Atkinson et al., 2011; Young and 
Young, 2002b).  The phospholipase (YplA) protein is an example of a Fop protein secreted 
by the flagellar type III secretion apparatus prior the formation of the flagellar filament 
(Atkinson et al., 2011).   Phospholipase (YplA) is a virulence factor that enables                    
Y. enterocolitica to colonize host tissues (Schmiel et al., 2000).  Although, the pathogenic 
role of Y. enterocolitica flagella towards the host is still enigmatic (Lepka and Wilharm, 
2010), it is suggested that the flagella pathogenic role occurs at the early stages of infection 
(Raczkowska et al., 2011).     
 
1.4.2.4 Lipopolysaccharides (LPS) O-antigen of Y. enterocolitica  
In Y. enterocolitica, the LPS O-antigen has been implicated in virulence and in colonisation 
of the murine infection model intestinal tissues (Bengoechea et al., 2004).  The O-antigen is 
an elongated sugar polymer by which each polymer is composed of 2–8 sugar residues 
(Sirisena and Skurnik, 2003).   The Y. enterocolitica O-antigen biosynthetic genes are 
chromosomally encoded by the wb-clusters genes (Bengoechea et al., 2002). Similar to        
Y. pseudotuberculosis, the Y. enterocolitica LPS O-antigen are temperature regulated 
(Bengoechea et al., 2004).   Y. enterocolitica LPS O-antigen is highly expressed when 
bacterial cells are grown in room temperature (22-25°C) and trace amounts of O-antigen are 
expressed at 37°C (Bengoechea et al., 2002; Bengoechea et al., 2004).  On the other hand,    
Y. pestis does not express the O-antigen due to the presence of five pseudogenes in the        
O-antigen biosynthesis wb-cluster genes (Bengoechea et al., 2002). 
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1.4.2.5 Y. enterocolitica HPI 
Y. enterocolitica high pathogenic biotype 1B is the only biotype that contains high 
pathogenicity island (HPI); (Carniel, 1999).  The HPI Island so-called because it 
differentiates the high pathogenic strains from the low pathogenic ones in Y. enterocolitica 
(Bach et al., 1999). The Y. enterocolitica HPI is 45kbp and carries virulence genes called the 
yersiniabactin locus responsible for iron uptake (Bach et al., 1999; Carniel et al., 1996).  
Yersiniabactin (Ybt) is a siderophore and enables the bacteria to gain iron molecules required 
for its in vivo growth and dissemination (Bach et al., 1999).  The yersiniabactin locus genes 
encode for yersiniabactin biosynthesis, transport and regulation.  As a result the Yersinia HPI 
is also called the “iron-capture island” (Carniel, 1999).   
 
 
1.4.2.6 Invasin protein (Inv) 
 Invasin (Inv) is an adhesin protein expressed by the enteric Yersiniae, Y. enterocolitica and 
Y. pseudotuberculosis.  Y. enterocolitica Invasin is an outer-membrane protein with a 92 kDa 
weight (Revell and Miller, 2000) and encoded by the chromosomal invA gene (Mikula et al., 
2013).  Invasin acts in the early stages of infection (Mikula et al., 2013) by promoting an 
early stage of intestinal infection (Schmid et al., 2004).  The Y. enterocolitica Invasin 
attaches to the Peyer‟s Patches of the small intestine by binding to the β1-Integrins of the    
M-cells followed by translocation to the underlying lymphoid tissues (Grassl et al., 2003). 
Invasin binds to different β1-Integrins such as α3β1, α4β1, α5β1, α6β1, and αvβ1.                 
Y. enterocolitica Invasin binding to β1-Integrins causes Y. enterocolitica internalization 
through the epithelial cells by an invasion mechanism called the “zipper” mechanism (Mikula 
et al., 2013).   
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1.4.2.7 Ail protein 
Ail refers to the “attachment-invasion locus” and it was first described in Y. enterocolitica 
species.  Ail is an outer membrane protein with a ~ 17 kDa molecular weight (Hinnebusch et 
al., 2011) and encoded by the ail locus gene (Miller and Falkow, 1988; Miller et al., 1990).  
Ail is expressed at 37°C (Białas et al., 2012) and enables Y. enterocolitica strains to invade 
the intestinal epithelium and to play an important role in serum resistant (Huang et al., 2010). 
Unlike the inv gene which is present in all pathogenic and non-pathogenic Y. enterocolitica 
strains, ail is only found in Y. enterocolitica virulent strains (Huang et al., 2010). Recent 
work based on whole genome sequence data of the entire genus Yersinia has shown that the 
ail gene was a main virulence factor, along with the pYV plasmid, that was gained during the 
evolution of Yersinia pathogenic lineage. This acquisition of ail gene separates the non-
pathogenic Yersinia lineages from the pathogenic ones (Reuter et al., 2014).   
 
 
1.4.3 Auxiliary Y. enterocolitica virulence factors  
1.4.3.1 Mucoid Yersinia factor (Myf)  
The Y. enterocolitica chromosomal myf locus encodes for the biosynthesis of the Myf antigen 
(Białas et al., 2012; Fàbrega and Vila, 2012).  The myf locus contains 5 genes which are the 
myfA, myfB, myfC, myfE and myfF which encodes for parts that build the Myf antigen.  MyfA 
forms a fibrous layer which covers the extracellular side of bacterial cells and expands two 
microns from the bacterial surface (Mikula et al., 2013).  Despite of the unknown function of 
the Myf antigen, some experimental work shows that the Y. enterocolitica Myf antigen can 
interact with the host intestinal epithelium and may protect Y. enterocolitica cells from the 
bactericidal activity of phagocytes (Białas et al., 2012).   
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1.4.3.2 YST (Yersinia stable toxins) 
YST (Yersinia stable toxins) is a chromosomally encoded, 7494 Da, thermostable enterotoxin 
produced by Y. enterocolitica strains (Bancerz-Kisiel et al., 2012; Platt-Samoraj et al., 2006).  
YST is a virulence factor that enables the Y. enterocolitica strains to invade and damage the 
intestinal epithelium tissues (Bancerz-Kisiel et al., 2012) causing diarrhoea (Platt-Samoraj et 
al., 2006).  Y. enterocolitica produces three variants of the Yst toxin which are the YstA, 
YstB and YstC encoded by ystA, ystB and ystC genes respectively.  The YstA is produced by 
pathogenic Y. enterocolitica strains while YstB and YstC variants are encoded only by the 
non-pathogenic biotype 1A strains. ystB has been found to be present in almost all clinical 
isolates of non-pathogenic biotype 1A strains (Bancerz-Kisiel et al., 2012).  As a result, ystB 
have been applied as a prominent PCR marker for the detection of the clinical isolates of non-
pathogenic biotype 1A strains (Ramamurthy et al., 1997).  
 
1.4.4 Y. enterocolitica Route of Infection:  
Y. enterocolitica is facultative intracellular enteropathogen (Beuscher et al., 1995) 
characterised as both a food-borne and water-borne pathogen (Belgin Siriken, 2004) by 
which it is believed to be transmitted through the fecal-oral route (Bari et al., 2011;Guinet et 
al., 2011).  When orally ingested, Y. enterocolitica crosses and survives the stomach using 
urease activity, to tolerate the high acidic nature of the stomach, and enters the small intestine 
(Handley et al., 2004).  Once reaching the small intestine Y. enterocolitica replicates 
(Oellerich et al., 2007) and rapidly colonizes the lumen of the small intestine (Trulzsch et al., 
2004). Then Y. enterocolitica strains invade and translocate through the M cells that overlie 
the follicle associated epithelium (FAE) (Oellerich et al., 2007) of the Peyer‟s Patches (PP) 
located in the distal part of the intestine (Jung et al., 2010). Once translocated,                       
Y. enterocolitica colonizes the Peyer‟s Patches by subverting the immune system through 
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stopping the phagocytosis action of macrophages and polymorphonuclear leukocytes (PMNs) 
and inhibiting several immune inflammatory cascade components (Handley et al., 2006).  
Finally, Y. enterocolitica proceeds to disseminate to other body organs (Trcek et al., 2010). 
 
1.4.5 Y. enterocolitica clinical manifestations 
1.4.5.1 Y. enterocolitica gastrointestinal infections 
Y. enterocolitica primarily causes gastrointestinal diseases with the ability to cause 
extraintestinal complications in patients with compromised immune systems (Bottone, 1997; 
Bottone, 1999). Y. enterocolitica gastrointestinal infections include acute enteritis 
accompanied with fever and watery diarrhoea, and rarely bloody diarrhoea in children.  Acute 
terminal ileitis and mesenteric lymphadenitis mimicking appendicitis are more common in 
young adults.  In infants, Y. enterocolitica can also cause prolonged severe gastrointestinal 
diseases such as fatal necrotizing enterocolitis and “pseudo-tumorgenic” form of suppurative 
mesenteric adenitis.  The infection period in infants may proceed for 3 to 28 days while in 
adults it lasts for 1 to 2 weeks.  The potency of the gastrointestinal disease is dependent on 
the Y. enterocolitica strain serotype.  Y. enterocolitica serotype O:8 strains can cause severe 
complications such as gastrointestinal tract ulceration and death.  On the other hand,             
Y. enterocolitica strains of serotypes O:9 and  O:3 are clinically found to be less virulent  to 
the gastrointestinal tract (Bottone, 1997).   
 
 
1.4.5.2  Y. enterocolitica extra intestinal infections: 
Y. enterocolitica also causes extra intestinal infections such as Septicaemia mostly in patients 
with immune complications or with iron overload complications.  Septicaemia may be 
accompanied with metastatic spread of the invading Y. enterocolitica strains to different body 
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organs (Bottone, 1999).  Metastatic diseases following Y. enterocolitica septicaemia are 
diverse and they include focal abscess formation in the kidneys, lungs, spleen, and liver.  It 
also includes cutaneous infections such as pyomyositis, cellulitis, pustules, and bullous 
lesions. Metastatic diseases may also involve meningitis, osteomyelitis, panophthalmitis, 
endocarditis, pneumonia and cavitary pneumonia (Bottone, 1997; Bottone, 1999).                 
Y. enterocolitica extra intestinal infections also include post-infection, long-term sequelae 
resulting from acute bacteraemia (Fàbrega and Vila, 2012). Sequelae manifestations include 
reactive arthritis, erythema nodosum, glomerulonephritis and myocarditis where reactive 
arthritis is strongly associated with HLA-B27-antigen positive individuals (Bottone, 1999).  
However, reactive arthritis and erythema nodosum are the most common sequelae diseases 
associated with Y. enterocolitica infection.  Sequelae infections are mainly observed in young 
adults and in rare clinical conditions they were found to be specifically linked to serotype O:3 
infections (Fàbrega and Vila, 2012).   
 
 
1.4.6  Project Background   
              Y. enterocolitica consists of six biotypes differentiated by their biochemical 
characteristics into 1A, 1B, 2, 3, 4 and 5.  These six biotypes are arranged in three lineages 
depending on their pathogenicity in the mouse infection model; the high pathogenic biotype 
1B, the low pathogenic biotypes 2-5 and the non-pathogenic biotype 1A.  The                       
Y. enterocolitica high pathogenic biotype 1B is lethal in a mouse infection model while the 
low pathogenic biotypes cause only a mild disease in mice without any death.  The               
Y. enterocolitica non-pathogenic biotype 1A doesn‟t cause any disease in the mouse infection 
model.  However, the high pathogenic biotype is rarely isolated from human clinical cases, 
whilst the low pathogenic biotypes are mostly associated with human diseases and they cause 
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the same disease. The non-pathogenic biotype is completely avirulent in mouse infection 
model but their pathogenicity in humans is controversial (Tennant et al., 2003).  A number of 
studies support the implication of the non-pathogenic biotype in human diseases while others 
deny it.  Non-pathogenic biotype 1A are frequently isolated strain types from healthy persons 
and from patients suffering from gastrointestinal diseases humans (Batzilla et al., 2011b). 
Although the non-pathogenic biotype strains lack all virulence factors present in the 
pathogenic biotypes such as the pYV plasmid, ysa T3SS, HPI, Ail, YstA and MyfA, they still 
repeatedly cause symptoms similar to those caused by the other pathogenic Y. enterocolitica 
(Batzilla et al., 2011b; Bhagat & Virdi, 2007; Stephan et al., 2013). This confusing 
pathogenic potential of Y. enterocolitica biotypes is the key reason of establishing this 
project.  In this project, the pathogenic potential of  Y. enterocolitica biotypes will be  
investigated in the in vitro model HEp-2 human epithelial cell line and in the emerging 
alternative insect infection model Galleria mellonella (G. mellonella).   
 
1.4.7  Project General Aims: 
1) Comparing the pathogenic potential of Y. enterocolitica biotypes using the HEp-2 cell line 
model and G. mellonella insect model.  
 
2) Investigating the in vivo interaction of Y. enterocolitica biotypes with the alternative 
infection model Galleria larvae. 
 
3) Investigating the role of the Y. enterocolitica major virulence factor pYV plasmid in 
modulating the virulence of the pathogenic biotypes in Galleria.   
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Chapter 2 
Materials & Methods 
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2.1 Materials and Reagents  
2.1.1 Bacterial strains and growth conditions:  All strains used in this project are listed in 
table 2.1 and were grown from (-80°C) freezer stocks prior to use.  All Y. enterocolitica were 
grown at either 25°C or 37°C according to the experiment conditions.  Strains other than       
Y .enterocolitica were grown at 37°C. All Y. enterocolitica strains were grown aerobically on 
LB agar plates and in LB broth medium at both 25°C and 37°C.  LB broth cultures were 
incubated overnight in a shaking incubator at 200 rpm for 18 hours.  
Table 2.1:  Bacterial strains used in this study   
No. Strain Name Bio/Serotype Biological Origin Source 
1 8081 1B/O:8 Human Thomson et 
al. (2006) 
2 0902  1A/O?* Sheep McNally, UK 
3 0903 1A/O:6,30 Human McNally, UK 
4 3403  1A/O:5  Human McNally, UK 
5 3503  1A/O?* Pig McNally, UK 
6 5303 1A/O:5 Human McNally, UK 
7 NZ3   1A/O?* Sheep Dr. Muriel 
Dufour, ESR 
NCBID, 
Australia 
8 119/02 2/O:9 Sheep McNally, UK 
9 21202 2/O:9  Pig McNally, UK 
10 215/02 3/O:9 Pig McNally, UK 
11 218/02 3/O:9 Pig McNally, UK 
12 2403 3/O:9 Human McNally, UK 
13 5603 3/O:9 Human McNally, UK 
14 5803  3/O:9 Human McNally, UK 
15 111/02 3/O:5,27 Sheep McNally, UK 
16 14902 3/O:5,27 Sheep McNally, UK 
17 153/02 3/O:5,27 Cattle   McNally, UK 
18 226/02 3/O:5,27 Pig McNally, UK 
19 231/02 3/O:5,27   Pig McNally, UK 
20 232/02 3/O:5,27 Pig McNally, UK 
21 01/2012 4/O:3 Human Claire 
Jenkins 
HPA,2012 
22 02/2012 4/O:3 Human Claire 
Jenkins 
HPA,2012 
23 03/03 4/O:3 Human McNally, UK 
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24 1203 4/O:3 Human McNally, UK 
25 201/02 4/O:3 Pig McNally, UK 
26 204/02 4/O:3 Human McNally, UK 
27 213/02 4/O:3 Pig McNally, UK 
28 NZ15 4/O:3 Unknown Dr. Muriel 
Dufour, ESR 
NCBID, 
Australia 
29 Y1 4/O:3 Human Petra Dersch, 
2009 
30 3094/96 5/O:2a,2b,3 Animal Fuchs lab 
31 14902/pAJD434            
(Transformed Strain)                                    
3/O:5,27 Sheep  
32 1203/pAJD434 
(Transformed Strain) 
4/O:3  Human This Study 
33 5303/pAJD434  
(Transformed Strain) 
1A/O:5 Human This Study  
34 21202/pAJD434 
(Transformed Strain) 
2/O:9 Pig This Study  
35 8081/pAJD434 
(Transformed Strain) 
1B/O:8  Human This Study  
36 8081c 
(pYV-cured 
derivative) 
1B/O:8 Human This Study  
37 14902c 
(pYV-cured 
derivative) 
3/O:5,27 Sheep This Study  
38 1203c 
(pYV-cured 
derivative) 
4/O:3 Human This Study  
39 E. coli DH5α 
 
(-ve) control   Unknown Invitrogen 
*?: Non-typable serotype  
 
2.1.2 Luria-Bertani Agar (LB) agar:  LB Agar Miller (Fisher Scientific) was used to grow 
all strains used in this project.  LB agar is manufactured from the following components (per 
L): Tryptone, 10g; Yeast extract, 5g; Sodium chloride, 10g; Agar 15g, pH7.0 ±0.2 at 25°C 
and was prepared according to the manufacturer instruction by dissolving LB agar powder in 
distilled water.   The molten agar suspension was then sterilised by autoclaving at 121°C for 
15 minutes.   
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2.1.3 Luria-Bertani Broth (LB) Broth: LB Broth (Lennox, SIGMA-ALDRICH) was used 
to grow all strains used in this project. The LB broth is pre made from the following 
components (per L): Tryptone, 10g; Yeast extract, 5g; Sodium chloride (NaCl), 5g. The LB 
broth was prepared according to the manufacturer instruction by dissolving LB broth powder 
in distilled water.   The broth suspension was then sterilised by autoclaving at 121°C for 15 
minutes.  The sterilized LB broth was incubated in room temperature and used within 4 
weeks or stored in 4°C fridge for long period usage.  
2.1.4 Yersinia Selective Agar (CIN) (Schiemann's CIN agar) Formula and Preparation: 
Yersinia selective agar was prepared from Yersinia selective agar base powder (Fisher 
Scientific) and the Yersinia Selective supplement (Fisher Scientific). The CIN agar base 
formula is manufactured from the following chemicals in (gram/litre): Special peptone, 
20g/L; Yeast extract, 2g/L; Mannitol, 20g/L; Sodium pyruvate, 2g/L; Sodium Chloride,1g/L; 
Magnesium Sulphate, 0.01g/L; Sodium desoxycholate, 0.5g/L; Neutral red, 0.03g/L; Crystal 
Violet, 0.001g/L; Agar,12.5g/L, pH 7.4 ± 0.2 @ 25°C. The Yersinia selective supplement is 
composed of Cefsulodin (7.5mg), Irgasan (2mg) and Novobiocin (1.25mg).  The content of 
one vial is enough to supplement 500 ml of the Yersinia Selective Agar Base. CIN agar was 
prepared according to the manufacturer‟s instructions.  Briefly, 29g of the Yersinia Selective 
Agar Base was dissolved in 500ml of distilled water and the suspension was then autoclaved 
at 121°C for 15 minutes. The autoclaved agar was then cooled down to approximately 55°C. 
The Yersinia Selective supplement was prepared by dissolving the whole powder amount in 
1ml of pure ethanol (95%) + 2ml of sterile distilled water.  The dissolved selective 
supplement was added to the cooled 500ml Yersinia Selective Agar Base and the mixture was 
mixed thoroughly.  The CIN agar was poured into 90mm sterile Petri Dishes and stored 
according to the manufacturer instructions.     
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2.1.5 CRMOX Agar Preparation: The CRMOX agar was prepared according to the 
protocol described in the handbook of microbiological media book (3rd edition); (Atlas, 
2004): The CRMOX agar was prepared in the lab using multiple components including 
chemicals and dehydrated media.  Each of the CRMOX agar components was prepared 
separately as a solution with a fixed concentration.  All the prepared solutions were finally 
mixed together to obtain 1 litre of CRMOX agar.  The CRMOX agar preparation procedure 
was carried out as follows:   
Table 2.2: CRMOX reagents and preparation procedure 
Chemical/Reagent Name Method of Preparation  Final Volume 
per litre 
Magnesium Chloride (MgCl2) 
(SIGMA-ALDRICH). 
  
 
0.25M of MgCl2 was prepared by dissolving 
50.8g of MgCl2 in 1L of distilled water.  The 
mixture was sterilised by autoclaving at 121°C 
for 15 minutes.  The sterile MgCl2 stock was 
stored aseptically in room temperature and 
volumes of 80ml were used to prepare 1L of 
CRMOX agar.    
 
 
 
 
 
 
80ml  
Sodium Oxalate (Na2C2O4) 
(SIGMA-ALDRICH) 
0.25M of Sodium Oxalate was prepared by 
dissolving 33.2g of Sodium Oxalate in 1L of 
distilled water.  The mixture was sterilised by 
autoclaving at 121°C for 15 minutes.  The sterile 
Sodium Oxalate stock was stored aseptically in 
room temperature and volumes of 80ml were 
used to prepare 1L of CRMOX agar.    
 
 
 
 
 
 
 
80ml 
D-galactose 
(SIGMA-ALDRICH). 
  
20% of D-galactose was prepared by dissolving 
2g of D-galactose in 10ml of distilled water.  
The mixture was filter sterilized and aseptically 
stored in room temperature.    
 
 
 
 
10ml 
Congo Red (Formula: 
C32H22N6Na2O6S2)  (SIGMA-
ALDRICH)  
1% of Congo Red was prepared by dissolving 
0.05g of Congo Red powder in 5ml of distilled 
water. The mixture was sterilised by autoclaving 
at 121°C for 15 minutes.   
 
 
 
 
 
5ml 
Tryptone soy agar (TSA) 40g of TSA have been dissolved in 825ml of 
distilled water and autoclaved at 121°C for 15 
minutes.  The molten autoclaved TSA agar was 
allowed to cool down to approximately 55°C 
then the last prepared chemicals were aseptically 
added to the warm TSA.   
 
 
 
 
 
 
825ml  
 CRMOX agar final volume 1L 
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2.1.6 Tryptone Soy Agar (TSA);(Fisher Scientific): Pancreatic digest of casein15.0g/L; 
Enzymatic digest of soya bean, 5.0g/L; Sodium chloride, 5.0g/L; Agar, 15.0g/L. 
 
2.1.7 1X TAE buffer preparation: 1X Aqueous Tris Acetate EDTA (TAE) buffer was 
prepared by diluting 20ml of the 50X concentrated TAE buffer (Fisher) in 980ml of sterile 
distilled water (sdH2O).  The 50X TAE buffer (Fisher) is composed of: 
- 242g Tris base 
- 100ml 0.5M Na2EDTA 
- 57.1ml Glacial acetic acid 
 
2.1.8 Agarose Powder (Fisher Scientific): Agarose DNase and RNase free, for 
electrophoresis. 
 
2.1.9 Phosphate Buffered Saline (PBS);(SIGMA-ALDRICH): PBS was prepared by 
dissolving 1 PBS tablet in 200mL of deionised water. The dissolved tablet yields 0.01 M 
phosphate buffer, 0.0027 M potassium chloride and 0.137 M sodium chloride, with pH 7.4.  
The mixture was then sterilized by autoclaving at 121°C for 15 minutes.  
 
2.1.10 Glycerol freezing medium preparation: Glycerol freezing medium is used to store 
bacterial cells for long term storage in extremely low temperatures.  80% Glycerol solution 
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was prepared by mixing 80% of pure Glycerol reagent with 20% distilled water.  The mixture 
then autoclaved at 121°C for 15 minutes and allowed to cool down in room temperature and 
finally stored in 4°C fridge. The freezing medium was prepared in 1ml aliquots and loaded in 
2ml sterile cryogenic plastic tubes.  Every 1ml contains 20% of the pre prepared Glycerol 
(0.2ml) with 80% of the appropriate broth medium (0.8ml).   
 
2.1.11 Trimethoprim antibiotic preparation: The Trimethoprim antibiotic was used in a 
100µg/ml concentration.  To prepare 100µg/ml Trimethoprim solution, 0.05g of 
Trimethoprim powder (SIGMA ALDRICH) was dissolved in 1ml of pure DMSO (Fisher 
Scientific) to produce 50µg/ml Trimethoprim stock solution.  The Trimethoprim stock 
solution was then sterilised by filtration using a sterile syringe and membrane filter size 
0.22µm.  The sterilized 50µg/ml Trimethoprim stock solution was added to 500ml media to 
obtain 100µg/ml concentration. 
2.1.12 TrypLE Express Enzyme (1X) + phenol red:  TrypLE (Gibco) is a recombinant 
enzyme alternative to porcine or bovine Trypsin.  TrypLE was used to dissociate the attached 
cell lines on the plastic tissue culture growing flasks.  Once received it was stored in 4°C. 
 
2.1.13 Dulbecco’s Phosphate Buffered Saline (DPBS):  Dulbecco‟s Phosphate Buffered 
Saline (SIGMA-ALDRICH UK) is a liquid buffer which is supplemented with MgCl2 and 
CaCl2 salts and it is sterile-filtered by the manufacturer.  Once received it was stored and 
used for all cell culture assays.  
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2.1.14 Minimum Essential Medium Eagle (MEM):  Minimum Essential Medium Eagle 
(SIGMA-ALDRICH UK) is sterile-filtered liquid medium supplemented with Earle′s salts, L-
glutamine and sodium bicarbonate.  The Minimum Essential Medium Eagle has been used 
primarily to grow the HEp-2 cell line in addition the other tissue culture assays.   
 
2.1.15 Penicillin-Streptomycin Antibiotics (Pen-Strep):  Penicillin-Streptomycin 
antibiotics (SIGMA-ALDRICH UK) are purchased as a sterile liquid bio reagent 
manufactured by mixing 10,000 units of penicillin with 10 mg streptomycin/ml. Penicillin-
Streptomycin antibiotics were used to maintain the HEp-2 cell line and prevent bacterial and 
fungal contamination. A specific amount of Penicillin-Streptomycin antibiotics was added to 
the Minimum Essential Medium to create a growth media for the HEp-2 cell line. Penicillin-
Streptomycin antibiotics were stored at 4°C. 
 
2.1.16 Gentamicin Antibiotic Solution: Gentamicin (SIGMA ALDRICH UK) was stored at 
4°C.  Gentamicin inhibits the growth of many Gram-positive and Gram-negative bacteria.  
Gentamicin was used in the invasion assay to kill the extracellular bacteria with a 
concentration of 100µg/ml.    
 
2.1.17 Triton X:  Triton X-100 (SIGMA ALDRICH UK) was used to lyse HEp-2 cells. 1% 
of Triton X-100 diluted stock solution was prepared by mixing 1ml of the 100X concentrated 
solution in 99ml distilled water.  The diluted mixture was then autoclaved at 121°C for 15 
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minutes.  The autoclaved mixture was left to cool down in room temperature and then stored 
in 4°C fridge for long term usage.   
 
2.1.18 HEp-2 cell line:  HEp-2 human laryngitic epithelial was used in all tissue culture 
work.  HEp-2 cell line was obtained from the liquid nitrogen storage chamber and prepared 
for tissue culture work.   
 
2.1.19 Hamilton Syringe Preparation: The 50μL volume Hamilton GASTIGHT Syringe 
with a removable 22s ga. sized bevel tip needle was used for all the Galleria injection 
procedures.  The Hamilton syringe was cleaned and sterilised prior to each injection 
procedure using 95% pure ethanol, sterile distilled water and the special metal string supplied 
with the syringe.  Syringe sterilization procedure is done by drawing up the ethanol into the 
syringe barrel and then thrust it out of the syringe and repeating this procedure three or more 
times followed by washing with sterile distilled water using the same last mechanical 
procedure to remove the excess ethanol. 
 
2.1.20 Galleria mellonella larvae storage and usage: All Galleria larvae batches in the final 
6 instars stage were purchased from (Livefood UK Ltd, Somerset). The Galleria larvae were 
stored in the dark on wood chips inside plastic boxes at room temperature and were used 
within 5 days from the day of delivery.  Only healthy larvae without dark spots and 
exhibiting a light creamy colour and active movement were selected for experimental work.  
Moreover, larvae with similar sizes ranging from 2cm-2.5cm were selected in order to obtain 
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similar results from different experiments. This selection was performed immediately prior to 
each individual experiment.    
2.1.21 Genomic DNA extraction: 
Genomic DNA was extracted from Y. enterocolitica strains pre-grown in LB agar cultures.  
Whole Y. enterocolitica colony content of each LB agar culture was collected by sterile 
cotton swabs and was dissolved in 1.5 ml of sterile PBS.  The genomic DNA was extracted 
from the PBS Y. enterocolitica cells suspension using the GenElute
TM
 Bacterial Genomic 
DNA kit (SIGMA) according to the procedure described in the manufacturer‟s user guide 
booklet.    
2.1.22 1kbp ladder (Promega) 
2.1.23 QIAprep Spin Miniprep Kit (50); (QIAGEN): For 50 high-purity plasmid 
minipreps extraction. 
2.1.24 SOC Medium:  The SOC medium (SIGMA-ALDRICH) is composed of: (20 g/L) of 
Tryptone, (5 g/L) of Yeast Extract, (4.8 g/L) of MgSO4, (3.603) g/L of dextrose, (0.5g/L) of 
NaCl & (0.186 g/L) of KCl.  
2.1.25 pAJD434 plasmid: pAJD434 plasmid contains a trimethoprim resistance gene.  
pAJD434 resulted from cloning the p34s-Tp trimethoprim resistant gene in the PstI site of the 
„λ red recombinase expression plasmid pKD46‟(Maxson and Darwin, 2004).  
2.1.26 GenePulser Xcell electroporator system (Bio-Rad)  
2.1.77 Electroporation cuvette (2ml); (Flowgen, UK) 
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2.2 Methods and Procedures  
2.2.1 Inoculum (Initial dose) and dose Preparation using the plate count technique:  The 
plate count technique has been used to approximately count and standardize inoculum 
numbers.  In this method, the optical density (O.D) of each strain is measured and linked to 
the number of bacteria.  This helps to initially estimate that the overnight broth culture is 
reaching the desired number of the bacterial cells.  In this procedure, the O.D of the bacterial 
overnight cultures were measured by spectrophotometer at 600nm wave length.  Then 
number of cells from the overnight broth cultures were enurmated using the Miles & Misra 
method (Hedges, 2002; Miles and Misra, 1938) followed by the colony forming unit 
formula (c.f.u.).  
 
2.2.2 Cell Line Growth and Maintenance:  The HEp-2 human laryngitic epithelial cell line 
(Draganov et al., 2008-2009) was used in all tissue culture assays.  The HEp-2 cell line was 
obtained from long term Liquid Nitrogen Storage and cultured in Minimum Essential 
Medium Eagle with L-glutamine (MEM; Sigma Aldrich UK) in specific 75cm3 tissue culture 
flasks. The MEM medium was supplemented with 10% of Fetal Bovine Serum (Sigma 
Aldrich UK), 1% of MEM Non-essential Amino Acid Solution (Sigma Aldrich UK) and 1% 
of Penicillin-Streptomycin antibiotics (Sigma Aldrich UK).    The HEp-2 cells were 
incubated at 37°C in the tissue culture humidified incubator with 5% CO2 atmosphere.  The 
cells were monitored daily and were sub-cultured either every four days or once every week.  
The growth medium was routinely changed every four days. The cultured HEp-2 cells were 
left until they became a fully confluent monolayer.  The HEp-2 cells were used on passage 6 
for all association and invasion assays. At 48 hours before the association and invasion 
assays, the monolayer cell lines were detached from the tissue culture flask surface using 
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TrypLE enzyme (Life Technologies).  The detached cells were centrifuged on 1500 rpm for 3 
minutes and the pellet was resuspended with 4 ml of growth medium.  Twenty microliters of 
the suspension was taken and loaded in the haemocytometer to determine the cell count.  
Depending on the haemocytometer count, approximately 2x10
5
 cells were seeded in 24-well 
plates.  Sterile 24-well plates (nunc) were used to seed the HEp-2 cells for the association and 
invasion assays. Each strain was seeded in triplicate for each assay.  The seeded 24-well 
plates were incubated in the tissue culture incubator at 5% atmospheric CO2 and humid 
conditions for approximately 48 hours till the seeded HEp-2 cells became almost or 
completely confluent.  
 
2.2.3 Association and Invasion assays: Overnight bacterial broth cultures were pelleted with 
centrifugation at 10,000 rpm for 5 minutes. The pellets were suspended with MEM tissue 
culture infection media supplemented with only 1% of MEM Non-essential Amino Acid 
Solution (Sigma Aldrich UK).  The suspended bacterial cells were diluted in the media to 
reach approximately 2x10
7
 cells as determined by the plate count method and these dilutions 
were used as inoculum.  Confluence of the 24-well plate seeded cells was checked under the 
inverted light microscope.  After that, the tissue culture growth medium was removed and all 
wells were washed twice with Dulbecco‟s Phosphate Buffered Saline (Sigma-Aldrich UK) 
and in each wash all wells were cleaned three times.  0.5 ml of each bacterial suspension was 
added in triplicate in the pre-seeded wells (M.O.I. 100).  Plates were incubated for 3 hours at 
37°C at 5% atmospheric CO2 and humid conditions.  After 3 hours, the bacterial suspensions 
were emptied from all wells and washed thrice with Dulbecco‟s Saline. After washing, the 24 
well plates specified for the invasion assay were filled with 0.5 ml of tissue culture media 
supplemented with 100µg/ml Gentamicin antibiotic and were further incubated for 2 hours in 
30 
 
the same last conditions.  At the same time, the association assay 24 well plates were loaded 
with 0.1ml of 1% of Triton X-100 in order to lyse the infected HEp-2 cells and release the 
bacterial cells.  The bacterial cells were serially diluted and counted using Miles & Misra 
method (Hedges, 2002; Miles and Misra, 1938). After 2 hours of incubation, the invasion 
assay 24 well plates were washed from the Gentamicin twice with the Dulbecco‟s Saline and 
also lysed with 0.1ml of 1% of Triton X-100.  The bacterial cells were also diluted and 
counted using Miles & Misra method (Hedges, 2002; Miles and Misra, 1938). 
2.2.4 Galleria infection assay:  Larvae were inverted on their backs over a 6mm diameter 
wide plastic tube attached to the lid of a 90mm Petri dish using the thumb and index fingers.  
All Galleria larvae were micro-injected in the second right leg from the head side using 
Hamilton syringe. Galleria larvae were infected with a series of nine, 10-fold serial dilutions 
containing 10
1
, 10
2
 ,10
3
 ,10
4
 ,10
5
, 10
6
 , 10
7
 , 10
8 
& 10
9
 cfu/ml of each Y. enterocolitica strain.  
Each dose was injected in 10µl-aliquots into a group of 10 G. mellonella larvae. After 
injection, each group was placed on a separate 90 mm sterile Petri Dish containing a 90mm 
diameter Whatman filter paper in order to observe any leakage caused by a Trauma.  The 
injected Galleria groups were then incubated in the dark statically at 25°C or 37°C.  In 
addition to the bacterial doses that were injected, 10 larvae were injected with a sterile PBS, 
and 10 were incubated without any form of injection or treatment. All experiments were 
repeated in triplicate independently.                                   
 
2.2.5 Monitoring of infected Galleria larvae:  Reduction in movement and changes in 
larvae cuticle colour were checked to distinguish dead larvae from living ones (Larvae 
mortality).  Each larva was gently agitated with a sterile plastic pipette tip and inverted on its 
back to check for the roll response as an indicative of larval life.  Galleria larvae darkening 
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and recorded as a sign of the larvae morbidity. Once the Galleria larvae failed to display any 
movement they were recorded as dead.  The dead larvae were instantly removed and 
aseptically disposed.   
 
2.2.6 Calculating the LD50: median lethal doses were calculated using the following 
Spearman Karber formula: Log10 Median Dose = m - ∆(∑p – 0.5); (Wardlaw, 1985, p.105).   
2.2.7 Time To Death (Survival Curves):  Survival curves were designed in order to predict 
the time of death by comparing the time post infection (x-axis) against the percentage of live 
Galleria (y-axis).  
 2.2.8 PCR Reaction Preparation  
All PCR amplification reactions were performed in 50µl final volumes in ice. The 50µl PCR 
reaction components and volumes are prepared as described in Table 2.3:  
Table 2.3 PCR reagents and their volumes and concentrations:  
PCR Reagent PCR Reagent Concentration PCR Reagent Volume 
Green Flexi PCR Buffer 
(Promega)    
5X  5µl 
MgCl2  (Promega) 1.5mM 5µl 
dNTPs Mix (Promega) 10µM 2µl 
sdH2O  - 33.7µl 
F-Primer  10 pmol 1µl 
R-Primer 10 pmol 1µl 
GoTaq DNA Polymerase 
(Promega) 
5U/µM   0.3µl 
DNA Template   10 ng 2µl  
Total Volume  50µl  
 
The same reaction was carried out for each type of template. PCR negative control reactions 
were carried out without adding template DNA and compensate it with sdH2O.   
32 
 
2.2.9 PCR Reaction  
PCR amplification reactions were carried out in Thermo cycler machine. Each 50µl PCR 
reaction mix was added in separate PCR sterile plastic tubes and then was placed in the 
thermo cycler machine.  The PCR thermo cycler was programmed using the following PCR 
condition: initial denaturation for 5 min at 94°C, followed by 30 denaturation cycles at 94°C 
for 30 sec for each cycle, annealing temperature for 30 sec by which the temperature was 
dependent on the primer‟s annealing temperature, extension at 72°C for 90 sec and a final 
extension at 72°C for 10 min. The final PCR products were held at 4°C at the end of the PCR 
amplification cycles.  
2.2.10  Amplified DNA analysis using agarose gel electrophoresis 
All PCR amplified products were visualised on 2% agarose gel.  The 2% agarose gel was 
prepared by adding 2g of the agarose powder to 100 ml of 1XTAE buffer.  The mixture was 
dissolved completely by boiling in microwave to produce a homogenised solution. The 
boiling agarose solution was left to cool down and was stained by adding 10µl of 0.01% 
SYBR® Safe
TM
 gel stain (Invitrogen, UK).  Then the ready gel solution was poured in gel 
tray containing a comb and the gel left to solidify in room temperature.  The comb was used 
to create wells in the gel. The ready gel was then placed in electrophoresis tank by which the 
wells side was located towards the negative electrical anode.  The electrophoresis tank was 
filled with 1XTAE buffer till the gel was completely covered with the TAE buffer. 5µl 
aliquots of each PCR product were loaded in the appropriate wells. In addition, 5µl of 100bp 
DNA ladder (Promega) were loaded in the first well to be used as DNA marker.  The loaded 
DNA samples were separated by the effect of electric field by running the agarose gel for 
45minutes on 90V.  Finally, the fragmented DNA bands on the gel were visualised by the 
InGenius® gel system under the ultraviolet (UV) light (Syngene; UK). 
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Chapter 3 
 Studying the Pathogenic Potential of Y. enterocolitica Biotypes in HEp-2 
Cell Line and G. mellonella Insect Model 
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3.1 Introduction  
 
3.1.1 In vitro infection models for Y. enterocolitica Pathogenesis  
Tissue culture cell lines have been widely used to study Y. enterocolitica pathogenesis in 
vitro (Portnoy et al., 1981). These cell lines have been derived from different human and 
animal tissue origins.  HEp-2 (human epithelial cell line), HeLa (human epithelial cell line) 
and CHO (Chinese Hamster Ovary cell line) are types of human and animal epithelial cell 
lines frequently used to study the association and invasion potential of Y. enterocolitica 
strains (Boyd et al., 2000; Finlay and Falkow, 1988).  Y. enterocolitica has been  shown to 
infect HEp-2 human epithelial cell line to higher levels than other epithelial cell lines 
commonly used to assay bacterial virulence (Finlay and Falkow, 1988).  HEp-2 human 
epithelial cells are derived from human larynx carcinoma (Nottet et al., 1993).  They were 
first established in 1952 by inducing tumours in young laboratory rats inoculated with a 
human epidermoid carcinoma tissue (Draganov et al., 2008-2009).   The HEp-2 cell line has 
been used to study many viruses and bacteria including Y. enterocolitica (Draganov et al., 
2008-2009).  In addition to epithelial cell lines models used to study Y. enterocolitica 
association and invasion potential, phagocytic cell lines have been used to study the              
Y. enterocolitica-Macrophage interaction in vitro. Examples of phagocytic cell lines include 
the murine macrophage cell line J774 (Hoffmann et al., 2004) and the human macrophage 
cell line U937 (Boyd et al., 2000).  J774 and U937 macrophage cell lines are widely used to 
study Y. enterocolitica interaction with and persistence within macrophages in vitro 
(Hoffmann et al., 2004; Grant et al., 1999). The HeLa cell line was used to study the 
intracellular behaviour of Y. enterocolitica and revealed that Y. enterocolitica have the ability 
to invade HeLa cells but without showing intracellular multiplication (Devenish and 
Schiemann, 1981). In vitro U937 macrophage tissue culture models also showed the ability of 
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the Y. enterocolitica biotypes to persist within macrophages as well as avoid the phagocytic 
effect of macrophages (McNally et al., 2006).   In vitro animal cell lines have also been used 
to investigate the pathogenic role of Y. enterocolitica flagella and motility in pathogenesis of 
Y. enterocolitica non-pathogenic biotype (McNally et al., 2007). Other studies have used 
tissue culture models to study the pathogenic role of many Y. enterocolitica adhisins and 
invasins in vitro including Ail protein (Miller & Falkow, 1988), YadA and invasin proteins 
(Uliczka et al., 2011;Young et al., 1992).  Tissue culture models have suggested that all         
Y. enterocolitica biotypes show human pathogenic potential  by their ability to invade HEp-2 
epithelial cell lines in vitro (McNally et al., 2006) including the non-pathogenic biotype 
strains (Grant et al., 1999; McNally et al., 2006).  In vitro U937 macrophage tissue culture 
models have shown that Y. enterocolitica pathogenic and non-pathogenic biotypes were able 
to persist in macrophages (McNally et al., 2006). Although tissue culture cell line models are 
considered as a powerful tool to study bacterial pathogenesis in vitro (Bhunia, 2008), they 
cannot be used alone to study the complex disease patterns caused by human pathogens 
because they lack the complex structure of the host organs which makes the need for live 
infection models important (Harrison et al., 2014).    
 
3.1.2 Mammalian Infection Models 
 
 Many mammalian infection models have been used to study the pathogenesis of                   
Y. enterocolitica including guinea pigs, gerbils, rabbits and mice (Portnoy et al., 1981). 
Attempts to study Y. enterocolitica pathogenicity using guinea pigs and rabbits as an animal 
infection model have failed because these animals require a very high dose of bacterial 
inoculum to kill them and also death occurs very rapidly (within  48 hours).  Further 
investigation has shown that guinea pigs and rabbits die from an enterotoxin effect and do not 
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resemble any similarities to the human infection caused by Y. enterocolitica. Carter and 
Collins successfully developed a suitable mouse infection model to investigate                      
Y. enterocolitica pathogenesis (Carter and Collins, 1975).  They used the CD-1 mouse strain 
to study the pathogenic potential of Y. enterocolitica WA strain (Carter and Collins, 1975) 
which belongs to bioserotype 2/O:8 and was isolated from blood of a human patient (Carter 
et al.,1973). They concluded from their study that the pathogenic phenotype induced by           
Y. enterocolitica in mice was similar to the natural pathogenic conditions observed in humans 
infected with the same Y. enterocolitica WA strain  (Carter and Collins, 1975). Consequently, 
the mouse model was widely applied to study the Y. enterocolitica infection process (Handley 
et al., 2004).  Y. enterocolitica doses can be injected intravenously or fed orally to the mouse 
infection model (Handley et al., 2004). Different inbred mice strains have been used to study 
the pathogenicity of Y. enterocolitica clinical strains (Schippers et al., 2008).  C3H/HeN, 
BALB/C, BALB/B, DBA/2, SWISS, SWR and C57BL/6 are different mice strains used to 
study Y. enterocolitica virulence (Autenrieth et al., 1994; Wang et al., 2013). C3H/HeN, 
BALB/C, BALB/B, DBA/2, SWISS and SWR mice strains are highly susceptible to infection 
with Y. enterocolitica with a median lethal dose (LD50) of 10
2
.  On the other hand, C57BL/6 
mouse strain was found to be resistant to Y. enterocolitica infection with a median LD50 of 
10
5
 (Wang et al., 2013).  Although the mouse infection model shows similar gastrointestinal 
disease patterns to those observed in humans (Carter, 1975a), the mouse infection model 
responded differently to infection with different Y. enterocolitica biotypes.  This variance in 
response classified Y. enterocolitica biotypes into three pathogenic groups by which biotype 
1B was able to kill the mouse infection model and as a result it was called the high 
pathogenic biotype.  Biotypes 2, 3, 4 and 5 caused mild disease by which they were called the 
low pathogenic biotypes and finally biotype 1A was called the non-pathogenic biotype 
because it was not able to cause any disease in the mouse infection model (Carter and 
37 
 
Collins, 1975; Howard et al., 2006). However, the Y. enterocolitica pathogenic potential in 
the mouse infection model doesn‟t reflect exactly the pathogenic potential of Y. enterocolitica 
biotypes observed in cell culture models as these models show that all Y. enterocolitica 
biotypes display a pathogenic potential towards the epithelial and Macrophage cell lines 
(Grant et al., 1999; McNally et al., 2006; McNally et al., 2007).  As a result, it is important to 
test a new alternative infection model to investigate the pathogenic potential of                     
Y. enterocolitica biotypes using the insect alternative infection model the lepidopteran 
Galleria mellonella wax worms larvae. 
 
3.1.3 Insect Infection Model 
 
Insects have emerged as a non-mammalian infection model to study bacterial pathogens and 
the virulence potential of human pathogenic bacteria (Champion et al., 2009).  The ethical 
and financial problems of using mammals as an infection model are the main reasons to 
choose an alternative insect infection model to study human pathogens (Garcia-Lara et al., 
2005).  The Caenorhabditis elegans (C. elegans) nematode and the tobacco hornworm 
Manduca sexta  (M. sexta ) are two types of insect host models that have been used to study 
Y. enterocolitica insecticidal toxin genes (tc) and their expression at lower temperatures of 
10°C -15°C (Fuchs et al., 2008; Spanier et al., 2010).  However, C. elegans and M. sexta 
have not been successfully used to study Y. enterocolitica infection as they don‟t live well at 
temperatures over 25°C (Fuchs et al., 2008; Spanier et al., 2010). As such, Y. enterocolitica 
virulence factors which are mainly expressed at the optimal mammalian body temperature 
(37°C) will not be expressed, and the relevance of pathogenesis data is therefore questionable 
(Champion et al., 2009).  To counter this, the greater Wax Worm moth Galleria mellonella 
caterpillars, which can live in a range of 15°C - 37°C, have emerged as a successful 
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alternative infection model to study the pathogenesis of numerous bacterial pathogens 
(Bender et al., 2013; Harding et al., 2012; Harding et al., 2013; Kavanagh & Reeves, 2004) 
including the virulence of Yersinia pestis and Yersinia pseudotuberculosis (Champion et al., 
2009; Erickson et al., 2011). This is because of the Galleria larvae ability to survive at 37°C 
incubation temperature in the lab (Joyce et al., 2010).  Incubating Galleria at 37°C enables 
the investigation of many human pathogenic virulence mechanisms (Desbois and Coote, 
2011; Jander et al., 2000; Vogel et al., 2011).  The main advantage of G. mellonella over the 
other insect models is that it can survive at wide range of incubation temperatures ranging 
from 15°C to 37°C (Aperis et al., 2007) and even in higher temperatures as when it was used 
to investigate specific C. jejuni virulence traits at 42°C (Champion et al., 2010; Senior et al., 
2011).  Technically, Galleria larvae are large in size , with an approximate weight of 250mg, 
which helps to infect them rapidly with precise different bacterial doses (Champion et al., 
2010; Jander et al., 2000).  Galleria larvae can be easily handled and they are able to survive 
for almost three weeks before going into the pupal stage without the need for feeding 
(Champion et al., 2010).  In addition, Galleria doesn‟t require ethical permissions for 
experimental work (Seed et al., 2008).  Other unique advantages of Galleria insect model is 
their ability to be treated with antibiotic which helps to assess antimicrobial agents efficiency 
towards the microbial pathogens (Peleg et al., 2009; Vogel et al., 2011). 
 
Additionally, Galleria possess an innate immune system similar to the human immune 
system which is able to respond to microbial infections making Galleria an important insect 
infection model to study many pathogens (Fallon et al., 2011; Mukherjee et al., 2013). This 
insect immune response is believed to be developed from Galleria interaction with several 
microbes in their natural habitat in beehives (Fuchs et al., 2010).  The Galleria immune 
system include cellular and humoral components similar to the mammalian immune system 
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(Harding et al., 2013; Kavanagh and Reeves, 2004). The Galleria insect cuticle and 
antimicrobial peptides are the first line of the Galleria innate immune defence (Brennan et 
al., 2002).  The G. mellonella cuticle is a part of the innate immune system which acts as an 
efficient physical barrier as the mammalian skin against the invading pathogens. In the case 
of Galleria cuticle penetration, the G. mellonella produces antimicrobial peptides as an innate 
humoral response (Brennan et al., 2002; Kavanagh and Reeves, 2004; Senior et al., 2011). In 
addition, the Galleria innate immune system includes phagocytic cells called „haemocytes‟. 
There are six types of Haemocytes identified in G. mellonella (Brennan et al., 2002; Fuchs et 
al., 2010; Mylonakis et al., 2007).  The six identified types of haemocytes in Galleria 
lepidopteran insect are granulocytes, spherulocytes, prohemocytes, oenocytoids, coagulocytes 
and plasmatocytes (Fuchs et al., 2010; Salem et al., 2014).  Haemocytes are capable of  
phagocytosis and eliminate invading pathogens similarly to the human innate immune system 
neutrophils (Fallon et al., 2011).  
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3.2 Aim and Objectives  
3.2.1 Aim 
To study the pathogenic potential of Y. enterocolitica biotypes in HEp-2 cell line and            
G. mellonella insect model.     
 
3.2.2 Objectives  
A) To study the interaction of all Y. enterocolitica 1A, 1B, 2, 3, 4 and 5 biotypes with the 
HEp-2 human epithelial cell line in vitro by evaluating the association and invasion levels of 
all biotypes. 
B) To investigate the pathogenic potential of all Y. enterocolitica 1A, 1B, 2, 3, 4 and 5  
biotypes in the insect alternative infection model Galleria mellonella (G. mellonella) by 
calculating the medial lethal dose (LD50) and survival curves on different incubation 
temperatures.   
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3.3 Materials & Methods 
3.3.1 Y. enterocolitica strains growth conditions:  All tested bacterial strains in this chapter 
are listed in table 3.1. All tested Y. enterocolitica strains were pre-grown on LB agar plates 
and in LB broth medium at both 25°C or 37°C temperatures.  LB broth was incubated in 
shaker incubator at 200 rpm for 18 hours as described in chapter two section 2.1.  
 Table 3.1 Bacterial strains used in chapter 3  
No. Strain Name Bio/Serotype Biological Origin Source 
1 8081 1B/O:8 Human Thomson et al. 
(2006) 
2 5303 1A/O:5 Human McNally, UK 
3 21202 2/O:9  Pig McNally, UK 
4 5603 3/O:9 Human McNally, UK 
5 14902 3/O:5,27 Sheep McNally, UK 
6 01/2012 4/O:3 Human Claire Jenkins 
HPA,2012 
7 02/2012 4/O:3 Human Claire Jenkins 
HPA,2012 
8 1203 4/O:3 Human McNally, UK 
9 Y1 4/O:3 Human Petra Dersch, 
2009 
10 3094/96 5/O:2a,2b,3 Animal Fuchs lab 
11 E. coli DH5α (-ve) control   Unknown Invitrogen 
 
3.3.2 Statistical analysis  
The significance of difference between the number of associated and invasive bacterial cells 
for each tested strain and that of the negative control strain E. coli DH5α strain was 
determined using the one-way ANOVA test available in Excel (2010). The significance of 
difference between the LD50 values of Y. enterocolitica strains were determined using the one 
sample T-test .  The significance of difference in virulence between the Y. enterocolitica     
pre-growing temperatures and between the Galleria incubation temperatures were determined 
using the T-test of two independent samples.  All the above statistical analysis was done with 
a statistical significance with a P value of ≤0.05.  
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3.4 Results 
3.4.1 Association and Invasion  
The HEp-2 human epithelial cell line was used to screen the ability of 10 Y. enterocolitica 
strains to adhere and invade the cultured cell line monolayer in vitro.  These 10 strains 
represent all the 6 biotypes of Y. enterocolitica species and they were isolated from different 
human and animal origins. All the 10 strains were pre-grown at 2 different temperatures,  
25°C and the 37°C prior to infection of cultured HEp-2 cell line.  All tissue culture results are 
represented in figures 3.1 and 3.2.  Figure 3.1 represents the results of the Association and 
Invasion assays of the Y. enterocolitica strains pre-grown on 25°C, while figure 3.2 shows the 
Association and Invasion assays of the Y. enterocolitica strains pre-grown at 37°C.  
Association and Invasion values were represented in Log10 c.f.u/ml.    
 
3.4.1.1 Association and Invasion results of the HEp-2 cell line infected with                    
Y. enterocolitica strains pre-grown at 25°C:  
The results show that all biotypes are able to adhere and invade the HEp-2 epithelial human 
cell line, with the high pathogenic biotype 1B and the low pathogenic biotypes 2, 3   4 
showing increased ability to attach and invade the HEp-2 cell line. The average value of 
association was  6.2 Log10 c.f.u/ml while the average invasion value was  5 Log c.f.u/ml.  
These data show that 10% of the bacterial inoculum was able to attach to the cultured HEp-2 
epithelial monlayers and 1% of the original inoculum invaded the cultured HEp-2 cell line 
monolayers.  The statistical analysis shows that the difference between all the tested strains 
and the negative control in terms of association ability was statistically insignificant             
(p-value= 0.255). In addition, the statistical analysis shows that the difference between all the 
tested strains and the negative control in terms of invasion ability was statistically significant 
(p-value ≤0.05). In contrast, the low pathogenic biotype 5, strain 3094/96 shows an 
attenuated ability to invade the cultured HEp-2 cell line compared to the other high and low 
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pathogenic biotypes. The invasion value was 3.44 Log10 c.f.u/ml which was statistically 
significant with a p-value = 0.000141 compared to the invasion levels of the other pathogenic 
biotypes.  Similarly, the non-pathogenic biotype 1A strain 5303 was showing a low invasion 
levels (invasion = 3 Log10 c.f.u/ml) and the 5303 invasion levels were statistically significant 
with a p-value = 0.001569 compared to all the other pathogenic biotypes.  The negative 
control E .coli DH5α strain was completely non-invasive. Moreover, there was no statistical 
significance in levels of invasion between the non-pathogenic biotype 1A strain 5303 and the 
low pathogenic biotype 5 strain 3094 (p-value = 0.0513).  
 
Figure 3.1: Association and Invasion of the HEp-2 cell line infected with Y. enterocolitica 
strains  pre-grown at 25°C. Graph represents the mean value of three independent tissue 
culture experiments including Association and Invasion assays at 25°C pre-grown                 
Y. enterocolitica representative strains. Error bars were plotted after calculating the standard 
deviation of the mean.  10 different Y. enterocolitica strains representing all the 6 biotypes 
were used to infect the HEp-2 human epithelial cell line.  The high pathogenic strain 8081 
bio/serotype 1B/O:8 used as a positive control and the E. coli DH5α strain used as a negative 
control.  All the bacterial numbers were calculated using the Log10 c.f.u/ml.   
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3.4.1.2 Association and Invasion results of the HEp-2 cell line infected with                     
Y. enterocolitica strains pre-grown at 37°C: 
          The same 10 Y. enterocolitica representative strains were pre-grown at 37°C and were 
able to attach and invade the cultured HEp-2 epithelial human cell line. The high pathogenic 
biotype 1B and the low pathogenic biotypes 2, 3 and 4 strains again showing high attachment 
and invasion levels to the cultured HEp-2 cell line in vitro.  The statistical analysis shows that 
difference between all the tested strains and the negative control in terms of association 
ability was statistically insignificant (p-value= 0.2). In addition, the statistical analysis shows 
that difference between all the tested strains and the negative control in terms of invasion 
ability was statistically significant (p-value ≤0.01).  The low pathogenic strain 3094/96 
biotype 5 remained the least invasive pathogenic strain between all the other pathogenic 
biotypes with a statistical significance of p-value = 0.000167. The non-pathogenic 5303 
strain remained the least invasive strain between the all biotypes with a statistical significance 
of a p-value = 0.000157.  There was no statistical significance in levels of invasion between 
the non-pathogenic biotype 1A strain 5303 and the low pathogenic biotype 5 strain 3094       
(p-value = 0.057).  Interestingly, the high pathogenic biotype 1B and the low pathogenic 
biotypes 2, 3 & 4 strains showed higher levels of association and invasion exceeding the 
number of microorganisms added in the inoculum (average inoculum ≈ 7.2 Log10 c.f.u/ml, 
average association value≈ 7.8 Log10 c.f.u./ml and average invasion value ≈ 7.2. Log10 
c.f.u/ml).  The negative control E. coli DH5α strain was completely non-invasive.  
Data suggests that all Yersinia enterocolitica strains pre-grown at both 25°C and 37°C 
temperatures were able to associate with and invade HEp-2 cell line monolayers in vitro.  
Strains belonging to biotypes 1B, 2, 3 and 4 showed a potent ability to attach and invade 
HEp-2 cell line.  The biotype 5 strain revealed weak virulence potential to the tissue culture 
model while the non-pathogenic BT 1A strain 5303 was the weakest strain among all the 
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biotypes.  Y. enterocolitica biotypes strains were more virulent to the HEp-2 cell line when 
pre-grown at 37°C.  This high virulence was unexpected since the Y. enterocolitica             
pre-grown at 37°C has been suggested to not be able to adhere (Lassen and Kapperud, 1986; 
Okamoto et al., 1980) and not be able to invade the in vitro cell line models (Cornelis et al., 
1987).  The interesting result here is that the BT1A strain was still invasive at the 37°C      
pre-growing temperature.  
 
Figure 3.2: Association and Invasion of the HEp-2 cell line infected with Y. enterocolitica 
strains pre-grown at 37°C. The graph represents the mean value of three independent tissue 
culture experiments including Association and Invasion assays of Y. enterocolitica 
representative strains pre-grown at 37°C.  Error bars were plotted after calculating the 
standard deviation of the mean. 10 different Y. enterocolitica strains representing the all 6 
Biotypes were used to infect the HEp-2 human epithelial cell line.  The high pathogenic strain 
8081 Bio/serotype 1B/O8 was used as a positive control and the E.coli DH5α strain used as a 
negative control.  All the bacterial numbers were calculated using the Log10 c.f.u/ml.   
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3.4.2 Galleria mellonella Alternative Infection Model Results  
3.4.2.1 Median Lethal Dose (LD50) Results:  
The median lethal dose (LD50) values are presented in figure 3.3 and figure 3.4.  Galleria 
larvae were infected with the same 10 Y. enterocolitica strains used to infect the HEp-2 cell 
line.  Figure 3 shows the LD50 values of the Y. enterocolitica strains when pre-grown at 25°C 
while figure 4 shows the LD50 results of the Y. enterocolitica strains pre-grown at 37°C. In 
both figures, the blue bars represent the LD50 results required to kill the infected Galleria 
larvae incubated at 37°C temperature post infection (p.i.) while the red bars represent the 
LD50 results required to kill the Galleria larvae incubated at 25°C temperatures post infection 
(p.i.).  
3.4.2.1.1 LD50 results of Y. enterocolitica strains pre-grown at 25°C: 
LD50 values of the 10 Y. enterocolitica representative strains pre-grown at 25°C are shown in 
figure 3.3.  Galleria mellonella larvae were infected with these strains and the infected larvae 
were incubated at two different temperatures, 25°C and 37°C. The blue bars represent the 
mean results of three independent experiments of incubating the infected Galleria larvae at 
37°C while the red bars shows the mean results of three independent experiments of 
incubating the infected Galleria larvae at 25°C.  All the LD50 values were calculated using 
the Spearman-Karber method.  High LD50 numbers indicate low pathogenicity in the model 
while small values represent high virulence of the strains used.  The observed data shows  
that the non-pathogenic 5303 strain has the lowest LD50 at both incubation temperatures. The 
non-pathogenic 5303 strain has a LD50 of only 10 bacteria when infected Galleria are 
incubated at 25°C while the LD50 at 37°C was 6.6 Log10c.f.u/ml. Conversely, the high 
pathogenic 8081 strain displays the highest LD50 result at 37°C incubation compared to all 
the other biotypes. The LD50 dose was 9.6 Log10 c.f.u/ml which means that the highest 
injected dose 2.33x10
9
 (Log10 c.f.u/ml = 9.36) was not able to kill any of the injected larvae 
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at 37°C incubation.  Additionally, the LD50 of the high pathogenic 8081 strain incubated at 
25°C was 7.6 Log10 c.f.u/ml. This LD50 value is in the same range as the low-pathogenic 
biotypes incubated at 25°C. The low pathogenic 14902 strain which belongs to the 
Bio/serotype 3/O:5,27 displayed the lowest LD50 values at 25°C incubation compared to the 
other low pathogenic and the high pathogenic biotypes while the LD50 results at 37°C 
incubation remain similar to the other low and high pathogenic biotypes.  Finally, the low 
pathogenic strain 3094/96 belonging to biotype 5 has the highest LD50 value at 25°C 
incubation, while the 37°C incubation results showing a similar LD50 result with the others. 
 
Figure 3.3 LD50 Results of Y. enterocolitica strains pre-grown at 25°C with the mean of three 
independent repeats of the LD50 experiments of infecting Galleria mellonella larvae with 10 
Y. enterocolitica representative strains that were pre-grown at 25°C. The infected Galleria 
larvae were incubated on 2 different temperatures; the 25°C & the 37°C temperatures.  The 
blue bars represent the mean of three different LD50 values for the Galleria larvae incubated 
at 37°C post infection. The red bars represent the mean of three different LD50 values for the 
Galleria larvae incubated at 25°C post infection. The LD50 values were calculated using the 
Spearman-Karber method.  Error bars were plotted after calculating the standard deviation of 
the mean. 
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3.4.2.1.2  LD50 results of Y. enterocolitica strains pre-grown at 37°C: 
LD50 values of the Y. enterocolitica strains pre-grown at 37°C are shown in figure 3.4.  
Galleria mellonella larvae were infected with these strains and the infected larvae were then 
incubated at two different temperatures; 25°C and 37°C.  Similar to figure 3.3, the blue bars 
represents the mean results of three independent experiments incubating the Galleria larvae 
at 37°C while the red bars show the mean results of three independent experiments 
incubating the Galleria larvae at 25°C.  All the LD50 values were calculated using the 
Spearman-Karber method.  The high LD50 numbers indicate the low virulence effect while 
the small LD50 values represent the high virulence of the strains used.  From the graph it can 
be noticed that the non-pathogenic 5303 strain again has the lowest LD50 at both incubation 
temperatures compared to the other biotypes with 1.4 and 1 Log10 c.f.u/ml LD50 value (≈10 
bacteria) at 25°C incubation temperature and 6.6 + 6.5 Log10 c.f.u/ml LD50 dose at 37°C 
incubation. To the contrary, both of the high pathogenic 8081 strain and the low pathogenic 
strain 3094/96 (biotype 5) share the highest LD50 values at both incubation temperatures 
between all the other biotypes. The low pathogenic 14902 (Bio/serotype 3/O:5,27) again 
showed the lowest LD50 result at 25°C incubation temperature, in comparison with the other 
low- and the high pathogenic biotypes, whereas the LD50 result at 37°C incubation condition 
continue to be in the same range with the other low and high pathogenic biotypes. 
The LD50 values obtained when infected larvae were incubated at 25°C were always lower 
than the LD50 values at 37°C except in one condition when the larvae were infected with 
strain 3094/96, pre-grown at 25°C, and incubated at 25°C.  Eight of the ten Y. enterocolitica 
representative strains show a difference in LD50 values not exceeding 2 logarithmic units 
between the two infected Galleria incubation temperatures.  However, the difference in LD50 
between both incubation temperatures was the highest in the non-pathogenic strain 5303 with 
approximately 5.4 logarithmic units while it is around 3.8 logarithmic units in the low 
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pathogenic strain 14902.  Moreover, the LD50 values of each Y. enterocolitica representative 
strain were closely similar when these strains were pre-grown either at 25°C or 37°C 
temperatures except for the Y1 strain of bioserotype 4/O:3.  The Y1 strain pre-grown at 37°C 
was more virulent to the Galleria larvae when pre-grown at 25°C.  The LD50 values of the Y1 
strain were 8.6 and 7.6 at 37°C and 25°C incubation temperatures respectively while          
pre-growing Y1 strain at 25°C show reduced LD50 values at 6.7 and 6.5 for the 37°C and the 
25°C incubation temperatures respectively.    
 
Figure 3.4 LD50 results of Y. enterocolitica strains pre-grown at 37°C with the mean of three 
independent repeats of the LD50 experiments of infecting Galleria mellonella larvae with 10 
Y. enterocolitica representative strains that were pre-grown at 37°C.  These strains represent 
all the 6 Biotypes of Y. enterocolitica species. The infected Galleria larvae were incubated at 
2 different temperatures, 25°C & 37°C temperatures.  The blue bars represent the mean of 
three different LD50 values for the Galleria larvae incubated at 37°C post infection. The red 
bars represent the mean of three different LD50 values for the Galleria larvae incubated at 
25°C post infection. The LD50 values were calculated using the Spearman-Karber method.  
Error bars were plotted after calculating the standard deviation of the mean. 
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3.4.2.2 Survival Curves  
3.4.2.2.1 Survival curves of Galleria infected with strain YE5303 (BT 1A/O:5) 
 
Strain 5303 was pre-grown at 25°C and 37°C.  Both temperatures led to the 5303 strain being 
virulent to Galleria larvae.  5303 strain pre-grown at 25°C caused death to the Galleria 
larvae when incubated at 25°C and 37°C (fig. 5.3a & 5.3b).  At the 37°C incubation 
temperature (fig. 5.3a), 4 doses including 10
9
,10
8
,10
7
 and 10
6
 doses were virulent to the 
Galleria larvae.  Both the 10
9
 and 10
8
 doses caused death for all larvae within 24h p.i.  In 
addition, doses of 10
7
 and 10
6
 caused the death of 3 larvae (60% survival) in each of these 
doses within the same time point of 96h p.i.  At the 25°C incubation temperature (fig 5.3b), 
all 9 used doses caused death of Galleria larvae including doses from 10
1
-10
9
.  Doses from 
10
2
-10
9
 killed all the larvae at varying time points.   Doses 10
9
,10
8
 and 10
7
 killed all the 
larvae in each dose after 24h p.i. while doses 10
6
,10
5
,10
4
,10
3
 and 10
2
 killed all the larvae after 
48h p.i.  In addition 10
1
 dose killed 3 larvae (40% survival) after 48h p.i.   Furthermore, 5303 
strain pre-grown at 37°C had a very similar survival-curve profile to that observed when the 
strain was pre-grown at 25°C (Fig. 5.3c & 5.3d).  At the 37°C incubation condition (Fig. 
5.3c), 4 doses including 10
9
,10
8
,10
7
 and 10
6
 caused mortality to the Galleria larvae.  10
9
 and 
10
8
 doses killed all the Galleria larvae during 24h p.i. in both doses.  The 10
7
 dose killed 3 
larvae (40% survival) during 72h p.i. while the 10
6
 dose killed 2 larvae (60% survival) after 
48h p.i.  In the 25°C incubation condition (Fig 5.3d), all the 9 used doses killed the Galleria 
larvae in doses from 10
1
-10
9
.  Doses from 10
2
-10
9
 killed all the Galleria larvae with a 
different time points.   Doses 10
9
,10
8
,10
7
 and 10
6
 killed all Galleria larvae in each dose after 
24h p.i.  while doses 10
5
,10
4
,10
3
 and 10
2
 killed all the larvae after 48h p.i.  Finally, 10
1
 dose 
killed 4 larvae (20% survival) after 48h p.i.  These results show that the non-pathogenic 5303 
strain was lethal to Galleria larvae regardless of the temperature it is pre-grown at.  The 
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infected Galleria larvae incubated at 25°C were susceptible to killing with all the doses used.  
However, when infected larvae were incubated at 37°C they were susceptible only to the 
10
9
,10
8
,10
7
 and 10
6
 doses. This is a 5 log reduction in lethal dose for the larvae incubated at 
25°C compared to the 37°C incubation temperature.    
a-Survival curve of Galleria incubated at 37°C and  infected with strain YE5303 pre-grown 
at 25°C  
 
b- Survival curve of Galleria incubated at 25°C and  infected with strain YE8081 pre-grown 
at 25°C  
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c- Survival curve of Galleria incubated at 37°C and  infected with strain YE8081 pre-grown 
at 37°C  
 
d- Survival curve of Galleria incubated at 25°C and  infected with strain YE8081 pre-grown 
at 37°C  
 
Figure 3.5: Survival curves of Galleria infected with the non-pathogenic strain YE5303 (BT 
1A/O:5).  Figure 3.5 includes four sub figures (3.5a, 3.5b, 3.5c & 3.5d) representing the 
percentage of survival rates of the Galleria mellonella larvae infected strain 5303.  A number 
of 5 larvae used for each dose. Figures 3.5a & 3.5b represent the Galleria survival percentage 
graphs injected with strain 5303 strain pre-grown at 25°C; Figure 3.5a shows the survival 
results of incubating the Galleria larvae at 37°C post infection while figure 3.5b shows the 
survival results of incubating Galleria larvae at 25°C post infection. Figures 3.5c & 3.5d 
represent the Galleria survival percentage graphs injected with strain 5303 pre-grown at 
37°C; Figure 3.5c shows the survival of Galleria at 37°C post infection while figure 3.5d 
shows the survival of Galleria at 25°C incubation. Values shown in each survival graph are 
representative values obtained from performing the experiment in triplicate.  
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3.4.2.2.2 Survival curves of Galleria infected with strain YE8081 (BT 1B/O:8) 
 
Strain 8081 Bioserotype 1B was pre-grown at 25°C and 37°C and doses from each pre-grown 
temperature were injected into Galleria larvae which were incubated at 25°C and 37°C.  The 
8081 strain didn‟t cause any death to the infected larvae when the larvae were incubated at 
37°C (Fig. 3.6a & 3.6c).  However when larvae were incubated at 25°C, doses from 8081 
strain pre-grown at both 25°C and 37°C caused killing to the Galleria larvae (Fig. 3.6b & 
3.6d).  Doses 10
9
,10
8
 and 10
7
 of the 8081 pre-grown at 25°C caused death to the injected 
Galleria larvae (Fig. 3.6b).  Doses 10
9
 and 10
8
 killed all the larvae groups after 24h p.i. while 
10
7
 dose killed all the Galleria larvae after 72h p.i.  The 10
9
 and 10
8
 doses of 8081 pre-grown 
at 37°C caused death to Galleria larvae with the 10
9
 dose killing 4 larvae (20% survival) at 
24h p.i. while the 10
8
 dose killed one larva (80% survival) after 72h p.i (Fig. 3.6d).  In 
summary, the injected larvae with the 8081 strain pre-grown at 25°C didn‟t die at the 37°C 
incubation temperature.  Contrary, 8081 strain caused death to the infected Galleria larvae 
incubated at 25°C temperature.  At the 25°C incubation condition, 8081 strain pre-grown on 
25°C caused more death to Galleria compared to the infection with doses from the 37°C pre-
grown 8081 strain.  
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a- Survival curve of Galleria incubated at 37°C and  infected with strain YE8081 pre-grown 
at 25°C  
 
b- Survival curve of Galleria incubated at 25°C and  infected with strain YE8081 pre-grown 
at 25°C  
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c- Survival curve of Galleria incubated at 37°C and  infected with strain YE8081 pre-grown 
at 37°C  
 
d- Survival curve of Galleria incubated at 25°C and  infected with strain YE8081 pre-grown 
at 37°C  
Figure 3.6:  Survival curves of Galleria infected with the high pathogenic strain YE8081 (BT 
1B/O:8). Figure 3.6 includes four sub figures (3.6a, 3.6b, 3.6c & 3.6d) representing the 
percentage of survival rates of the Galleria larvae infected strain 8081. A number of 5 larvae 
were used for each dose. Figures 3.6a & 3.6b represent the Galleria survival injected with 
strain 8081 pre-grown at 25°C; Figure 3.6a shows the survival of incubating Galleria at 37°C 
while figure 3.6b shows the survival of incubating Galleria at 25°C post infection. Figures 
3.6c & 3.6d represent the Galleria survival percentage graphs injected with the strain 8081 
pre-grown at 37°C; Figure 3.6c shows the survival results of incubating the Galleria larvae at 
37°C post infection while figure 3.6d shows the survival of Galleria larvae at 25°C 
incubation. Values shown in each survival graph are representative values obtained from 
performing the experiment in triplicate.  
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3.4.2.2.3 Survival curves of Galleria infected with strain YE14902 (BT 3/O:5,27)  
Strain 14902 was pre-grown at both 25°C and 37°C and both growing temperature induced 
virulence into the infected Galleria larvae.  Strain 14902 pre-grown at 25°C induced death in 
the infected larvae incubated at both 25°C and 37°C incubation temperatures (Fig. 3.7a & 
3.7b).  At the 37°C incubation temperature, dose 10
9
 and dose 10
8
 caused mortality in the 
infected Galleria larvae by which dose 10
9
 killed all the Galleria larvae during 24h p.i. while 
the 10
8
 dose killed 4 larvae (80% survival) after 24h p.i (Fig. 3.7a). At the 25°C incubation 
condition, 7 different doses killed the infected larvae and these doses are 
10
3
,10
4
,10
5
,10
6
,10
7
,10
8
 and 10
9 
(Fig. 3.7b).  All the Galleria larvae groups infected with 
doses 10
9
,10
8
,10
7
 and 10
6
 were killed.  Doses 10
9
,10
8
 and 10
7
 killed all the infected larvae at 
24h p.i. while 10
6
 killed all the infected larvae at 72h p.i.  In addition, each of the 10
4
 and 10
5
 
doses killed 4 larvae (20% survival) after 120h p.i. while the 10
3
 dose killed only 1 larva 
(80% survival) after 24h p.i.  Pre-growing the 14902 strain at 37°C lead to death of the 
infected larvae at both incubation temperatures (25°C and 37°C); (Fig. 3.7c & 3.7d).  In the 
37°C incubation temperature, 10
9
 and 10
8
 doses caused death to the Galleria larvae where the 
10
9
 dose killed all the larvae after 24h p.i. while the 10
8
 dose killed 2 larvae (60% survival) 
after 24h p.i (Fig. 3.7c).  At the 25°C incubation temperature, doses from 10
3
-10
9
 caused 
death to the infected Galleria larvae (Fig. 3.7d).  Doses 10
9
 and 10
8
 killed all the Galleria 
groups at 24h p.i. and 48h p.i. respectively for each dose.  Dose 10
7
 killed 4 larvae (80% 
survival) after 48h p.i.  Doses 10
6
 and 10
5
 killed 3 larvae (40% survival) of the infected 
larvae groups at the same 72h p.i. time point for both doses.  In addition, dose 10
4
 killed 2 
larvae (60% survival) during 72h p.i. while dose 10
3
 killed 1 larva (80% survival) after 72h 
p.i.  Strain 14902 was more lethal at 25°C incubation condition compared to the 37°C 
incubation. At the 37°C incubation temperatures the first 3 high doses 10
7
-10
9
 caused death 
to the injected Galleria larvae while at 25°C incubation temperature a wider range of doses 
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10
3
-10
9
 caused death to the infected larvae.  However, pre-growing 14902 strain at the 25°C 
temperature shows a small increase in virulence towards the infected larvae.   
a- Survival curve of Galleria incubated at 37°C and  infected with strain YE14902 pre-grown 
at 25°C  
 
b- Survival curve of Galleria incubated at 25°C and  infected with strain YE14902 pre-grown 
at 25°C  
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c- Survival curve of Galleria incubated at 37°C and  infected with strain YE14902 pre-grown 
at 37°C  
 
d- Survival curve of Galleria incubated at 25°C and  infected with strain YE14902 pre-grown 
at 37°C  
Figure 3.7: Survival curves of Galleria infected with the low pathogenic strain YE14902 (BT 
3/O:5,27). Figure 3.7 includes four sub figures (3.7a, 3.7b, 3.7c & 3.7d) representing the  
survival of Galleria infected with the strain 14902. Figures 3.7a & 3.7b represent the 
Galleria survival graphs injected with strain 14902 pre-grown at 25°C;  Figure 3.7a shows 
the survival of Galleria at the 37°C incubation while figure 3.7b shows the survival of 
incubating Galleria larvae at 25°C post infection. Figures 3.7c & 3.7d represent the Galleria 
survival injected with strain 14902 pre-grown at 37°C; Figure 3.7c shows the survival of 
Galleria at 37°C while figure 3.7d shows the survival Galleria at 25°C incubation. Values 
shown in each survival graph are representative values obtained from performing the 
experiment in triplicate.  
0
20
40
60
80
100
120
2 4 6 8 10 24 48 72 96 120
Su
rv
iv
al
 p
e
rc
e
n
ta
ge
 
Observation time post infection (h) 
No Injection
PBS
1.00E+07
1.00E+08
1.00E+09
0
20
40
60
80
100
120
2 4 6 8 10 24 48 72 96 120
Su
rv
iv
al
 p
e
rc
e
n
ta
ge
 
Obsevation time post infection (h) 
No Injection
PBS
1.00E+02
1.00E+03
1.00E+04
1.00E+05
1.00E+06
1.00E+07
1.00E+08
1.00E+09
59 
 
3.4.2.2.4 Survival Curves Galleria infected with Strain YE5603 (BT 3/O:9): 
 
Low pathogenic strain 5603 which belongs to bioserotype 3/O:9 was able to kill Galleria 
larvae when pre-grown at both 25°C and 37°C temperatures.  At 25°C and 37°C incubation 
of the infected larvae, the 25°C and 37°C pre-grown cultures were lethal to Galleria at only 
the highest doses 10
8
 and 10
9
.  5603 strain pre-grown at 25°C killed all the injected larvae 
groups after 24 h p.i with the highest dose 10
9
 in both of the larvae incubation temperatures 
25°C and 37°C (Fig. 3.8a & 3.8b).  The 10
8
 dose killed 4 larvae (20% survival) within 48 
hours p.i. in the 37°C incubation condition (Fig. 3.8a) while the same dose killed 3 larvae 
(40% survival) and in a longer period of 72h at the 25°C incubation temperature (Fig. 3.8b).  
The virulence effect of strain 5603 was similar when it was pre-grown at 37°C. The 10
9
 and 
10
8
 doses of 5603 strain pre-grown at 37°C was able to kill Galleria larvae.  The 10
9
 dose 
killed all larvae within 24 h p.i. The 10
8
 dose killed 3 larvae (60%) after 72h at the 37°C 
incubation (Fig. 3.8c) while at the 25°C incubation temperature all larvae were killed with in 
72h p.i (Fig. 3.8d). 
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a- Survival curve of Galleria incubated at 37°C and  infected with strain YE5603 pre-grown 
at 25°C  
 
 
b- Survival curve of Galleria incubated at 25°C and  infected with strain YE5603 pre-grown 
at 25°C 
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c- Survival curve of Galleria incubated at 37°C and  infected with strain YE5603 pre-grown 
at 37°C 
 
 d- Survival curve of Galleria incubated at 25°C and  infected with strain YE5603 pre-grown 
at 37°C 
 
Figure 3.8: Survival curves of Galleria infected with the low pathogenic strain YE5603 (BT 
3/O:9). Figure 3.8 includes four sub figures (3.8a, 3.8b, 3.8c & 3.8d) representing the 
percentage of survival rates of the Galleria larvae infected with the strain 5603. A number of 
5 larvae were used for each dose. Figures 3.8a & 3.8b represent the Galleria survival 
percentage injected with strain 5603 pre-grown at 25°C; Figure 3.8a shows the survival 
results of incubating Galleria at 37°C post infection while figure 3.8b shows the survival 
results of incubating Galleria at 25°C post infection. Figures 3.8c & 3.8d represent the 
Galleria survival percentage graphs injected with strain 5603 pre-grown at 37°C; Figure 3.8c 
shows the survival results of incubating the Galleria larvae at 37°C post infection while 
figure 3.8d shows the survival results of incubating Galleria larvae at 25°C post infection. 
Values shown in each survival graph are representative values obtained from performing the 
experiment in triplicate.  
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3.4.2.2.5 Survival curves of Galleria infected with strain YE21202 (BT 2/O:9): 
 
Low pathogenic strain 21202 (bioserotype 2/O:9) was also virulent to Galleria larvae at both 
pre-growing temperatures (25°C and 37°C).   The larvae injected with the 25°C pre-grown 
21202 strain were killed with doses of 10
8
 and 10
9
 at the 37°C incubation temperature       
(Fig. 3.9a) while at the 25°C incubation temperature the lethal doses where 10
7
,10
8
 and 10
9
 
(Fig. 3.9b).  At 37°C incubation temperature, the 10
9
 highest dose killed all the 5 larvae 
during 24 h post infection and the 10
8
 dose killed all the 5 larvae after 96h p.i.  At the 25°C 
incubation temperature, 10
9
 dose killed all the larvae within 24 hours p.i., 10
8
 dose killed 4 
larvae (20% survival) after 120 hours post infection while 10
7
 dose killed only 1 larva (80% 
survival) after 96h p.i. Moreover, pre-growing strain 21202 at 37°C temperature lead to death 
of the Galleria larvae in both incubation temperatures. At the 37°C incubation temperature 
(Fig. 3.9c), 10
9
, 10
8
 doses were virulent to the Galleria larvae while on the 25°C incubation 
temperature (Fig. 3.9d), 4 doses managed to cause mortality to Galleria (10
6
-10
9
 doses).  
Dose 10
9
 killed all the Galleria larvae after 24h and the 10
8
 dose killed 4 larvae (20% 
survival) after 48h.  In the 25°C incubation temperature, the 10
9
 dose managed to kill all the 
larvae within 24 h p.i.  The 10
8
 dose was lethal to 3 larvae (40% survival) at 48h p.i, 10
7
 dose 
killed 2 larvae (60% survival) and 10
6
 dose killed 1 larva (80% survival) at 48 hours post 
infection. 
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a- Survival curve of Galleria incubated at 37°C and  infected with strain YE21202 pre-grown 
at 25°C 
 
b- Survival curve of Galleria incubated at 25°C and  infected with strain YE21202 pre-grown 
at 25°C 
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c- Survival curve of Galleria incubated at 37°C and  infected with strain YE21202 pre-grown 
at 37°C 
 
d- Survival curve of Galleria incubated at 25°C and  infected with strain YE21202 pre-grown 
at 25°C 
 
Figure 3.9: Survival curves of Galleria infected with the low pathogenic strain YE21202 (BT 
2/O:9). Figure 3.9 includes four sub figures (3.9a, 3.9b, 3.9c & 3.9d) representing the 
percentage of survival rates of the Galleria infected with strain 21202. A number of 5 larvae 
were used for each dose. Figures 3.9a & 3.9b represent the Galleria survival injected with 
strain 21202 strain pre-grown at 25°C; Figure 3.9a shows the survival of Galleria incubated 
at 37°C post infection while figure 3.9b shows the survival of incubating Galleria at 25°C. 
Figures 3.9c & 3.9d represent the Galleria survival injected with strain 21202 pre-grown at 
37°C; Figure 3.9c shows the survival results of incubating the Galleria larvae at 37°C post 
infection while figure 3.9d shows the survival results of incubating Galleria larvae at 25°C 
post infection. Values shown in each survival graph are representative values obtained from 
performing the experiment in triplicate.  
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3.4.2.2.6 Survival curves of Galleria infected with strain YE1203 (BT 4/O:3): 
Low pathogenic strain 1203, of bioserotype 4/O:3, was able to show mortality to Galleria 
larvae with both 25°C and 37°C pre-grown temperatures.  Strain 1203 is the representative 
strains of the bioserotype 4/O:3 used to infect the Galleria larvae.  With the 1203 strain 25°C 
pre-grown temperature, the infected larvae were killed with the 3 highest doses 10
9
,10
8
 and 
10
7
 at the 37°C incubation temperature (Fig. 3.10a) while at the 25°C incubation temperature 
only the highest doses 10
8
 and 10
9
 were lethal to the infected larvae (Fig. 3.10b).  At the 37°C 
incubation temperature (Fig. 3.10a), 10
9
 dose killed all the infected larvae after 24 hours. 10
8
 
dose killed 4 larvae (20% survival) and the 10
7
 dose killed 2 larvae (40% survival) and both 
killing times were observed after 24 hours.  At the larval 25°C incubation temperature (Fig. 
3.10b), 10
8
 and 10
9
 doses killed all the infected larvae by which 10
9
 dose killed all larvae 
within 24h while the 10
8
 dose killing effect proceeded to the 120h p.i. time point.  When the 
1203 strain was pre-grown at 37°C, only the highest doses 10
9
 and 10
8
 caused death to the 
infected larvae. The 10
9
 dose killed all the infected larvae after 24 h p.i. and the 10
8
 dose 
killed 3 larvae (40% survival) within 96h at both 25°C and 37°C incubation temperatures 
(Fig. 3.10c & 3.10d).  These result show that pre-growing the 1203 strain on 25°C 
temperature shows  a higher virulence to the infected Galleria at the 37°C incubation 
temperature compared to a less virulence at the 25°C larval incubation temperature.  
However, pre-growing the 1203 strain on the 37°C temperature was more virulent to the 
infected Galleria larvae when the larvae incubated at the 25°C temperature from the larvae 
incubated at 37°C.    
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a-Survival curve of Galleria incubated at 37°C and  infected with strain YE1203 pre-grown 
at 25°C 
 
 
b- Survival curve of Galleria incubated at 25°C and  infected with strain YE1203 pre-grown 
at 25°C 
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c- Survival curve of Galleria incubated at 37°C and  infected with strain YE1203 pre-grown 
at 37°C 
 
d- Survival curve of Galleria incubated at 25°C and  infected with strain YE1203 pre-grown 
at 37°C 
 
Figure 10: Survival curves of Galleria infected with the low pathogenic strain 1203 (BT 
4/O:3). Figure 3.10 includes four sub figures (3.10a, 3.10b, 3.10c & 3.10d) representing the 
percentage of survival rates of the Galleria larvae infected with strain 1203. A number of 5 
larvae were used for each dose. Figures 3.10a & 3.10b represent the Galleria survival 
injected with strain 1203 pre-grown at 25°C; Figure 3.10a shows the survival of Galleria 
incubated at 37°C while figure 3.10b shows the survival results of incubating Galleria at 
25°C post infection. Figures 3.10c & 3.10d represent the Galleria survival injected with 
strain 1203 pre-grown at 37°C; Figure 3.10c shows the survival results of incubating the 
Galleria larvae at 37°C post infection while figure 3.10d shows the survival results of 
incubating Galleria larvae at 25°C post infection. Values shown in each survival graph are 
representative values obtained from performing the experiment in triplicate.  
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3.2.2.2.7 Survival curves of Galleria infected with strain YE3094/96 (BT 5/O: 2a,2b,3) 
Low pathogenic strain 3094/96 (Bioserotype 5/O: 2a,2b,3) was pre-grown at 25°C and 37°C 
and doses from each pre-growing temperature caused death in Galleria larvae.  Injecting 
Galleria larvae with the 25°C pre-grown 3094/96 strain caused death in larvae incubated at 
25°C and 37°C (Fig. 3.11a & 3.11b). At the 37°C incubation temperature (Fig. 3.11a), dose 
10
9
 and dose 10
8
 was able to kill Galleria larvae.  The 10
9
 dose killed all the larvae after 24h 
p.i. and the 10
8
 dose killed 4 larvae (20% survival) within a period of 48h p.i.  At the 25°C 
incubation temperature (Fig. 3.11b), only the 10
9
 dose caused killing to the injected larvae by 
which 3 larvae (40% survival) killed within 72h p.i.  Furthermore, the infected Galleria 
larvae with different doses from growing the 3094/96 strain at 37°C caused death in both pre-
growing conditions.  At both larval incubating conditions, the only mortal dose was 10
9
.  
Dose 10
9
 killed 4 larvae (80% survival) within 24h p.i. at the 37°C incubation temperature 
(Fig. 3.11c) while this dose killed only 2 larvae (60% survival) at 24h p.i. in the 25°C larval 
incubation condition (Fig. 3.11d). There was a difference in virulence between pre-growing 
the 3094/96 strain at 25°C from 37°C.  The 25°C pre-growing temperature of the 3094/96 
strain caused more death to Galleria larvae compared to the 37°C pre-growing temperature.  
However, the infected Galleria larvae incubated at 37°C were more susceptible for killing 
from ones incubated at 25°C.  In addition, it has been observed that the effective lethal dose 
for the 3094/96 strain was only the 10
9
 dose in most of the larval incubating conditions.  This 
reflects the low pathogenic potential of the 3094/96 strain. 
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a- Survival curve of Galleria incubated at 37°C and  infected with strain YE3094/96 pre-
grown at 25°C 
 
b- Survival curve of Galleria incubated at 25°C and  infected with strain YE3094/96 pre-
grown at 25°C 
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c- Survival curve of Galleria incubated at 37°C and  infected with strain YE3094/96 pre-
grown at 37°C 
 
d- Survival curve of Galleria incubated at 25°C and  infected with strain YE3094/96 pre-
grown at 37°C 
 
Figure 3.11: Survival curves of Galleria infected with the low pathogenic strain YE3094/96 
(BT 5/O:2a,2b,3). Figure 3.11 includes four sub figures (3.11a, 3.11b, 3.11c & 3.11d) 
representing the survival of Galleria infected with strain 3094/96. A number of 5 larvae were 
used for each dose. Figures 3.11a & 3.11b represent the Galleria survival injected with strain 
3094/96 pre-grown at 25°C; Figure 3.11a shows the survival Galleria larvae incubated at 
37°C post infection while figure 3.11b shows the survival results of incubating Galleria at 
25°C post infection. Figures 3.11c & 3.11d represent the Galleria survival injected with 
strain 3094/96 pre-grown at 37°C; Figure 3.11c shows the survival results of incubating the 
Galleria larvae on 37°C post infection while figure 3.11d shows the survival results of 
incubating Galleria larvae at 25°C post infection. Values shown in each survival graph are 
representative values obtained from performing the experiment in triplicate.  
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In summary, all Y. enterocolitica strains start killing the Galleria larvae within 24h.  
However, the low-pathogenic and high-pathogenic strains were killing fewer numbers of 
Galleria larvae and in longer time periods.  All injected doses of high pathogenic biotype 
1B/O:8 strain 8081 were avirulent to Galleria larvae at 37°C incubation condition.  On the 
other hand, all injected doses of the non-pathogenic biotype biotype 1A/O:5 strain 5303 were 
able to kill the injected Galleria larvae.  Y. enterocolitica strains were killing higher numbers 
of Galleria larvae at 25°C incubation temperature and fewer numbers at the 37°C incubation 
condition.   
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3.5 Discussion 
          Y. enterocolitica have two life stages including living freely in the environment 
followed by a stage of living inside a specific host. The free-living period includes the growth 
of Y. enterocolitica strains in nature in temperatures below  28°C while the host-dependent 
stage requires the growth of Y. enterocolitica in temperatures above 35°C (Young et al., 
1999).  Y. enterocolitica adapts its physiological characteristics including its virulence factors 
as a result of changes in the environmental conditions (Bottone, 1997). Most Y. enterocolitica 
virulence factors are thermoregulated and their expression or repression is regulated by 
temperature (Fàbrega and Vila., 2012).  For this reason, the pathogenicity of Y. enterocolitica 
biotypes at two different temperatures; 25°C and the 37°C was studied.  The 25°C 
temperature is known to be the optimal temperature to grow Y. enterocolitica strains (Gu et 
al., 2012) because Y. enterocolitica shows higher metabolism levels and more physiological 
activities at this temperature (Grassl et al., 2003; Gu et al., 2012; Kawaoka et al., 1983). In 
contrast, at 37°C temperature, Y. enterocolitica strains show lower metabolic levels and most 
of the physiological activities are abolished (Kawaoka et al., 1983).  In addition, Y. 
enterocolitica pathogenic biotypes undergo virulence gene induction upon temperature 
shifting from environmental temperatures (25°C-28°C) to the 37°C human optimal body 
temperature (Fàbrega and Vila., 2012). Since Y. enterocolitica is environmentally ubiquitous 
(Rahman et al., 2011), this shift in temperature is essential in allowing the organism to move 
from the free living state and adapt to the mammalian host (Fàbrega and Vila., 2012). Y. 
enterocolitica pathogenic strains have been found to be more efficient at invading 
mammalian cells after this temperature upshift from 25°C to 37°C (Fàbrega and Vila., 2012 
& Kawaoka et al., 1983). The most significant thermoregulated virulence factor in Y. 
enterocolitica pathogenic strains is the VirF transcription regulator protein.  VirF is encoded 
by the pYV plasmid and is highly expressed and activated after shifting to the 37°C 
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temperature (Fàbrega and Vila., 2012 & Rohde et al., 1999). When it is expressed, VirF up 
regulates the secretion of the Yop proteins and the assembly of Ysc secretion system subunits 
to start the infection of the intestine epithelial tissue and to overcome the immune protection 
of the host (Fàbrega and Vila., 2012).  The high pathogenic biotype 1B is considered the most 
virulent of all the Y. enterocolitica biotypes since it is lethal in the mouse infection model in 
addition to its acquisition of extra virulence factors such as the high pathogenic island (HPI) 
and the Ysa chromosomal type three secretion system (Garzetti et al., 2012).  The high 
pathogenic strain 8081 shows a high invasion potential toward the HEp-2 cell line on both 
pre-growing temperatures (25°C and 37°C).  However, the 8081 strain gave unexpected 
results with the Galleria larvae infection model, and was completely avirulent to the Galleria 
larvae incubated at 37°C post infection.  However 8081 strain was able to kill Galleria larvae 
injected with doses of 10
9
,10
8
 and 10
7
 cfu/ml incubated at 25°C after 24 hours post infection. 
Indeed at the 37°C incubation temperature, the high pathogenic biotype was the least virulent 
of all the biotypes.  At the Galleria 37°C incubation, the 25°C pre-grown 8081 strain and the 
37°C pre-grown 8081 strain were the weakest strains with a statistical significance of p-value 
= 0.000979 and p-value = 0.001232 respectively for each strain compared to all other 
biotypes. At the 25°C incubation condition, the high pathogenic biotype lethal dose (LD50) 
was similar to the effect of the other low pathogenic biotypes which logically should be 
higher (LD50=7.6 and 8.7 Log10c.f.u/ml).   
The non-pathogenic strain 5303 also showed unexpected results and was the most lethal of all 
the biotypes used to infect the Galleria host model.  Although the 5303 strain was the strain 
least able to invade the tissue culture cell line, it was the most virulent strain towards the 
Galleria larvae.  The extraordinarily high lethal effect was detected (when the strain was pre-
grown at both 25°C and 37°C) and also at both of the incubation temperatures used (25°C 
and 37°C) post-infection.  The LD50 values of strain 5303 at the Galleria 37°C incubation 
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were the lowest compared to all the LD50 values of the other tested biotypes and showing a 
statistical significant of p-value < 0.00001 (when the 5303 strain was pre-grown at 25°C) and 
p-value = 0.000107 (when the 5303 strain was pre-grown at 37°C). Moreover, The LD50 
values of strain 5303 at the Galleria 25°C incubation also were the lowest compared to all the 
LD50 values of the other tested biotypes and showing a statistical significant of p-value < 
0.00001 for both 25°C and 37°C pre-growing temperatures of strain 5303.  In addition, LD50 
results were always lower at the 25°C incubation conditions from the LD50 values at 37°C 
incubation and the difference was statistically significant with a p-value = 0.0015. At 25°C 
incubation temperature, the lethal dose equalled about 1.4 Log10 c.f.u/ml (or = 10
1.1 
c.f.u.) 
while at the 37°C incubation temperatures the lethal dose was 6.6 Log10 c.f.u/ml (or = 10
6 
c.f.u) at both pre-growing temperatures.  In addition, strain 5303 was the only strain that 
caused killing of the Galleria larvae in all the nine doses used at the 25°C incubation 
temperature by which the maximum number of the Galleria larvae was killed in a lethal time 
between 24 hours, for the first four highest doses, and 48 hours for the rest doses.  In the 
same time and at the 37°C incubation temperature, the 5303 lethal time used to kill the 
maximum number of larvae was ranging from 24 hours to 96 hours post infection.  These 
results generate a large debate about the pathogenicity of the non-pathogenic biotype 1A.  
The biotype 1A is classified as a non-pathogenic biotype since it doesn‟t cause any 
symptomatic disease in the mouse infection model in addition to the fact that it does not 
harbour any of the Y. enterocolitica virulence factors such as the pYV virulence plasmid 
(Tennant et al., 2003). However, there is growing evidence that the non-pathogenic 1A 
biotype may be associated with human disease (McNally et al., 2007; Tennant et al., 2003).  
In addition, the non-pathogenic 1A biotype strains were the most commonly isolated strains 
from clinical cases in the United Kingdom (McNally et al., 2004) and in other parts of 
Europe such as Finland (Huovinen et al., 2010). Previous studies by McNally‟s group had 
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suggested that the non-pathogenic biotype 1A strains were able to infect and invade epithelial 
cells and macrophages in vitro causing cellular physiological changes in them (McNally et 
al., 2006).  The present results of the high virulence of the non-pathogenic biotype 1A 
towards the infection model Galleria further support potential virulence of these strains 
certainly in insect hosts, and maybe in other untested models.                
Insecticidal toxin genes, called tc genes, which encode for an insect Toxin complex (Tc), 
have been found in all Y. enterocolitica low pathogenic biotypes strains but absent from the 
high pathogenic biotype 1B strains and the majority of the non-pathogenic known biotype 1A 
strains tested. The conservative clusters of these genes are carried on a specific chromosomal 
locus called the „tc pathogenicity island (tc-PAIYe) of Y. enterocolitica‟ (Fuchs et al., 2008) 
which is present in all the low pathogenic biotypes 2-5 strains (Fuchs et al., 2008).  Among 
the 1A non-pathogenic biotype strains, only the previously studied T83 strain was found to 
include remnants of the tc genes with homology to the well described conservative tc genes 
in the tc-PAI
Ye
 (Bresolin et al., 2005; Tennant et al., 2005).  The tc genes of the non-
pathogenic T83 strain were highly expressed at low temperatures from 10-20°C and down-
regulated at 37°C. However, these tc genes are completely absent from the non-pathogenic 
biotype BT1A lineage (Reuter et al., 2014), so their role in strain 5303 virulence observed 
phenotype is impossible.  
Bioserotype 4/O:3 is becoming the most predominant biotype of Y. enterocolitica species and 
it is the most isolated biotype from Y. enterocolitica disease cases in Europe and worldwide 
(Batzilla et al., 2011a; Rosner et al., 2010).  Due to the high prevalence of the bioserotype 
4/O:3, four strains including the German Y1 strain (Uliczka et al., 2011) have been studied 
since infections with bioserotype 4/O:3 strains are very high in Germany (Rosner et al., 
2010).  All strains of the bioserotype 4/O:3 , that were pre-grown on both temperatures the 
25°C and 37°C, were able to invade the HEp-2 human cell line in high numbers and in 
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constant ratios between the two pre-growing temperature. Interestingly, the 25°C pre-grown 
Y1 strain was a slightly more invasive than the other BT4 strains used.  This highly invasive 
ability of the 4/O:3 biotype strains may support other studies which show the high incidence 
of this bioserotype in clinical isolates worldwide.  In addition, 4/O:3  bioserotype have 
acquired a number of unique presumed virulence determinants including RtxA-like toxin, an 
insecticidal toxin, novel beta-lactamase -encoding GIYep-01 genomic island and the 
genetically active PhiYep-3 prophage.  These newly characterized virulence determinants are 
believed to enhance the pathogenic potential of Y. enterocolitica 4/O:3 bioserotype  making it 
more adaptable in hosts and consequently emerging as a worldwide spread isolate (Batzilla et 
al., 2011a).  Similarly, all the strains of the bioserotype 4/O:3 were lethal to the Galleria 
larvae.  The bioserotype 4/O:3 strains killed the injected Galleria larvae at the highest 
10
9
,10
8
&10
7
 doses at all the pre-growing and incubating temperatures. Most of the 4/O:3 
strains, which were pre-grown on both 25°C and 37°C temperatures, didn‟t show large 
differences in the LD50 lethal doses between both incubation temperatures of the Galleria 
larvae and were statistically insignificant (p value = 0.174688). Exceptionally, the Y1 strain 
pre-grown at 37°C has shown more lethality among the 4/O:3 strains with a lower lethal dose 
values (LD50) at the both incubation temperatures in comparison with its lethality when it was 
pre-grown at 25°C temperature but this difference is statically insignificant (p-value = 0.098). 
Moreover, although there was little difference in LD50 results of the 4/O:3 biotype strains, 
they have displayed different survival results.  In general, the 4/O:3 biotype strains has shown 
a time to death ranging from 24 hours to 72 hours at all pre-growing and incubation 
temperatures.   
Moreover, two representative strains of the biotype 3, one strain belongs to serotype O:9 and 
one strain belongs to serotype O:5,27 were studied.  Strain 5603 is a representative of the 
bioserotype 3/O:9 which is associated with human diseases (McNally et al., 2004; Wang et 
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al, 2011).  Strain 14902 represents the bioserotype 3/O:5,27 which is only isolated from 
animals in the UK and is never associated with human disease (McNally et al., 2011).  In 
tissue culture experiments, both strains were the highest invasive strains between all the 
biotypes used on both of the two pre-growing temperatures and in particular the human 5603 
strain was the most invasive.   
More Interestingly, the 14902 bioserotype 3/O:5,27, pre-grown on both 25°C and 37°C 
temperatures, was the most lethal strain to the Galleria larvae at the 25°C incubation 
temperatures among all the low pathogenic and high pathogenic biotypes and showing a 
statistical significance of a p-value = 0.0145.  This is an unexpected result from an animal 
restricted strain since it managed to show a pathogenic potential towards an insect host 
model. The ability of the animal restricted bioserotype to infect other types of organisms may 
support the ubiquitous nature of Y. enterocolitica. The LD50 at the 37°C incubation 
temperature was in the same range with the other low biotypes LD50 results incubated at the 
same 37°C incubation temperatures.  The high virulence of the 3/O:5,27 bioserotype strain at 
the 25°C temperatures may be linked to a virulence factors expressed at these low 
temperatures.  The  time of death caused by 3/O:9 strain was between 24 hours and 72 hours 
post infection at all the incubation temperatures.  The time of death for the 14902 bioserotype 
3/O:5,27 strain was shorter time between 24 hours and 48 hours post infection.  This ability 
of rapid killing positively correlates with the low LD50 results of this 14902 strain.  
Biotype 2 strains are also implicated in causing human disease in particular strains belonging 
to the O:9 serotype (Rahman et al., 2011). The bioserotype 2/O:9 strains are frequently 
isolated in many parts of the world (Rahman et al., 2011) but they are less commonly isolated 
in the UK (McNally et al., 2011).  The pig isolate strain 21202  was used as a representative 
strain to the bioserotype 2/O:9.  The low pathogenic bioserotype 2/O:9 21202 strain was 
highly invasive to the human epithelial cell line and the invasion levels were more close to 
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the invasion levels of the 4/O:3 bioserotype strains.  Using the Galleria larvae infection, the 
21202 strain pre-grown on 25°C and 37°C temperatures was more lethal to the Galleria 
larvae at the 25°C incubation temperatures of the infected larvae with a statistical 
significance of p-value = 0.47.  In addition, the biotype 2 strain 21202 has shown more 
prolonged lethal time periods compared to the strains of the low pathogenic biotypes 3 and 4.  
The lethal time of killing the Galleria larvae with the 21202 strain was between 24 hours and 
96 hours at both incubation temperatures.  In addition, the lethal dose values (LD50) of the 
bioserotype 2/O:9 strain where slightly higher than the biotypes 3 and 4 strains.   
Although biotype 5 is classified as a low pathogenic biotype, it is extremely rare and has only 
ever been isolated form Hares (Iteman et al., 1996).  Strain 3094/96 was used as a 
representative to the low pathogenic biotype 5.  Strain 3094/96 was the weakest strain to 
invade the HEp-2 cell line among the low and high pathogenic biotypes.  In addition, the 
3094/96 strain was also the weakest virulent strain among the low pathogenic and the non- 
pathogenic biotypes and it was showing a high LD50 values with a statistical significance 
difference of p-value = 0.000761.  As a result the 3094/96 strain can be considered as the 
second weakest strain towards Galleria larvae after the high pathogenic strain which was the 
weakest among all the biotypes used.  The 3094/96 strain managed to kill a small number of 
larvae at the 37°C incubation temperatures by which the high pathogenic biotype strain 8081 
didn‟t manage to kill any at this incubation temperature.  In comparison, at the 25°C 
incubation temperature the high pathogenic 8081 strain was more lethal than the low 
pathogenic biotype 5 strain, but the biotype 5 strain 3094/96 could be considered to be more 
virulent since it managed to kill in both incubating temperatures.    
Moreover, the T-test statistical analysis shows that there was no statistical significance 
difference between the LD50 values of Y. enterocolitica strains at the 25°C and 37°C           
pre-growing temperatures (p-value = 0.22389 and p-value = 0.369193 respectively).  This 
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indicates that the Y. enterocolitica pre-growing temperature doesn‟t have any effect on the      
Y .enterocolitica strains virulence in Galleria.  On the other hand, there was a statistical 
significance difference between the LD50 values of Y. enterocolitica strains at the 25°C and 
the 37°C incubation temperatures (p-value = 0.030845 and p-value = 0.038294 respectively) 
at both pre-growing temperatures.  This indicates that the Galleria incubation temperature 
have an effect on the virulence of Y. enterocolitica strains in Galleria.  The LD50 values of    
Y. enterocolitica strains at 25°C incubation temperatures are lower from the LD50 values of  
the same strains at 37°C incubation temperature which indicates that at the 25°C incubation 
temperatures Y. enterocolitica strains are more virulent in Galleria.  
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3.6 Conclusion 
        The HEp-2 epithelial cell line was used to study the pathogenicity of Y. enterocolitica 
biotypes.  HEp-2 cell line is applied to study the virulence of many bacterial pathogens 
(Draganov et al., 2008-2009).  It has been observed from tissue culture results (Fig 3.1 & 3.2) 
that all Y. enterocolitica biotypes were capable to invade the HEp-2 cell line including the 
non-pathogenic biotype 1A representative strain 5303.  However, the non-pathogenic 5303 
representative strain was the least invasive to HEp-2 cell line (Fig 3.1 & 3.2).   
The high pathogenic biotype which is historically known to be lethal in the mouse infection 
model was completely avirulent to Galleria larvae at 37°C incubation temperature which 
mimics the human normal physiological temperature.   On the other hand, the non-pathogenic 
biotype 1A, which lacks all the classical virulence factors of the pathogenic biotypes and 
does not cause any symptomatic disease in animals or humans, was the most lethal biotype in 
the alternative infection model.  All low pathogenic biotype representative strains caused 
death to Galleria host model. The low biotype representative strains display a diverse 
pathogenic potential to the infected Galleria larvae by which the low pathogenic biotype 5 
representative strain 3094/96 was the less virulent towards Galleria host model. The High 
pathogenic biotype 1B/O:8 strain 8081 and the non-pathogenic biotype 1A/O:5 strain 5303 
have shown opposing results between tissue culture and Galleria infections. The non-
pathogenic strain 5303 was the least invasive strain to the HEp-2 cell line but it was the most 
pathogenic to Galleria alternative infection model.  On the other hand, the high pathogenic 
strain 8081 was highly invasive to the HEp-2 cell line but was completely avirulent to the 
Galleria infection model at the 37°C incubation temperature.   
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Chapter 4 
Diverse Pathogenic Potential and in vivo Interaction of Y. enterocolitica 
Biotypes in Galleria 
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4.1 Introduction 
The previous chapter provided new results on the pathogenic potential of Y. enterocolitica 
biotypes in Galleria. The high pathogenic representative strain 8081 was completely 
avirulent to moderately pathogenic in Galleria depending on the incubation temperature used.  
The non-pathogenic representative strain 5303 was the most lethal in Galleria between all the 
Y. enterocolitica biotypes at all incubation conditions.  On the other hand, the low pathogenic 
biotypes were all mildly virulent to Galleria.  These results show that both the                   
non-pathogenic biotype and the high pathogenic biotype show a distinct pathogenic profile 
from the low pathogenic biotypes.  This distinctive pathogenic profile can be linked to the 
phylogenetic distribution of Y. enterocolitica biotypes when both of the high pathogenic BT 
1B and the non-pathogenic BT 1A were clustered in a separate species cluster (SC6) while all 
the low pathogenic biotypes were clustered in a the SC7 cluster (Reuter et al., 2014).   The 
results obtained in the previous chapter were observed from a limited number of                    
Y. enterocolitica representative strains. Here the data were tested against a wider set of strains 
to validate the previous results. In addition, the in vivo behaviour of Y. enterocolitica strains 
inside the Galleria larvae was investigated.  Moreover, the virulence effect of heat killed        
Y. enterocolitica strains in Galleria larvae was also investigated. Heat-killed Y. enterocolitica 
have been found to stimulate an immune response in the murine infection model and this 
response was believed to be due to the presence of outer membrane proteins and mainly LPS 
(Ruiz-Bravo et al., 2003).  The Galleria response between live and killed Y. enterocolitica 
cells is going to be tested here.  Here, an evidence showing that Galleria larvae are dying 
from an active process or from an outer membrane antigen is needed to be provided. 
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4.2 Aims: 
 
a) To study the pathogenic potential of diverse Y. enterocolitica strains, from different human 
and animal origins and belonging to a diverse group of biotypes and serotypes, in the            
G. mellonella alternative infection model.   
b) To investigate the virulence potential of heat killed Y. enterocolitica wild type strains in 
the G. mellonella insect infection model.   
c) To study the in vivo infection dynamics of the Y. enterocolitica High- Low- and Non-
pathogenic biotypes in the G. mellonella alternative infection model.   
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4.3 Materials and Methods  
4.3.1 Y. enterocolitica culture and Galleria infection procedures: 
All Y. enterocolitica strains studied in this chapter are listed in table 4.1.  The strains used to 
infect Galleria belong to the low pathogenic bioserotype 4/O:3, the low pathogenic 
bioserotype 3/O:5,27, the non-pathogenic biotype 1A and to serotype O:9.  Five                    
Y. enterocolitica strains were tested for each of the bioserotype 3/O:5,27, biotype 1A and 
serotype O:9.  Eight strains of the bioserotype 4/O:3, half of  human origin and half of non-
human origin were tested.  All Y. enterocolitica strains were pre-grown at 25°C temperature 
in LB agar and LB broth media as described in chapter two section 2.1.  The Galleria larvae 
were injected with the tested Y. enterocolitica strains following the same injection procedure 
described in chapter two section 2.2.4.  The injected Galleria larvae were incubated and 
monitored using the same incubation and monitoring protocols described in chapter two 
section 2.2.5.  Median lethal doses and survival curves were calculated following procedures 
described in chapter two sections 2.2.6 & 2.2.7.    
 
Table 4.1: Bacterial strains used in chapter 4  
No. Strain Name Bio/Serotype Biological Origin Source 
1 0902  1A/O?* Sheep McNally, UK 
2 0903 1A/O:6,30 Human McNally, UK 
3 3403  1A/O:5  Human McNally, UK 
4 3503  1A/O?* Pig McNally, UK 
5 NZ3   1A/O?* Sheep Dr. Muriel 
Dufour, ESR 
NCBID, 
Australia 
6 119/02 2/O:9 Sheep McNally, UK 
7 215/02 3/O:9 Pig McNally, UK 
8 218/02 3/O:9 Pig McNally, UK 
9 2403 3/O:9 Human McNally, UK 
10 5803  3/O:9 Human McNally, UK 
11 111/02 3/O:5,27 Sheep McNally, UK 
12 153/02 3/O:5,27 Cattle   McNally, UK 
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13 226/02 3/O:5,27 Pig McNally, UK 
14 231/02 3/O:5,27   Pig McNally, UK 
15 232/02 3/O:5,27 Pig McNally, UK 
16 01/2012 4/O:3 Human Claire Jenkins 
HPA,2012 
17 02/2012 4/O:3 Human Claire Jenkins 
HPA,2012 
18 03/03 4/O:3 Human McNally, UK 
19 201/02 4/O:3 Pig McNally, UK 
20 204/02 4/O:3 Human McNally, UK 
21 213/02 4/O:3 Pig McNally, UK 
22 NZ15 4/O:3 Unknown Dr. Muriel 
Dufour, ESR 
NCBID, 
Australia 
23 Y1 4/O:3 Human Petra Dersch, 
2009 
24 E. coli DH5α  Unknown Invitrogen 
25 14902/pAJD434 3/O:5,27 Sheep This Study 
26 1203/pAJD434 4/O:3 Human This Study 
27 5303/pAJD434  1A/O:5 Human This Study 
28 21202/pAJD434 2/O:9 Pig This Study 
29 8081/pAJD434 1B/O:8 Human This Study 
30 E. coli 
DH5α/pAJD434 
 Unknown This Study 
*?: Non-typable serotype 
 
4.3.2  Heat Killed Y. enterocolitica: 
The Y. enterocolitica representative strains 8081, 1203, 14902, 5603 & 5303 were pre-grown 
on LB agar and in LB broth medium at 25°C as shown in chapter two (section 2.1).  The 
overnight LB broth cultures were heat killed in water bath preheated at 60°C for 1hour 
(Autenrieth et al., 1994).  The O.D values were measured in a spectrophotometer at 600nm 
absorption.  The O.D600 values for each strain were measured in triplicate before and after the 
heat killing procedure to compare the concentration of the cellular material.  The heat killed 
Y. enterocolitica strains were serially diluted and plated on LB agar plates using the Miles 
and Misra method to confirm complete cell killing.  
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4.3.3 Infection Dynamics  
4.3.3.1 Preparation of Y. enterocolitica electro-competent cells  
1 ml of overnight bacterial broth culture was used to inoculate 49 ml fresh LB broth culture 
in 1:50 dilution. The diluted bacterial suspension was then incubated at 25°C with shaking at 
200 rpm until the OD600 value reaches a range between 0.6 and 0.9. Bacterial suspension was 
then aseptically transferred to a 50ml pre-chilled falcon tube and left in ice for 5 minutes. 
Then bacterial cells were pelleted by centrifugation at 4,000 rpm for 10 minutes at 4°C. The 
supernatant was discarded and pellet was then gently suspended in 25ml of ice cold 10% 
glycerol. Bacterial cells were then harvested as above and re-suspended in 12.5 ml of ice cold 
10% glycerol. The Bacterial suspension was then statically incubated in ice for 1 hour. 
Lastly, the Y. enterocolitica bacterial suspension was harvested again and re-suspended in 
2ml of 10% glycerol. 50μl aliquots of bacterial suspension were then transferred into1.5ml 
microcentrifuge tubes and were reserved in -80°C freezer for future work. E. coli DH5α 
strain was used as a control for the electro-competent cells preparation procedure.  
 
4.3.3.2 Transformation of Y. enterocolitica electro-competent cells  
1μl of pAJD434 plasmid was added into 50μl aliquot of Y. enterocolitica competent cells and 
the E. coli DH5α competent cells, mixed by gentle pipetting, and incubated on ice for 10 
minutes. The mixture was then aseptically transferred to a 2ml chilled electroporation cuvette 
(Flowgen, UK). The electroporation was done using the GenePulser Xcell electroporator 
system (Bio-Rad) and the electroporation programme was set out at 2.5kV, 2.5μF, 200Ω. 
Immediately after electroporation 950μl of sterile SOC medium was added to the electro-
transformed bacterial cells, mixed gently,  and the suspension was then transferred to a 1.5ml 
microcentrifuge tube. The reaction was incubated for 2 hours at 25°C with shaking at 
200rpm. 400μl of the electro-transformed bacterial cells were plated on pre-warmed LB agar 
87 
 
plate with 100µg/ml Trimethoprim antibiotic. Plates were then incubated overnight at 25°C.  
Transformation of the pAJD434 plasmid was confirmed by plasmid purification and by PCR. 
The E. coli DH5α strain was used as a control for the efficiency of electroporation.   
 
4.3.3.3  pAJD434 plasmid extraction: 
1-5 colonies were picked from the overnight agar cultures of each of the electro-transformed 
Y. enterocolitica strains including the E. coli DH5α control strain and were used to inoculate  
5 ml of LB broth containing 100 µg/ml of Trimethoprim.  The broth culture was incubated 
aerobically in shaker incubator on 200rpm at 25°C for overnight and not exceeding 18 hours 
incubation time.  Next day, 1.5 ml aliqoutes of overnight broth culture were used for plasmid 
extraction.  Plasmid extraction was done by the manufacturer protocol supplied with the 
Qiagen miniprep (QIAGEN).  The extracted plasmid was then visualised on agarose gel.   
 
4.3.3.4 PCR procedure: The pAJD434 plasmid was further confirmed by PCR amplification 
targeting the trimethoprim gene located on the pAJD434 plasmid. The trimethoprim gene was 
amplified using primers listed in Table 4.1. PCR reaction and condition were carried out as 
described in parts 2.2.8 and 2.2.9 described in chapter 2 except the annealing temperature 
which was adjusted depending on the primers annealing temperature described in Table 4.1. 
PCR products were visualized on agarose gel electrophoresis as described in part 2.2.10 in 
chapter 2. 
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Table 4.2: PCR primers 
Primer  
Name 
Nucleotide Sequence  Primer 
Function 
Annealing 
Temperatur
e (°C)    
Riplico
n size 
(bp) 
pAJD5' 
 
5'-CTG CAC TCG CAA CGC TG-3' Checking for 
the presence of 
the pAJD434 
by targeting 
the 
Trimethoprim 
gene 
      
        54 
 
 
 300 
pAJD3' 
 
5'-GGC ATG TAC AGG ATT CAT-3' 
 
 4.3.3.5 Strain preparation and growth conditions: Galleria larvae were infected with 5      
Y. enterocolitica strains containing pAJD434 plasmid. Strains YE8081/pAJD434, 
YE1203/pAJD434, YE14902/pAJD434, YE5303/pAJD434 and YE21202/pAJD434 are 
Trimethoprim resistance due to the presence of Trimethoprim gene harboured on the 
pAJD434 plasmid.  Trimethoprim Y. enterocolitica resistance strains were grown on LB agar 
plates and LB broth media containing 100µg/ml Trimethoprim using the same procedure 
described in chapter two (section 2.1). The cultured YE8081/pAJD434, YE1203/pAJD434, 
YE14902/pAJD434 and YE21202/pAJD434 strains were incubated at 25°C while 
YE5303/pAJD434 strain was incubated at 37°C.  Cells from 1ml overnight broth cultures for 
each strain were harvested by centrifugation and the pellets were suspended in 1ml sterile 
PBS.  The cells were serially diluted in sterile PBS and counted using Miles & Misra 
(Hedges, 2002; Miles and Misra, 1938) and CFU/ml methods to determine the initial dose 
for each strain.  
 
4.3.3.6 Infection and bacterial cells recovery:  Bacterial lethal and non-lethal doses were 
selected from each of the reference strains listed in table 4.2. A number of 60 Galleria larvae 
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were injected with each selected lethal and non-lethal dose (total of 120 injected larvae per 
strain).  The selected lethal and non-lethal doses were injected in Galleria larvae in 10µl 
microinjected doses using the same injection procedure described in chapter two section 
(2.2.4) and all the injected larvae were incubated using the same procedure described in 
chapter two part (2.2.5). Bacterial cells were recovered from the infected larvae for a total 
period of 5 days at the following time points; 2h,4h,6h,8h,24h,48h,72h,96h & 120h. At each 
time point, bacterial cells were isolated from a pool of 5 larvae for each selected lethal and 
non-lethal dose (total of 10 larvae for each strain). Bacterial cells were recovered from each 
Galleria larva by dissecting the bottom section of the larva.  Prior to dissection, all the 
infected larvae were placed in ice for 20 minutes. After incubation on ice, each larva was 
surface sterilised with 70% ethanol.  Approximately 2mm from the tail side of each Galleria 
larva was removed using sterile scissors and each larva was placed inside sterile eppendorf 
tube containing 0.5ml of sterile PBS.  The total internal content of each larva was drained 
inside the eppendorf tube using sterile forceps. The scissors and forceps were sterilised 
between each larva dissecting procedure with 70% ethanol and sterile distilled water 
(sdH2O).  In addition, after each time point the scissors and forceps were sterilised with 70% 
ethanol and sterile distilled water (sdH2O) followed by flame sterilization using a Bunsen 
burner. The drained contents were serially diluted and the recovered bacterial cells were 
enumerated on LB agar plates containing 100µg/ml Trimethoprim using the Miles & Misra 
(Hedges, 2002; Miles and Misra, 1938) and CFU counting methods.  All experiments were 
repeated independently in triplicate.  PBS and non-injection controls were used in each 
separate experiment.   
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4.3.3.7 Statistical analysis  
The statistical work done in this chapter was done using the one sample T-test and the two 
independent samples T-test .  All the statistical analysis was done by a statistical significance 
with a P value of ≤0.05.  
 
4.4 Results 
4.4.1 Results of the pathogenic effect of the Y. enterocolitica diverse strains  
Twenty three Y. enterocolitica strains were tested for their pathogenesis in the Galleria 
alternative infection model.  All the 23 strains were pre-grown at 25°C and were injected in 
Galleria larvae followed by incubating the infected larvae at 37°C.  Twenty one of the tested 
Y. enterocolitica strains were able to kill the infected Galleria larvae with the remaining two 
strains unable to induce any sort of virulence in Galleria.  The results of the median lethal 
dose and survival time curve of each strain are represented below. 
4.4.1.1 Median Lethal Dose (LD50) Results:  
All median lethal doses (LD50) of the 23 Y. enterocolitica strains are presented in figure 4.2. 
These strains belong to biotype 1A, bioserotype 3/O:5,27, bioserotype 4/O:3 and serotype 
O:9. Twenty one strains managed to kill the infected Galleria larvae.  Only 2 strains were 
avirulent to the infected larvae which are the animal origin strain 119/02 (bioserotype 2/O:9) 
and the non-human origin strain NZ15 (bioserotype 4/O:3).  The LD50 values of biotype 1A 
strains are ranging from 7.09 to 8.99 with an average LD50 of 7.83.  When comparing the 
LD50 values of the biotype 1A diverse strains they show higher LD50 results than the 
reference strain 5303 of bioserotype 1A/O:5 which has a LD50=6.6 and showing a statistical 
significance of p-value = 0.022.  However, The Y. enterocolitica non-pathogenic biotype 1A 
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strains group is showing a significance difference from all the other Y. enterocolitica biotypes 
strains with a p-value of 0.003148.  This result shows that the non-pathogenic biotype 1A 
strains are the most virulent in Galleria compared to all the other Y. enterocolitica biotypes 
strains.  Moreover, LD50 values of bioserotype 3/O:5,27 strains are ranging from 8.1 to 8.9 
and the average LD50 of this bioserotype is 8.6. The reference strain LD50 value is 8.8 and it 
exists in the same range of the bioserotype 3/O:5,27 diverse strains and was statistically 
insignificant with a p-value = 0.877173.  Furthermore, strains of serotype O:9 belong to 
biotypes 2 and 3.  Strain 204/02 was the only strain belongs to biotype 2 serotype O:9. The 
remaining strains belongs to biotype 3 serotype O:9 and these strains are 5803, 24/03, 215/02 
and 218/02. The LD50 values of serotype O:9 ranges from 8.55 to 9.82 and the average LD50 
value is 8.934. The range of the LD50 values of serotype O:9 diverse strains is similar to the 
LD50 values of serotype O:9 reference strains which are strain 5603 (bioserotype 3/O:9) and 
strain 21202 (bioserotype 2/O:9) by which these two reference strains have LD50 values of 
8.5 and 8.8 respectively. Statistical analysis shows that there is no statistical significant 
difference between the LD50 values of serotype O:9 diverse strains and the LD50 value of the 
reference strain 5603 (bioserotype 3/O:9) giving a p-value = 0.167. Statistical analysis also 
shows that there is no statistical significant difference between the LD50 values of serotype 
O:9 diverse strains and the LD50 value of the reference strain 21202 (bioserotype 2/O:9) and 
giving a p-value = 0.179. Finally, strains of bioserotype 4/O:3 were divided into human 
origin and non-human origin strains.  The human origin strains are Y1, 01/2012, 02/2012 and 
03/03.  On the other hand, the non-human bioserotype 4/O:3 strains are 204/02, NZ15, 
213/02 and 201/02.   The LD50 values of bioserotype 4/O:3 human origin strains are ranging 
from 7.8 to 8.6 with an average LD50 value of 8.4. On the other hand,  LD50 values of 
bioserotype 4/O:3 non-human origin strains are ranging from 8.48 to 9.85 with an average 
LD50 value of 9.06.  When comparing the LD50 values of the human origin bioserotype 4/O:3 
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strains with LD50 values from the non-human origin strains, the difference between them was 
statistically insignificant (p-value = 0.181006).  This indicates that both of the human origin 
and non-human origin bioserotype 4/O:3 strains are behaving to some extent similarly and 
may be causing a similar virulence levels in Galleria.  The representative strain 1203 
(bioserotype 4/O:3) has LD50 value of 8.9 which is higher than most of the bioserotype 4/O:3 
strains.  However, when statistically comparing the LD50 value of the representative strain 
1203 (bioserotype 4/O:3) with LD50 values of bioserotype 4/O:3 human origin strains the 
result was statistically insignificance with a p-value = 0.106.  In contrast, the  LD50 value of 
the  representative strain 1203 (bioserotype 4/O:3) was statistically compared to the LD50 
values of bioserotype 4/O:3 non-human origin strains and shown statistical insignificance 
with a p-value = 0.474.  This statistical measurement indicates that all the 4/O:3 strains are 
behaving similarly to the reference strain 1203.  Although there was no significance 
difference between the reference strain 1203 LD50 value and the LD50 values of both the 
human origin and non-human origin bioserotype 4/O:3 strains the p-value of comparing the 
reference strain 1203 to the human origin strains was lower  (p-value = 0.106) compared to 
the non-human origin bioserotype 4/O:3 (p-value = 0.474).  This indicates that the 
bioserotype 4/O:3 human origin strains are statistically behaving more similarly to the 
reference strain 1203 in Galleria by which the reference strain 1203 is a human origin strain 
as well. 
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- LD50 results of infecting Galleria mellonella larvae with 23 Y. enterocolitica diverse strains 
 
 
Figure 4.1: LD50 results of infecting Galleria mellonella larvae with 23 Y. enterocolitica 
strains       pre-grown at 25°C.  These strains belong to biotype 1A, bioserotype 3/O:5,27, 
serotype O:9 and bioserotype  4/O:3.  Bioserotype 4/O:3 strains are sub divided into human 
origin and non-human origin strains.  Y. enterocolitica strains were injected into Galleria 
larvae and the infected larvae were incubated at 37°C temperatures.  Values in the graph 
shows the mean of 3 independent experiments. The LD50 values were calculated using the 
Spearman-Karber method.  All LD50 numbers were calculated using Log10 c.f.u/ml.  The x-
axis shows strains names and the y-axis shows the LD50 values in Log10 c.f.u/ml.  Error bars 
were plotted after calculating the standard deviation of the mean. 
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4.4.1.2 Survival Curves  
4.4.1.2.1 Bioserotype 4/O:3 Strains 
A) Strains of Human Origin:  
Section 4.4.1.2.1 (A) Includes the survival results of four strains of the low pathogenic 
bioserotype 4/O:3 which were isolated from human origin 01/2012,02/2012,Y1 & 03/03. All 
four strains caused death to the infected Galleria larvae.   Strain 01/2012 caused death to 
Galleria larvae with doses 10
9
,10
8
 & 10
7
 (Fig. 4.2a).  Dose 10
9
 killed all injected larvae 
within 24h post infection while the dose 10
8
 killed 4 of the infected Galleria larvae at 24h 
post infection (20% survival).  The 10
7
 dose was lethal for only 2 larvae (60% survival) at the 
72h time of observation post infection.  Moreover, strain 02/2012 caused killing in the 
infected Galleria larvae with 10
9
 and 10
8
 doses (Fig. 4.2b).  Dose 10
9
 killed all the injected 
Galleria larvae after 24h post infection and the 10
8
 dose killed 3 out of 5 larvae (40% 
survival) after 48h post infection.  Strain Y1 strain is showing mortality to Galleria larvae by 
which only the highest doses 10
9
 and 10
8
 were lethal to the Galleria larvae (Fig. 4.2c).  Dose 
10
9
 killed all the infected larvae within 24h post infection while the 10
8
 dose was lethal to 
only one larva (80% survival) at 48h post infection.  The last strain in this section is strain 
03/03.  Strain 03/03 caused death to the infected Galleria larvae with only the highest 10
9
 
dose (Fig. 4.2d) by which this dose killed all the injected larvae within 24h post infection.  
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Figure 4.2: Survival curves of Galleria infected with BT 4/O:3 human origin strains pre-
grown at 25°C of 37°C incubated Galleria. Figure 4.2 includes four sub figures (4.2a, 4.2b, 
4.2c & 4.2d) representing the survival of Galleria larvae at 37°C incubation temperature 
infected with the 25°C pre-grown Y. enterocolitica human origin strains belonging to the low 
pathogenic bio/serotype 4/O:3. A number of 5 larvae were used for each dose. Figure 4.2a 
shows representative survival data of Galleria infected with strain 01/2012.  Figure 4.2b 
shows representative survival data of Galleria infected with strain 02/2012. Figure 4.2c 
shows representative survival data of Galleria  infected with strain Y1.  Figure 4.2d shows 
representative survival data of Galleria infected with strain 03/03.   Values shown in each 
survival graph are representative values obtained from performing the experiment in 
triplicate.  
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B) Non-Human Origin 4/O:3 Strains: 
Section 4.4.1.2.1 (B) includes the survival results of the low pathogenic bioserotype 4/O:3 
strains belong to origins other than the human origin.  This section includes strains from an 
animal origin or with an unknown origin. Strain 204/02 isolated from pigs caused death in 
Galleria larvae with only the highest dose 10
9
 by which a maximum number of 4 Galleria 
killed at 72 h post infection (20% survival) (Fig. 4.3a).  On the other hand, strain NZ15 was 
completely avirulent to the Galleria injected larvae (Fig. 4.3b).  This strain is from unknown 
origin and all doses injected in the Galleria larvae didn‟t cause any death.  Furthermore, 
strains 213/02 (Fig. 4.3c) and 201/02 (Fig. 4.3d) are both isolated from pigs and they caused 
similar killing patterns in the infected Galleria larvae.  Doses 10
9
 and 10
8
 from both 213/02 
and 201/02 strains caused death to Galleria larvae.  10
9
 killed all the Galleria larvae after 24h 
post infection in both strains. Dose 10
8
 killed 2 larvae out of 5 (60% survival) after 24h post 
infection also in both strains.  This indicates that the highest doses 10
9
 and 10
8
 of strains 
213/02 and 201/02 killed the same numbers of Galleria larvae with the same time of death.  
Compared to the 1203 reference strain (bioserotype 4/O:3) only the human origin strain 
01/2012 killed the Galleria larvae with a similar doses similar to the 1203 reference strain 
and these doses are 10
9
 , 10
8
 and 10
7
. Four of the strains were able to kill the Galleria larvae 
with the 10
9
 and 10
8
 doses and two of them were killing the Galleria larvae with only the 10
9
 
compared to the 1203 reference strain.  Only the strain NZ15 was avirulent to the injected 
Galleria larvae.   
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Figure 4.3: Survival curves of Galleria infected with BT 4/O:3 human origin strains pre-
grown at 25°C of 37°C incubated Galleria  Figure 4.3 includes four sub figures (4.3a, 4.3b, 
4.3c & 4.3d) representing the survival of Galleria at 37°C incubation temperature infected 
with the 25°C pre-grown non-human origin strains belonging to bio/serotype 4/O:3. A 
number of 5 larvae were used for each dose. Figure 4.3a shows representative survival of 
Galleria infected with strain 204/02.  Figure 4.3b shows representative survival of Galleria 
infected with strain NZ15. Figure 4.3c shows representative survival of Galleria  infected 
with strain 213/02.  Figure 4.3d shows representative survival of Galleria infected with strain 
201/02.  Values shown in each survival graph are representative values obtained from 
performing the experiment in triplicate.  
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4.4.1.2.2 Survival curves of Galleria infected with biotype 1A strains 
Section 4.4.1.2.2 describes the survival results of strains belonging to the non-pathogenic 
biotype 1A.  The survival of five strains in was studied in this section, strain 3403 (Fig. 4.4a), 
strain 0903 (Fig. 4.4b), strain 3503 (Fig. 4.4c), strain NZ3 (Fig. 4.4d) and strain 0902 (Fig. 
4.4e). These strains were isolated from different origins and they belong to different 
serotypes and all of them caused death in the infected Galleria. Strain 3403 is isolated from 
humans and belongs to serotype O:5.  Doses 10
9
,10
8
 and 10
7
 from this strain caused death to 
the infected Galleria larvae. Both 10
9
 and 10
8
 doses killed all the infected larvae at 24h post 
infection (in both doses) while dose 10
7
 killed 4 larvae (20% survival) within 24h post 
infection (Fig. 4.4a). Strain 0903 is a human isolate and it belongs to bioserotype O:6,30.  
0903 strain killed the Galleria larvae with doses 10
9
,10
8
 & 10
7
.  Doses 10
9
 and 10
8
 killed all 
the infected Galleria larvae at 24h post infection while dose 10
7
 killed 3 larvae (40% 
survival) within 48h post infection (Fig. 4.4b).  Strain 3503 is isolated from pigs but the 
serotype of this strain is unknown (O:?).  Strain 3503 caused death to the infected Galleria 
larvae with doses 10
9
,10
8
 & 10
7
.  Both 10
9
 and 10
8
 doses killed all the infected Galleria at 
24h and 48h post infection respectively for each dose.  The 10
7
 dose killed only one Galleria 
larva at 48h post infection (Fig. 4.4c).  In addition, strain NZ3 was isolated from sheep and it 
belongs to an unknown serotype. Strain NZ3 caused death to Galleria with doses 10
9
 and 10
8
.  
10
9
 killed all the Galleria larvae within 24h post infection while the 10
8
 dose killed 3 out of 5 
larvae (40% survival) after 96h post infection(Fig. 4.4e).  Strain 0902 is the last strain studied 
from the biotype 1A strains.  Similar to strain NZ3, strain 0902 is also isolated from sheep 
and belongs to unknown serotype.  Doses 10
9
 and 10
8 
from strain NZ3 was able to kill the 
Galleria larvae.  Dose 10
9 
killed 4 larvae out of 5 (20% survival) post infection while the 
dose 10
8
 killed only 1 larvae (80% survival) post infection (Fig. 4.4e).  The last results are 
similar to what previously observed in the 5303 reference strain.  
101 
 
- Survival curves of Galleria infected with biotype 1A strains 
 
 
0
20
40
60
80
100
120
2 4 6 8 10 24 48 72 96 120
Su
rv
iv
al
 p
e
rc
e
n
ta
ge
 
Observation time post infection (h) 
(a) Strain 3403 
No Injection
PBS
1.00E+06
1.00E+07
1.00E+08
1.00E+09
0
20
40
60
80
100
120
2 4 6 8 10 24 48 72 96 120
Su
rv
iv
al
 p
e
rc
e
n
ta
ge
 
Observation time post infection (h) 
(b) Strain 0903 
No Injection
PBS
1.00E+06
1.00E+07
1.00E+08
1.00E+09
0
20
40
60
80
100
120
2 4 6 8 10 24 48 72 96 120
Su
rv
iv
al
 p
e
rc
e
n
ta
ge
 
Observation time post infection (h) 
(c) Strain 3503 
No Injection
PBS
1.00E+06
1.00E+07
1.00E+08
1.00E+09
102 
 
- Survival curves of Galleria infected with biotype 1A strains 
 
Figure 4.4: Survival curves of Galleria infected with BT 1A strains pre-grown at 25°C of 
37°C incubated Galleria. Figure 4.4 includes five sub figures (4.4a, 4.4b, 4.4c,4.4d & 4.4e) 
representing the percentage of survival rates of the Galleria mellonella larvae at 37°C 
incubation temperature infected with the 25°C pre-grown Y. enterocolitica strains belonging 
to the non-pathogenic biotype 1A. A number of 5 larvae were used for each dose. Figure 4.4a 
shows representative survival data of Galleria infected with strain 3403 Bio/serotype 1A/O:5.  
Figure 4.4b shows representative survival data of Galleria infected with strain 09/03 
Bioserotype 1A/O:6,30. Figure 4.3c shows representative survival data of Galleria infected 
with strain 35/03 Biotype 1A/O?  Figure 4.4d shows representative survival data of Galleria  
infected with strain NZ3 Biotype 1A/O?  Figure 4.4e shows representative survival data of 
Galleria infected with strain 09/02 Biotype 1A/O?. Values shown in each survival graph are 
representative values obtained from performing the experiment in triplicate.  
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4.4.1.2.3 Survival curves of Galleria infected with Serotype O:9 strains 
Part 4.4.1.2.3 shows the survival results of 5 Y. enterocolitica strains belong to serotype O:9. 
The first strain is the human isolate 5803 which belongs to bioserotype 3/O:9.  This strain 
was lethal to Galleria larvae with only the 10
9
 dose from which a total of 4 Galleria were 
killed (20% survival) within 72h post infection (Fig. 4.5a). The second strain belongs to 
serotype O:9 and is a human isolate strain 24/03 which belongs to bioserotype 3/O:9           
(Fig. 4.5b).  Strain 24/03 caused death to Galleria larvae with doses 10
9
 and 10
8
.  Dose 10
9
 
killed all the infected larvae at 48h post infection.  Dose 10
8
 killed only one larva out of the 5 
(80% survival) within 24h. The third strain studied in the O:9 serotype group is strain 119/02 
(Fig. 4.5c).  Strain 119/02 belongs to bioserotype 2/O:9 and was isolated from sheep.  Strain 
119/02 was completely avirulent to the infected Galleria larvae and didn‟t cause any death to 
the Galleria larvae with all the injected doses. The fourth strain belongs to serotype O:9 part 
is strain 215/02 (Fig. 4.5d).  Strain 215/02 belongs to bioserotype 3/O:9 and it was isolated 
from pigs.  Doses 10
9
 and 10
8
 of strain 215/02 were able to kill Galleria.  Dose 10
9
 killed 
only 4 larvae of the 5 used (20% survival) after 72h post infection while dose 10
8
 killed only 
one larva out of 5 (80% survival) at 72h (Fig. 4.5d). The fifth and last strain studied in this 
section is strain 218/02 belonging to bioserotype 3/O:9 and was isolated from pigs.  Dose 10
9
 
of strain 218/02 killed all the Galleria larvae within 24 h post infection while dose 10
8
 killed 
only one larva out of 5 (80% survival) within 24h post infection (Fig. 4.5e).  Comparing the 
survival results of strains of bioserotype 3/O:9 to the reference strain 5603 (bioserotype 
3/O:9)  show that three strains are killing Galleria with the same doses of the reference strain 
while only one strain kills Galleria with one dose less.  Moreover, the reference strain 21202 
of bioserotype 2/O:9 was able to kill Galleria with doses 10
9
 and 10
8
 while the strain 119/02 
(bioserotype 2/O:9) was completely avirulent to Galleria.  
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Figure 4.5: Survival curves of Galleria infected with serotype O:9 strains pre-grown at 25°C 
of 37°C incubated Galleria. Figure 4.5 includes five sub figures (4.5a, 4.5b, 4.5c,4.5d & 
4.5e) representing the percentage of survival rates of Galleria larvae at 37°C incubation 
temperature infected with the 25°C pre-grown Y. enterocolitica strains belonging to the non-
pathogenic serotype O:9. A number of 5 larvae were used for each dose. Figure 4.5a shows 
representative survival data of Galleria  infected with strain 5803 Bioserotype 3/O:9.  Figure 
4.5b shows representative survival data of Galleria infected with strain 2403 Bioserotype 
3/O:9. Figure 4.5c shows representative survival data of Galleria infected with strain 119/02 
Biotype 2/O:9.  Figure 4.5d shows representative survival data of Galleria infected with 
strain 215/02 Bioserotype 3/O:9. Figure 4.5e shows representative survival data of Galleria  
infected with strain 218/02 Bioserotype 3/O:9.  Values shown in each survival graph are 
representative values obtained from performing the experiment in triplicate.  
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4.4.1.2.4 Survival curves of Galleria infected with Serotype 3/O:5,27 strains: 
Section 4.4.1.2.4 includes the survival results of 5 strains of the low pathogenic bioserotype 
3/O:5,27 which were isolated from different animal origins.  The 5 strains are 232/02 
(isolated from pigs); (Fig. 4.6a), strain 231/02 (isolated from pigs); (Fig. 4.6b), strain 111/02 
(isolated from sheep); (Fig. 4.6c), strain 153/02 (isolated from cattle); (Fig. 4.6d) and strain 
226/02 (isolated from pigs); (Fig. 4.6e). All the 5 strains caused death to the infected Galleria 
larvae.  Dose 10
9
 of strain 232/02 killed all the Galleria larvae at 24h post infection and the 
10
8
 dose killed 3 out of 5 larvae (40% survival) within 72h post infection (Fig. 4.6a).  Strain 
231/02 also caused death to the infected Galleria.  Strain 231/02 killed all the Galleria larvae 
with only the dose 10
9
 by which killing was observed after 24h post infection (Fig. 4.6b).  
Furthermore, strain 111/02 caused death to Galleria after the injection with the dose 10
9
 only 
by which all the infected Galleria larvae were killed at 96h post infection (Fig. 4.6c).  
Moreover, strains 153/02 and 226/02 caused death with doses 10
9
 and 10
8
 from each strain.  
Dose 10
9
 from both strains killed all the Galleria larvae at 24h post infection.  Dose 10
8
 from 
each strain killed 1 larva out of 5 (80% survival) after 24h post infection in both strains     
(Fig. 4.6d & 4.6e).  In comparison to the reference strain 14902 (bioserotype 3/O:5,27), it can 
be observed that three of the five bioserotype 3/O:5,27 tested  strains were killing infected 
Galleria larvae with the same doses 10
9
 and 10
8
 while only two strains were killing the 
Galleria larvae with only the 10
9
 dose.  
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Figure 4.6: Survival curves of Galleria infected with BT 3/O:5,27 strains pre-grown at 25°C 
of 37°C incubated Galleria.  Figure 4.6 includes five sub figures (4.6a, 4.6b, 4.6c,4.6d & 
4.6e) representing the percentage of survival rates of the Galleria mellonella larvae at 37°C 
incubation temperature infected with the 25°C pre –grown Y. enterocolitica strains belonging 
to the non-pathogenic serotype 3/O:5,27. A number of 5 larvae were used for each dose. 
Figure 4.6a shows representative survival data of Galleria  infected with strain 232/02.  
Figure 4.6b shows representative survival data of Galleria infected with strain 232/01. Figure 
4.6c shows representative survival data of Galleria infected with strain 111/02.  Figure 4.6d 
shows representative survival data of Galleria infected with strain 153/02. Figure 4.6e shows 
representative survival data of Galleria infected with strain 226/02.   Values shown in each 
survival graph are representative values obtained from performing the experiment in 
triplicate.  
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4.4.2 Heat Killed Y. enterocolitica (HKY): 
Heat killed Y. enterocolitica strains were injected in Galleria larvae to observe any lethal 
effect from Y. enterocolitica dead cells. Y. enterocolitica strains 8081, 1203, 14902, 5603 & 
5303 were heat killed at 60°C for 1h and different doses from each strain were injected into 
the Galleria larvae.  All the heat killed Y. enterocolitica strains were harmless to the infected 
Galleria larvae and didn‟t induce any killing.  All the injected doses were avirulent to the 
infected larvae.  There was no growth for any viable cells on the LB agar plates which 
indicates a successful heat killing procedure.   
 
4.4.3 Electroporation results: 
The pAJD434 plasmid transformation was checked by plasmid extraction from all the 
electro-transformed Y. enterocolitica strains 8081, 1203, 14902, 21202 & 5303 and from the 
E. coli DH5α control strain followed by visualisation on agarose gel electrophoresis and PCR 
amplification.  Gel electrophoresis images shows bands of DNA content which initially 
displays a successful transformation and extraction of the pAJD434 plasmid DNA in all the 
Y. enterocolitica and the E. coli DH5α control strain (Fig. 4.7a).  To confirm that the 
transformed plasmid is the pAJD434 plasmid, PCR targeting the trimethoprim gene located 
on the pAJD434 plasmid was done for all the extracted plasmid samples.  PCR product was 
visualized on agarose gel electrophoresis and the gel image shows bands which indicates a 
successful amplification of the PCR trimethoprim target gene and hence confirms the 
successful transformation of the pAJD434 plasmid (Fig. 4.7b).    
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a- Gel electrophoresis image for the pAJD434 plasmid extraction  
 
 
 
 
 
 
b- Gel electrophoresis image for the Trimethoprim gene PCR amplification   
 
 
 
 
 
Figure 4.7: Gel electrophoresis results of checking the pAJD434 plasmid transformation. 
Figure 4.7 contains two subfigures 4.7a and 4.7b.  Figure 4.7a represents a gel image of 
extracting the pAJD434 plasmid from the electro-transformed Y. enterocolitica strains (1-5) 
and from the control strain E.coli DH5α. Figure 4.7b represents the gel image of detecting the 
trimethoprim gene located on the pAJD434 plasmid by PCR amplification.  The trimethoprim 
gene was from all Y. enterocolitica electro-transformed strains (1-10) and from the E. coli 
DH5α strain which is used as a positive control (+ve).  M= the 1kbp DNA marker. 
 
 
 
M     +ve        1        2         3        4        5        6       7        8         9       10      -ve 
       500bp→ 
  M              1              2               3             4              5              6   
     3000bp→ 
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4.4.4 Infection Dynamics Results  
Here, five Y. enterocolitica strains were examined to study the infection dynamics inside the 
Galleria alternative infection model.  The 5 Y. enterocolitica strains were transformed with 
pAJD434 plasmid which makes them trimethoprim-resistant in order to enable the recovery 
of these strains on a selective media containing trimethoprim antibiotic.  The strains tested 
are the non-pathogenic strain 5303/pAJD434 (Bioserotype 1A/O:5), the high pathogenic 
strain 8081/pAJD434 (Bioserotype 1B/O:8), and the low pathogenic strains 1203/pAJD434 
(Bioserotype 4/O:3), 14902/pAJD434 (Bioserotype 3/O:5,27) and 21202/pAJD434 
(Bioserotype 3/O:9).  The infection dynamics results are shown in different parts. Part 4.4.4.1 
include the infection dynamics of the low pathogenic strains (1203/pAJD434, 
14902/pAJD434 & 21202/pAJD434). Part 4.4.4.2 shows the infection dynamics of the high 
pathogenic strain 8081/pAJD434 and part 4.4.4.3 shows the infection dynamics of the non-
pathogenic strain 5303/pAJD434.  The infection dynamics of each strain is represented in a 
separate graph.  Each graph represents the mean of 3 independent experiments.   
4.4.4.1 Infection dynamics of the low pathogenic biotypes Y. enterocolitica strains:  
This section describes the in vivo infection dynamics of the low pathogenic strains 1203 
(Bioserotype 4/O:3), 14902 (Bioserotype 3/O:5,27) and 21202 (Bioserotype 2/O:9).  All the 
low pathogenic strains were pre-grown at 25°C and the infected Galleria larvae with these 
strains were incubated at 25°C.  Lethal doses of all the low pathogenic strains have killed all 
the injected larvae at the 24h time point while all larvae injected with the non-lethal doses 
remained alive. For strain 1203, the selected lethal dose was 9.35 Log10 c.f.u/ml (10
9
) and the 
non-lethal dose was 6.35 Log10c.f.u/ ml (10
6
); (Fig. 4.8a). Bacterial numbers of the lethal 
dose started to increase gradually during the incubation time reaching a bacterial maximum in 
vivo growth at the 48h time point with a recovered bacterial numbers that equal 11.1Log10 
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c.f.u/ml. This increase was statistically significant with a p-value = 0.0002. The bacterial cells 
then started to decrease from the 48h time point and ending with a final bacterial number 
equal to 9.94 Log10 c.f.u/ml at 120h time point.  This decrease from the 48h time point to the 
120h time point is showing a statistical significance of a p-value = 0.0001. On the other hand, 
bacterial numbers of the non-lethal dose were fluctuating by which the starting inoculum was 
6.35 Log10 c.f.u/ml and the last recovered bacterial number was 5.99 Log10 c.f.u/ml. This 
fluctuation in recovered bacterial numbers is statistically insignificant (p-value = 0.060).   In 
strain 14902, the chosen lethal dose was 9.14 Log10 c.f.u/ml (10
9
) and the non-lethal dose was 
2.14 Log10 c.f.u/ml (10
2
) (Fig. 4.8b).  The bacterial numbers started to increase gradually 
during the first 8 hours of incubation.  At the 24h time point, the bacterial numbers reached a 
maximum growth of 11.02 Log10 c.f.u/ml and this increase was statistically significant giving 
a p-value = 0.0002.  Then the bacterial numbers started to decrease slowly by which the final 
recovered bacterial number recovered at the last time point (120h) was 9.86 Log10 c.f.u/ml. 
This decrease in bacterial numbers from the 24h time point to the 120h time point was 
statistically significant with a p-value = 0.0005.  Moreover, bacterial numbers of the non-
lethal dose showed a remarkable increase.  The non-lethal starting dose was 2.14 Log10 
c.f.u/ml then the bacterial numbers increased sharply after only 2 hours post infection 
reaching a numbers of recovered cells equals 4.4 Log10 c.f.u/ml with more than 2 Log10 units 
difference giving a statistical significance of p-value = 0.0006. After the 2h time point, the 
bacterial numbers started to increase reaching a maximum growth at 72h with a bacterial 
numbers equals 6.09 Log10 c.f.u/ml and giving a statistical significance of a p-value = 0.0008. 
Then the  growth monitoring ended with a 5.95 Log10 c.f.u/ml at the last 120h time point with 
no statistical significance from the 72h time point (p-value = 0.053).  For strain 21202, the 
selected lethal dose is 9.17 Log10 c.f.u/ml (10
9
) and the non-lethal dose is 5.17 Log10c.f.u/ml 
(10
5
); (Fig. 4.8c).  In the lethal dose, the bacterial numbers started to decrease slightly and 
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constantly in the first 8h by which the starting inoculum was 9.17 Log10 c.f.u/ml and the 
recovered bacterial numbers at the 8h time point was 8.66 Log10c.f.u/ml with statistical 
insignificance (p-value = 0.08).  At the 24h time point, the bacterial numbers showed a 
sudden increase with the maximum growth equals 10.45 Log10 c.f.u/ml.  This increase in 
bacterial number was statistically significant wit a p-value = 0.0005. Then the bacterial cells 
started to decrease until they reached a final growth number of 9.35 Log10 c.f.u/ml at the last 
120h recovery time point and this decrease was statistically significant showing a p-value = 
0.0029.  On the other hand, bacterial growth of the non-lethal dose was showing fluctuating 
decrease and increase during the 5 days incubation period.  The starting inoculum was 5.17 
Log10 c.f.u/ml, the maximum growth was indicated at the 72h time point with a bacterial 
number equals 5.86 Log10 c.f.u/ml and the final bacterial numbers recovered at the last 120h 
time point were 5.29 Log10 c.f.u/ml.  Statistical analysis shows that there is no statistical 
significance difference in the recovered bacterial numbers between the starting inoculum and 
the 72h time points (p-value = 0.06) and no statistical significance between the 72h time 
point and the last 120h time point (p-value = 0.081).   
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Figure 4.8: Infection dynamics results of Y. enterocolitica low pathogenic biotypes strains. 
Figure 4.8 contains three sub figures 4.8a, 4.8b & 4.8c.  Figure 4.8a represents the infection 
dynamics of the low pathogenic 1203 strain Bioserotype 4/O:3. Figure 4.8b represents the 
infection dynamics of the low pathogenic strain 14902 Bioserotype 3/O:5,27. Figure 4.8c 
represents the infection dynamics of the low pathogenic strain 21202 Bioserotype 2/O:9.  
Strains 1203, 14902 & 21202 were pre-grown at 25°C and the infected Galleria with each 
strain were incubated at 25°C.  Galleria larvae were injected with the highest lethal dose and 
the highest non-lethal dose from each strain.  Values in each graph shows the mean of 3 
independent experiments. Error bars were plotted after calculating the standard deviation of 
the mean. 
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4.4.4.2 Infection dynamics results of the high pathogenic strain 8081 (Bioserotype 
1B/O:8): 
The high pathogenic 8081 strain is used here to represent the infection dynamics of the high 
pathogenic bioserotype 1B/O:8 (Fig. 4.9). The high pathogenic strain was pre-grown at 25°C 
prior the infection of the Galleria larvae.  The infected Galleria larvae were incubated at both 
25°C and 37°C.  Galleria larvae incubated at 25°C were infected with the lethal dose 9.45 
Log10 c.f.u/ml (10
9
) and the non-lethal dose 5.45 Log10 c.f.u/ml (10
5
). Galleria larvae 
incubated at 37°C were infected only with the highest dose 9.45 Log10 c.f.u/ml (10
9
).  The 
lethal dose injected into the 25°C incubated Galleria larvae has killed all infected larvae at 
24h post infection. The bacterial numbers of the lethal dose started to increase regularly till 
they reached a maximum growth at 24h time point with a total number of recovered bacteria 
that equals 11.06 Log10 c.f.u/ml with a statistical significance difference of p-value = 0.0004. 
Following that, the bacterial numbers started to decrease slightly till they reached a final 
number of bacterial cells of 10.72 Log10 c.f.u/ml isolated at the final time point (120h) and 
were statistically insignificant (p-value = 0.17). On the other hand, all the Galleria larvae, 
incubated at 25°C, and infected with the non-lethal dose 5.45 Log10 c.f.u/ml (10
5
) have 
survived.  The bacterial growth of the non-lethal dose was fluctuating by which the highest 
bacterial number was recovered after only 8h post infection (bacterial cells = 6 Log10 
c.f.u/ml), while the lowest recovered number was 4.74 Log10 c.f.u/ml which was recovered at 
the 72h time point with a statistical significance of a p-value = 0.0006.  The final recovered 
bacterial cells at the final 120h time point was 5.39 Log10 c.f.u/ml and it still showing a 
significant difference from the recovered bacterial numbers at 72h time point giving a          
p-value = 0.03.  Furthermore, the Galleria larvae incubated at 37°C was infected with the 
highest dose 9.45 Log10 c.f.u/ml (10
9) didn‟t cause any killing to the Galleria larvae. The in 
vivo bacterial growth started to decrease drastically until it reached a minimum bacterial 
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growth at 72h time point by which the recovered bacterial number was 4.86 Log10 c.f.u/ml.  
The bacterial numbers had decreased dramatically within 72h by which the growth difference 
between the starting inoculum and the 72h bacterial growth was 4.5 Log10 units 
approximately and was statistically very significant showing a p-value ˂ 0.00001.  The 
growth then jumped approximately 1.20 Log10 units difference during the last 48h monitoring 
time and the last recovered bacterial number was 6.05 Log10c.f.u/ml and still showing a 
significant difference with a p-value = 0.0014.   
 
Figure 4.9: Infection dynamics results of the high pathogenic 8081 strain of bioserotype 
1B/O:8. Strain 8081 was pre-grown at 25°C and the infected Galleria were incubated at 25°C 
and 37°C.  Galleria larvae incubated at 25°C were injected with both of the highest lethal 
dose and the highest non-lethal dose. Galleria larvae incubated at 37°C were injected with 
only the highest dose. Values in the graph shows the mean of 3 independent experiments. 
Error bars were plotted after calculating the standard deviation of the mean. 
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4.4.4.3 Infection dynamics of the non-pathogenic strain 5303 (Bioserotype 1A/O:5): 
The non-pathogenic 5303 strain has been applied here to study the infection dynamics of the 
non-pathogenic biotype 1A (Fig. 4.10). The non-pathogenic strain was pre-grown at 25°C 
prior the infection of the Galleria larvae.  The infected Galleria larvae were incubated at 
37°C.  Galleria larvae incubated at 25°C were infected with the lethal dose 9.33 Log10 
c.f.u/ml (10
9
) and the non-lethal dose 4.33 Log10 c.f.u/ml (10
4
).  The lethal dose has killed all 
the infected Galleria larvae at the 24h post infection while the non-lethal dose didn‟t kill any 
of the infected larvae. Bacterial cells of the injected lethal dose were drastically killed during 
the 5 days incubation period.  Within 24 hours, the in vivo growth of the non-pathogenic 5303 
strain was hugely dropped and reached a bacterial cell number of 5.85 Log10 c.f.u/ml with a 
3.48 Log10 units difference showing a statistical significance difference from the starting 
inoculum with a p-value = 0.00017.  The bacterial cell growth commenced to decease slightly 
in the remaining 96h incubation period by which the final bacterial number recovered at the 
last time point (120h) was 5.46 Log10c.f.u/ml which was showing no statistical significance 
difference (p-value = 0.1074).  On the other hand, the bacterial cells of the non-lethal dose  
were rapidly eliminated in vivo in 2 hours‟ time post infection.  The recovered bacterial cells 
from the non-lethal dose of non-pathogenic 5303 strain at the 2h time point was zero giving a 
huge statistical significant difference of p-value < 0.00001.  The recovery of the bacterial 
cells was commenced to 5 days to recover any possible viable bacterial cells. No bacterial 
growth was observed after the 2h recovering time point.  
 
 
 
 
119 
 
 
Figure 4.10: Infection dynamics results of the non-pathogenic 5303 strain of bioserotype 
1A/O:5. Strain 5303 was pre-grown at 25°C and the infected Galleria were incubated at 
37°C.  Galleria larvae incubated at 37°C were injected with both of the highest lethal dose 
and the highest non-lethal dose.  Values in the graph shows the mean of 3 independent 
experiments. Error bars were plotted after calculating the standard deviation of the mean. 
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4.5 Discussion  
               Y. enterocolitica species contains heterogeneous strains which belong to six 
different biotypes and many serotypes (Reuter et al., 2014). Some literature has documented 
that Y. enterocolitica contains more than 50 serotypes (Virdi and Sachdeva, 2005) while more 
recent publications describe more than 70 serotypes (Garzetti et al., 2013; Skurnik and 
Toivonen, 2011).   This wide diversity of the Y. enterocolitica species increases the need to 
study the pathogenicity of a more diverse set of Y. enterocolitica strains belonging to 
different biotypes and serotypes in the Galleria infection model.  Adding a larger number of 
Y. enterocolitica strains to this study allows to investigate the pathogenic potential of            
Y. enterocolitica biotypes and serotypes in more detail and in a wider range rather than 
depending only on the 10 representative strains that have been extensively studied in Chapter 
three.    
                 
Twenty three different Y. enterocolitica strains which belong to different biotypes and 
serotypes were tested in this chapter.  These 23 strains have been isolated from human and 
animal origins including pigs, sheep and cattle. These strains also include isolates from 
unknown origin.  All the 23 Y. enterocolitica strains were pre-grown at 25°C prior their 
injection into the Galleria larvae.  The infected Galleria larvae with all the 23                       
Y. enterocolitica strains were incubated at 37°C post infection.   This condition, of             
pre-growing Y. enterocolitica diverse strains at the environmental 25°C temperature and 
incubating the infected Galleria at 37°C, was chosen  since Y. enterocolitica pathogenic 
strains induce their virulence in human bodies by up shifting from environmental 
temperatures (25°C-28°C) to the 37°C human optimal body temperature (Fàbrega and Vila., 
2012).  The chosen 23 Y. enterocolitica strains were organized under 4 biotypes and 
serotypes which are the low pathogenic bioserotype 4/O:3, the low pathogenic bioserotype 
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3/O:5,27, serotype O:9 and the non-pathogenic biotype 1A.  Five strains for each of the 
bioserotype 3/O:5,27, serotype O:9 and biotype 1A were tested.  
 
Eight strains from bioserotype 4/O:3 were studied.  Moreover, the selected 8 strains of the 
bioserotype 4/O:3 were further subdivided into two sub groups by which each sub group 
contains 4 strains.  The first bioserotype 4/O:3 sub group contains 4 strains of human origin.   
The second bioserotype 4/O:3 sub group contains 4 non-human origin strains by which these 
strains were isolated from animal and unknown origins. However, bioserotype 4/O:3 have 
been described as a predominant bioserotype by which bioserotype 4/O:3 clinical strains were 
frequently isolated from humans worldwide (Fredriksson-Ahomaa 2000; Pham et al., 1995).  
Seven out of the 8 bioserotype 4/O:3 tested strains were virulent to Galleria  larvae. Strain 
NZ15 was the only avirulent in Galleria infection model among the rest bioserotype 4/O:3 
strains by which strain NZ15 was isolated from an unknown origin.  The percentage of the 
bioserotype 4/O:3 virulent strains is 87.5%. 
 
Y. enterocolitica strains belongs to serotype O:9 are pathogenic to humans and they are 
frequently isolated in Europe and Scandinavia in addition to other parts of the world (Skurnik 
and Toivonen, 2011). We studied 5 Y. enterocolitica strains that belong to serotype O:9 
(biotypes 2 and 3) by which 4 strains belong to bioserotype 3/O:9 and 1 strain was from 
bioserotype 2/O:9.  All the 4 strains of the bioserotype 3/O:9 were lethal to the infected 
Galleria larvae.  Strain 119/02 bioserotype 2/O:9 was the only serotype O:9 strain that didn‟t 
cause any killing to Galleria.  The percentage of the virulent serotype O:9 strains is 80.0%.   
 
The non-pathogenic biotype 1A is serologically the most heterogeneous biotype between all 
the 6 Y. enterocolitica biotypes (Tennant et al., 2003).  The pathogenic potential of 5 strains 
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of the non-pathogenic biotype 1A was tested in the Galleria host infection model.  These 
strains belong to different serotypes and were isolated from human and different animal 
origins.  All the 5 tested biotype 1A strains were lethal to the infected Galleria larvae.  These 
biotype 1A strains belong to serotypes O:5, O:6,30 in addition to the O-non typable serotype.  
Biotype 1A strains that belong to the O-non typable, O:5 and O:6,30 serotypes are the most 
isolated strains from human cases worldwide (Tennant et al., 2003).  The percentage of 
virulent biotype 1A strains is 100%.    
 
Finally the human pathogenic potential of the low pathogenic bioserotype 3/O:5,27 was 
studied using 5 strains.  All the bioserotype 3/O:5,27 tested strains were virulent to Galleria 
and caused killing to the infected larvae.  These strains have been isolated from several 
animal origins including pigs, sheep and cattle.  The bioserotype 3/O:5,27 strains have been 
isolated from animals in the UK and never associated with human disease (McNally et al., 
2011). The percentage of the virulent bioserotype 3/O:5,27  strains is 100%.  In conclusion, 
Galleria results shows that 21 out of the 23 diverse strains tested here were lethal and caused 
death to the Galleria larvae.  This means that 91.3% of the selected Y. enterocolitica diverse 
strains were pathogenic to the Galleria alternative infection model.  More importantly, the 
results of the reference strains were validated against this more diverse strain collection 
suggesting that the lineage specific results observed in the Galleria model are not strain 
specific but truly reflect the pathogenic potential of each lineage. 
 
Since all previous results were observed from a live Y. enterocolitica strains, the pathogenic 
potential of the Heat Killed Y. enterocolitica (HKY) cells in the Galleria host model was 
investigated.  Examining if the killing caused by Y. enterocolitica strains in the Galleria 
infection model is resulting from an interaction of an active live virulence mechanism with 
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Galleria larvae and not resulting from a larval passive cellular response for a foreign antigen 
or from blocking the larvae hemocoel with a large number of bacterial cells is necessary.  
Previous studies have used HKY in mouse infection model to test the immune response 
between the HKY and the live Y. enterocolitica strains (Autenrieth et al., 1994; Ruiz-Bravo 
et al., 2003).  HKY were found to be immunomodulatory in the mouse infection model 
immune system but to a limited extent compared to the live Y. enterocolitica cells (Ruiz-
Bravo et al., 2003).  Five HKY Y. enterocolitica strains belonging to different bioserotypes 
were tested to detect any biotype or serotype specific differences.  Y. enterocolitica strains 
8081, 1203, 14902, 5603 & 5303 were heat killed at 60°C for 1 hour in order to avoid cellular 
damage and therefore avoid damaging the surface antigens.  Y. enterocolitica LPS are an 
example of surface antigens and they are able to stimulate the murine model immune system 
(Ruiz-Bravo et al., 2003). However, the HKY results show that all the heat killed                   
Y. enterocolitica strains didn't cause any death to the infected Galleria larvae.   As a result, it 
can be observed that only the Y. enterocolitica living cells that can cause killing to the 
Galleria larvae.  These results guided me to investigate the fate (dead or alive) of the             
Y. enterocolitica cells inside the infected Galleria larvae and how do they behave inside the 
infected larvae.   
 
Next, the 8081, 1203, 14902, 21202 and 5303 Y. enterocolitica strains transformed with 
trimethoprim pAJD434 resistance plasmid, were tested for their in vivo behaviour in the 
alternative infection model G. mellonella.  This was done to measure the bacterial growth 
rates within Galleria at different time points. All strains were pre-grown at 25°C optimal 
growth temperature. Galleria larvae were infected with a chosen lethal dose and a non-lethal 
dose from each strain to compare their in vivo behaviour.  I chose to incubate the infected 
Galleria larvae with the low pathogenic biotype strains at the 25°C temperature since the 
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25°C incubation temperature shows more virulence in the infected Galleria larvae and hence 
enable an easy selection of a lethal dose.  The previous work in chapter three ,which involved 
infecting Galleria larvae with the high pathogenic 8081 strain bioserotype 1B/O:8, revealed 
that the infected Galleria larvae incubated at 25°C were susceptible to killing while the 
incubated larvae at the 37°C were completely resistant to killing and remained alive.  For this 
reason, an extra group of infected Galleria larvae at 37°C was incubated in addition to the 
group incubated at 25°C. This non-lethal effect at the 37°C incubation temperature is unique 
for the high pathogenic 8081 strain and it is important to investigate the bacterial behaviour at 
this temperature.  Since the Galleria larvae infected with the high pathogenic strain 8081 
don‟t die at the 37°C incubation temperature, thus there will be no lethal dose that can be 
selected.  As a result, I chose only one dose to infect the Galleria larvae and I decided to 
select the highest dose 10
9
 since this dose is also selected to infect the Galleria larvae at the 
25°C incubation temperature. This will provide a similar comparison of the same bacterial 
number but at two different incubation temperatures.  Selecting the highest dose 10
9 
to infect 
the Galleria larvae provides enough bacterial numbers that can remain and recovered through 
the 5 days incubation period.  I named this non killing 10
9
 high dose as the highest injected 
dose but not “as non-lethal” to avoid confusing with the non-lethal doses in the rest 
incubation conditions. The infected Galleria larvae with the non-pathogenic strain 5303 were 
incubated at 37°C but not at 25°C as were done previously.  This is because all doses of the 
non-pathogenic 5303 strain can kill the Galleria larvae at the larval 25°C incubation 
temperature and as a result there are no any possible non-lethal doses that can be selected.  
Alternatively, Galleria larvae infected with the non-pathogenic strain 5303 and incubated at 
37°C contains both lethal and non-lethal doses which allows selecting both types of doses.  
All the injected doses were delivered in 10µl volumes in the Galleria larvae.  This volume 
contains cell number 100 times less than the actual stock suspension.  As a result, to provide 
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an accurate bacterial numbers compared to the actual stock, every recovered bacterial number 
was multiplied in 100 (x100) to obtain the actual bacterial cells number.  G. mellonella have 
been frequently used to study the in vivo infection dynamics of many human pathogens 
comprising Listeria monocytogenes (Joyce et al., 2010), Campylobacter jejuni (Senior et al., 
2011), Group A Streptococcus (GAS) (Olsen et al., 2011), Yersinia pseudotuberculosis 
(Champion et al., 2009) and Yersinia pestis (Erickson et al., 2011).  These studies show that 
species manage to grow and persist in the G. mellonella insect infection model.  The recent 
experimental work shows that the high pathogenic biotype and low pathogenic biotypes 
strains were growing and persist in both dead and alive infected Galleria larvae during the 5 
day incubation period.  However, the non-pathogenic biotype strain showed a marked 
reduction in growth in the lethal dose and a complete elimination of bacterial cells in the non-
lethal dose but also the remaining live bacterial cells of the lethal dose stayed alive till the 
end of the incubation period. Death in G. mellonella larvae infected with lethal doses of both 
the high and low pathogenic biotypes was accompanied with an in vivo bacterial growth with 
a peak of maximum growth at 24h (and at 48h for only the low pathogenic strain 1203 
bioserotype 4/O:3).  Galleria death resulted from the lethal dose of the non-pathogenic 5303 
strain and was accompanied by bacterial cell death with a maximum growth drop occurring at 
24h post infection.  On the other hand, all the tested Y. enterocolitica strains were starting to 
cause death in Galleria larvae at the 24h time point.  This indicates that the maximum host- 
pathogen interaction occurs between 8h and 24h time points post infection.  Moreover, the 
statistical analysis of the recovered numbers of bacterial cells from Galleria is showing that 
(p) values of the early and middle stages of Galleria infection, from the starting inoculum to 
the 72h time point recovery, were always lower than (p) values at the late Galleria infection 
stages that occur at the last 48h hours of the 5 days incubation period.  This indicates that the 
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maximum Y. enterocolitica in vivo interaction with Galleria occurs during the first 72h post 
infection weather this interaction was an increase or decrease in bacterial numbers.  
 
4.6 Conclusion  
In conclusion, Galleria insect infection model was susceptible to killing by a heterogeneous 
collection of Y. enterocolitica diverse strains. The heat-killed Y. enterocolitica  strains were 
completely avirulent in Galleria larvae.  The pathogenic Y. enterocolitica biotypes bacterial 
cells were growing inside Galleria while the non-pathogenic biotype cells were dying. This 
proves that there are lineage specific differences in the virulence of Y. enterocolitica to 
Galleria. This also shows that the extreme virulence shown by Biotype 1A strains to Galleria 
is not as a result of surface associated factors, but rather is the result of interplay between the 
Galleria and the bacteria, which results in a reduction in bacterial cell numbers, but 
ultimately death to the Galleria.  
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Chapter 5 
Investigating the role of pYV in modulating the lack of virulence of the 
pathogenic biotypes in Galleria host model 
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5.1 Introduction 
 
               Y. pestis, Y. pseudotuberculosis and Y. enterocolitica are the human pathogenic 
species of the genus Yersinia.  These three species share a conserved 70-kb pYV (Plasmid of 
Yersinia Virulence) plasmid which has been shown to be fundamental for their virulence 
(Bhaduri and Smith, 2011; Hammer et al., 2007).  The loss of the pYV plasmid correlates 
with a loss of virulence in the pathogenic Yersinia species (Hammer et al., 2007).  pYV is the 
name most commonly used to describe the virulence plasmid when referring to                      
Y. enterocolitica but it‟s also called pCD1 in Y. pestis and pIB1 in Y. pseudotuberculosis 
(Mulder et al., 1989).  These names derive from the first genetically mapped virulence 
plasmids: pYV227 which was mapped from the low pathogenic Y. enterocolitica W22703 
strain bioserotype 2/O:9; pCD1 from Y.pestis KIM of biovar medievalis; and pIB1 from        
Y. pseudotuberculosis strain YPIII (Cornelis et al., 1998).  Y. enterocolitica pathogenic 
strains harbour a pYV plasmid with a size ranging from 64- to 75-kb (Bottone, 1997).  Recent 
phylogeny of genome sequenced Y .enterocolitica pYV plasmids revealed that the                
Y. enterocolitica pathogenic biotypes carry different copies of the pYV plasmid (Reuter et al., 
2014).  According to the phylogenetic tree analysis, the pYV plasmid copies of the low- 
pathogenic biotypes are closely related while the pYV plasmid of the high-pathogenic 
biotype forms a distant lineage with a unique replication origin (Reuter et al., 2014).  The 
pYV plasmid is found in the Y. enterocolitica high pathogenic biotype 1B strains and the low 
pathogenic 2-5 biotypes strains but absent from the non-pathogenic biotype 1A strains 
(Howard et al., 2006).  Y. enterocolitica pYV plasmid encodes for the major virulence factors 
of these organisms, the Ysc type three secretion system, the secreted Yops (Yersinia outer 
membrane proteins) and the YadA adhesin protein.  The Ysc system enables Y. enterocolitica 
to avoid phagocytosis by injected the cytotoxic Yop proteins into the cytosol of 
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Macrophages.  The injected Yops inhibit the phagocytic mechanisms and cause apoptosis to 
Macrophages (Cornelis et al., 1998).  The injected effector Yop proteins (YopH , YopE, 
,YopO , YopM,  YopP and YopT) into the cytosol of the eukaryotic host cell proteins are a 
set of virulence factors that interrupt the cytoskeletal dynamics of macrophages and 
polymorphonuclear leukocytes which inhibit the phagocytosis process (Perez-Gutierrez et al., 
2007) and hence enable Y. enterocolitica to avoid the immune system (Sing et al., 2002). In 
addition to the Yop effector proteins, Y. enterocolitica Ysc secretes another set of Yop 
proteins called the translocator proteins  (LcrV, YopB and YopD) required to translocate the 
Yop effector proteins (Sorg et al., 2006).  Moreover, YadA binds to collagen, fibronectin and 
laminin extracellular proteins and secures Y. enterocolitica from lysis by complement system 
and from phagocytosis (Schaake et al., 2013).   
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5.2 Aim:  
To Investigate the role of pYV in modulating the lack of virulence of the Y. enterocolitica 
pathogenic biotypes in Galleria host model.  
 
5.3 Objectives: 
A) To study the pathogenic potential of pYV-cured high pathogenic and low pathogenic        
Y. enterocolitica strains in the Galleria infection model.  
 
B) To investigate the stability of the pYV plasmid (pYV plasmid dynamics) during the 
infection of the Galleria larvae with strains of high pathogenic and low pathogenic                
Y. enterocolitica biotypes.    
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5.4 Materials and Methods 
5.4.1 Bacterial strains list  
All bacterial strains tested in chapter 5 are listed in table 5.1. 
Table 5.1:  Bacterial strains tested in chapter 5. *: Y. enterocolitica strains carrying the virulence plasmid pYV.          
**: Y. enterocolitica strains cured from (lack) the virulence plasmid pYV. 
No. Strain Name Bio/Serotype Biological Origin Source 
1 
 
8081* 1B/O:8 Human Thomson et al. 
(2006) 
2 
 
21202* 2/O:9  Pig McNally, UK 
3 
 
14902* 3/O:5,27 Sheep McNally, UK 
4 
 
1203* 4/O:3 Human McNally, UK 
5 8081c** 
 
1B/O:8 This Study Thomson et al. 
(2006) 
6 14902c** 
 
3/O:5,27 This Study McNally, UK 
7 1203c** 
 
4/O:3 This Study McNally, UK 
 
5.4.2 PCR Primers 
Table 5.2: PCR  primers 
Primer  
Name 
Nucleotide Sequence  Primer 
Function 
Annealing 
Temperature 
(°C)    
Riplicon 
size 
(bp) 
Yent1_F 
(16S) 
5'-AAT ACC GCA TAA CGT CTT CG-3' 
 
Control for     Y 
.enterocolitica 
16S rDNA 
 gene 
amplification 
 
      
       
      57 
 
 
 300 Yent2_R 
(16S) 
5'-CTT CTT CTG CGA GTA ACG TC-3' 
 
YscP1_F  
 
5'-ATT AGA ACC TGA GTA TCA ACC-3' 
 
Retention of 
virulence 
plasmid 
pYV. yscP 
gene 
amplification 
 
 
      
      52 
 
 
 500 YscP2_R 
 
5'-AAC AAA TAA CTC ATC ATG TCC-3' 
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5.4.3 pYV Plasmid curing procedure: 
The pYV plasmid was knocked out of the high pathogenic biotype 1B/O:8 strain 8081, the 
low pathogenic biotype 4/O:3 strain 1203 and the low pathogenic biotype 3/O:5,27 strain 
14902.  The pYV curing procedure involves subsequent sub culturing on LB agar plates at 
37°C.  All wild type strains pYV
+
 were grown on LB agar plates aerobically at 37°C in static 
incubator and incubated overnight for 24 hours. For each strain, three similar colonies were 
individually picked up from each overnight culture and sub cultured on separate LB agar 
plate. After every 2 passages on LB agar plates the third passage was cultured on CRMOX 
agar using the same last sub culturing procedure.  The cultured CRMOX agar plates were 
incubated aerobically in static incubator at 37°C for 18-24 hours.  Each experiment was 
repeated individually three times. The presence of the pYV plasmid was checked by PCR by 
targeting the yscP gene with YscP1 and YscP2 primers pair described in table 5.2.  The non-
pathogenic biotype 1A/O:5 strain 5303 was used as a pYVˉ negative control since this strain 
naturally lacks the pYV plasmid.  All pYVˉ cured strains were stocked in glycerol freezing 
medium and stored in -80°C freezer. To ensure the plasmid cured colonies were not 
contaminants the primers pair Yent1 and Yent2 (described in table 5.2) were used to detect 
the Y. enterocolitica 16S rDNA gene.    
 
5.4.4 pYV plasmid Stability:  
Four wild type Y. enterocolitica pYV
+ 
strains were used to study the stability of pYV: the 
high pathogenic biotype 1B/O:8 strain 8081, the low pathogenic biotype 4/O:3 strain 1203, 
the low pathogenic biotype 2/O:9 strain 21202 & the low pathogenic biotype 3/O:5,27 strain 
14902.  Y. enterocolitica strains were injected in Galleria larvae to study the stability of the 
pYV plasmid during the infection of the Galleria larvae.  The Y. enterocolitica strains were 
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pre-grown on 25°C as described in chapter two section 2.1.  The lethal dose in addition to the 
non-lethal dose was selected for each strain as previously described in chapter four.  Each 
dose was injected in 50 Galleria larvae (total of 100 Galleria per strain). All the infected 
Galleria larvae with all tested strains were incubated at 25°C for 5 days.  Every 24H, 
bacterial cells were recovered from a pool of 5 larvae for each lethal and non-lethal dose for 
each injected strain.  The recovering procedure was carried out as previously described in 
chapter four.  The bacterial cells were recovered from each larva and was drained and diluted 
as described in chapter four. All recovered bacterial cells were plated on CIN agar and 
incubated at 37°C for 24h.  Bulls-eye forming colonies were picked up and the presence of 
the plasmid was checked by PCR by detecting the presence of the yscP gene.  Primers pair 
Yent1 and Yent2 described in table 5.2 were used to detect the 16S rDNA gene confirm 
recovering testing Y. enterocolitica strains.   
 
5.4.5 Statistical analysis  
The statistical significance difference between the recovered bacterial numbers for each strain 
in the infection dynamics assay was determined by the one sample T-test.  The statistical 
significance difference of LD50 values between the Y. enterocolitica wild type strains and 
their pYV-cured derivative tested strains were determined by one sample T-test.  The 
statistical difference between the 25°C and 37°C  Galleria incubation temperatures were 
determined by the T-test of two independent samples. 
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5.5 Results 
5.5.1 pYV curing  
The pYV plasmid was cured from three Y. enterocolitica pathogenic strains; the high 
pathogenic bioserotype 1B/O:8 strain 8081, the low pathogenic bioserotype 4/O:3 strain 1203 
and the low pathogenic bioserotype 3/O:5,27 strain 14902. pYV plasmid loss was checked by 
PCR targeting the yscP gene followed by visualizing the PCR product on gel electrophoresis 
(Fig.5.1a). The Y. enterocolitica 16S rDNA gene was detected by PCR (Fig.5.1b) to ensure 
the isolated plasmid minus mutants were Y. enterocolitica.  The pathogenicity of the              
Y. enterocolitica cured strains in the Galleria infection model was tested by calculating the 
median lethal doses (LD50) and the survival curves for each strain.  All the Y. enterocolitica 
pYV cured strains were pre-grown at 25°C and the infected galleria with each strain were 
incubated at 25°C and 37°C. The median lethal doses (LD50) and survival results of the  
pYV- cured derivatives strains were compared to the median lethal doses (LD50) and survival 
results of the wild type references strains at the same Y. enterocolitica pre-growing 
temperatures and the injected Galleria larvae incubation condition.    
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5.5.1.1 Gel electrophoresis image of pYV curing results 
 
a- Gel of yscP gene amplification 
 
 
 
 
 
 
b- Gel of 16S rDNA gene amplification 
 
 
 
 
 
 
Figure 5.1: Gel electrophoresis image of pYV curing results. Figure 5.1 contains two 
subfigures 5.1a and 5.1b.  Figure 5.1a represents the gel image of checking the pYV plasmid 
curing by detecting the Y. enterocolitica yscP gene of the 3 pYV-cured Y. enterocolitica 
strains YE8081c, YE1203c and YE14902c.  Figure 5.1b represents the gel image of detecting 
the Y. enterocolitica 16S rDNA gene of the 3 pYV-cured Y. enterocolitica strains YE8081c, 
YE1203c and YE14902c.  The lanes of both figure 5.1a and figure 5.1b gel images are 
labelled with numbers from 1-12 and each number represents a different sample. In figure 
5.1a, 1= yscP gene detection of the wild type YE8081 strain which is used as a positive 
control (+ve) to insure that the yscP gene amplification primers are working.   
 
 
 
 M       1       2       3        4        5        6       7        8       9       10     11     12       -ve   
500bp― 
 M       1        2       3        4        5        6       7        8       9       10     11     12       -ve   
500bp― 
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5.5.1.2 The LD50 values of Y. enterocolitica pYV-cured strains  
The LD50 results show that the LD50 value of 8081c derivative strain was 9.56log10 c.f.u/ml at 
37°C incubation temperature and 7.6log10 c.f.u/ml at 25°C incubation temperature (Fig. 5.2).  
The LD50 of the 8081c derivative strain at the 37°C incubation temperature had slightly 
decreased from the 8081 wild type strain at the same incubation temperature by which the 
LD50 value was 9.6log10 c.f.u/ml.  Therefore strain 8081c has the same LD50 value as the wild 
type 8081 strain at the 25°C incubation temperature which was 7.6log10 c.f.u/ml in both.  The 
1203c derivative strain had LD50 values of 8.5log10 c.f.u/ml and 7.3log10 c.f.u/ml at 37°C and 
25°C incubation temperatures respectively.  The 1203c derivative strain also showed a 
decreased LD50 value compared to the wild strain 1203 at both incubation temperatures.  
Wild type 1203 strain have LD50 values of 8.9log10 c.f.u/ml and 7.8log10 c.f.u/ml at 37°C and 
25°C incubation temperatures respectively which are higher than the LD50 values of the 
1203c derivative strain.  The last tested pYV-cured strain in this part is the 14902c.  The LD50 
values of the derivative 14902c strain at both the 25°C and 37°C incubation temperatures 
were noticeably lower than the 14902 wild type strain LD50 values.  The 14902 LD50 values 
were 7.6log10 c.f.u/ml and 3.8log10 c.f.u/ml at 37°C and 25°C incubation temperatures 
respectively while LD50 values of the 14902 wild type strain were 8.8log10 c.f.u/ml (at 37°C 
incubation temperature) and 3.8log10 c.f.u/ml (at 25°C incubation temperature).  The Y. 
enterocolitica pYV-cured strains are showing a significance difference between the 25°C and 
37°C incubation temperatures (p= 0.001898).  This shows that the Y. enterocolitica pYV-
cured strains still respond differently to different incubation temperature and still more 
virulent at the 25°C incubation temperature where the LD50 values are lower from those at the 
37°C.  The Y. enterocolitica pYV-cured strains where then compared to the Y. enterocolitica 
wild strains (pYV
+
) at the same pre-growing and incubation temperatures and we found that 
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there was no significance difference between the Y. enterocolitica (pYV
-
) and                       
Y. enterocolitica (pYV
+
) strains (p-values= 0.055175 and 0.237761 respectively).   
 
 
 
Figure 5.2: LD50 values of Y. enterocolitica pYV-cured strains 8081 (Bioserotype 1B/O:8), 
1203 (Bioserotype 4/O:3) and 14902 (Bioserotype 3/O:5,27).  The graph shows the mean 
LD50 of independent triplicate experiments for each individual strains.  The LD50 values of 
the wild type pYV
+
 and the cured pYVˉ derivative for each strain are represented in columns 
by which each strain is represented in 2 columns. The x-axis represents the strain name and 
the y-axis represents the LD50 values in log10 c.f.u/ml. The blue bars represent the LD50 
values of Y. enterocolitica strains incubated at 37°C. The red bars represent the LD50 values 
of Y. enterocolitica strains incubated at 25°C.  Error bars were plotted after calculating the 
standard deviation of the mean. 
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 5.5.1.3 Survival Curves  
5.5.1.3.1 The survival curves of Galleria infected with the derivative strain 8081c 
Strain 8081c was pre-grown on 25°C and it was virulent to Galleria larvae.  The infected 
Galleria larvae with the 8081c strain were incubated at both 25°C and 37°C incubation 
temperatures.  At the 37°C incubation temperature, dose 10
9
 was the only dose caused killing 
to the infected Galleria larvae by which only one larva was killed (80% survival) at 24h p.i. 
(Fig. 5.3a). This is the first result of 8081 strain was able to kill the injected larvae at this 
condition by which the wild type 8081 strain was completely avirulent at the 37°C incubation 
(Fig. 5.3b). At the 25°C incubation temperature, 10
9
 and 10
8
 doses killed all the infected 
Galleria larvae by which the 10
9
 dose killed all the infected Galleria larvae after 48h p.i. 
while the 10
8
 dose killed all the infected larvae after 72h p.i. (Fig. 5.3c).  No difference in 
survival was observed at this condition compared to the survival result of the 8081 wild type 
reference strain in the same conditions (Fig. 5.3d).   
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a- Survival curve of Galleria incubated at 37°C and infected with the pYV-cured derivative 
strain 8081c 
 
b- Figure 5.3b: Survival curve of Galleria incubated at 37°C and infected with the pYV
+
 wild 
type  strain 8081 
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c- Survival curve of Galleria incubated at 25°C and infected with of the pYV-cured 
derivative strain 8081c 
 
d- Survival curve of Galleria incubated at 25°C and infected with of the pYV
+
 wild type 
strain 8081 
 
Figure 5.3: Survival curves results of Galleria infected with the derivative strain 8081c & the 
wild type 8081 strain. Figure 5.3 includes four sub figures (5.3a,5.3b,5.3c & 5.3d). Figures 
5.3a & 5.3b represent the survival curves results of the pYV
- 
derivative strain 8081c and the 
wild type pYV
+ 
8081 strain respectively at the 37°C incubated Galleria. Figures 5.3c & 5.3d 
represent the survival curves results of the pYV
- 
derivative strain 8081c and the wild type 
pYV
+ 
8081 strain respectively at the 25°C incubated Galleria.  Values shown in each survival 
graph are representative values obtained from performing the experiment in triplicate.  
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5.5.1.3.2 The survival curves of Galleria infected with the derivative strain 1203c 
Strain 1203c was pre-grown at 25°C and it was also virulent to Galleria larvae.  The infected 
Galleria larvae with the 1203c strain were incubated at both 25°C and 37°C incubation 
temperatures.  At the 37°C incubation temperature, dose 10
7
,10
8
 and 10
9
 produced killing to 
the infected Galleria larvae. Doses 10
9
 and 10
8
 killed all the infected larvae at 24h p.i. while 
doses 10
7
 killed 3 larvae (40% survival) also at the 24h p.i. time point (Fig. 5.4a).  At the 
25°C incubation temperature, 10
9
 and 10
8
 doses caused death to the Galleria larvae where the 
10
9
 dose killed all the infected Galleria larvae after 24h p.i. while the 10
8
 dose killed 2 larvae 
(60% survival) after 48h p.i. (Fig. 5.4c).   Compared to the wild type strain 1203 at the same 
condition of the 1203c derivative strain, it can be observed that same doses of 1203c strain 
were able to kill the Galleria larvae compared to the wild type reference strain 1203 (Fig. 
5.4b & 5.4d).  However, the number of killed larvae injected with the doses of the 1203c 
derivative strain have slightly increased compared to the 1203 wild type strain.   
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a- Survival curve of Galleria incubated at 37°C and infected with of the pYV-cured 
derivative strain 1203c 
 
b- Survival curve of Galleria incubated at 37°C and infected with the pYV
+
 wild type strain 
1203 
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c- Survival curve of Galleria incubated at 25°C and infected with the pYV-cured derivative 
strain 1203c 
 
d- Survival curve of Galleria incubated at 25°C and infected with of the pYV
+
 wild type 
strain 1203 
 
Figure 5.4: Survival curves results of Galleria infected with the derivative strain 1203c & the wild 
type 1203 strain. Figure 5.4 includes four sub figures (5.4a,5.4b,5.4c & 5.4d). Figures 5.4a & 5.4b 
represent the survival curves results of the pYV
- 
derivative strain 1203c and the wild type pYV
+ 
1203 
strain respectively at the 37°C incubated Galleria. Figures 5.4c & 5.4d represent the survival curves 
results of the pYV
- 
derivative strain 1203c and the wild type pYV
+ 
1203 strain respectively at the 
25°C incubated Galleria.  Survival graphs of the Galleria larvae were constructed by plotting the time 
of observation post infection in hours (x-axis) against the percentage of the larvae survival (y-axis). 
The coloured lines represent the different doses used to infect Galleria addition to the controls used.  
Values shown in each survival graph are representative values obtained from performing the 
experiment in triplicate.  
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5.5.1.3.3 The survival curves of Galleria infected with the derivative strain 14902c: 
The pYV-cured 14902 strain (14902c) was pre-grown at 25°C.  Strain 14902c was injected 
into the Galleria larvae and the infected larvae were incubated at both 25°C and 37°C. At 
both incubation temperatures, strain 14902c caused death to the infected Galleria larvae. At 
the 37°C incubation temperature, doses 10
9
,10
8
 and 10
7
 were virulent to the Galleria larvae.  
Both the 10
9
 and 10
8
 doses killed all the infected larvae at 24h p.i. and 48h p.i. respectively 
for each dose.  In addition, doses of 10
7
 killed 2 larvae (60%) at the 48h p.i. (Fig. 5.5a). At 
the 25°C incubation condition, 8 different doses of the 14902c strain killed the infected larvae 
and these doses are 10
2
,10
3
,10
4
,10
5
,10
6
,10
7
,10
8
 and 10
9
. All the Galleria larvae groups 
infected with doses 10
9
,10
8
,10
7
 and 10
6
 were killed. Doses 10
9
 and 10
8
 killed all the infected 
larvae at 24h p.i. while doses 10
7
 and 10
6 
killed all the infected larvae at 48h p.i.  In addition, 
dose 10
5
 killed 4 larvae (20% survival) after 48h p.i. and the dose 10
4
 killed 3 larvae (60% 
survival) after 96h p.i.  On the other hand, the 10
3
 dose killed 2 larvae (60%) at 96h p.i. while 
the 10
2
 dose killed only one larva (80% survival) at 96h p.i. (Fig. 5.5c). Comparing the 
survival results of the 14902c derivative strain to the survival results of the wild type 14902 
reference strain, at the same conditions, it can be observed that the 14902c derivative strain 
was able to kill Galleria larvae with one more dose at each incubation temperature while the 
wild type pYV
+
 strains kills Galleria with one less dose at each incubation temperature (Fig. 
5.5b & 5.5d).   
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a- Survival curve of Galleria incubated at 37°C and infected with the pYV-cured derivative 
strain 14902c 
 
b- Survival curve of Galleria incubated at 37°C and infected with the pYV
+
 wild type strain 
14902
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c- Survival curve of  Galleria incubated at 25°C and infected with the pYV-cured derivative 
strain 14902c 
 
d- Survival curve of Galleria incubated at 25°C and infected with the pYV
+
 wild type strain 
14902 
 
Figure 5.5: Survival curves results of Galleria infected with the derivative strain 14937c & 
the wild type 14937 strain. Figure 5.5 includes four sub figures (5.5a,5.5b,5.5c & 5.5d). 
Figures 5.5a & 5.5b represent the survival curves results of the pYV- derivative strain 14937c 
and the wild type pYV
+ 
14937 strain respectively at the 37°C incubated Galleria. Figures 
5.5c & 5.5d represent the survival curves results of the pYV- derivative strain 14937c and the 
wild type pYV
+ 
14937 strain respectively at the 25°C incubated Galleria.  Values shown in 
each survival graph are representative values obtained from performing the experiment in 
triplicate.  
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5.5.2 Stability of  pYV dynamics during Galleria infection  
 
The plasmid occurrence of 4 Y. enterocolitica wild type strains was tested during their 
infection in the Galleria larvae. The selected lethal and lethal doses, of each strain, were 
chosen depending on previous survival curves described in chapter three.  The stability of the 
pYV plasmid was checked by PCR targeting the yscP gene at time points 24h, 72h and 120h 
post infection. The Y. enterocolitica 16S rDNA gene was detected by PCR to ensure the 
isolation of the Y. enterocolitica strains only. The PCR detection of the yscP gene revealed 
that Y. enterocolitica strains YE8081, YE1203 and YE21202 have retained the pYV plasmid 
during the in vivo Galleria infection while only the YE14902 Y. enterocolitica strains had 
lost the pYV plasmid during the in vivo infection (Fig. 5.6).  The low pathogenic bioserotype 
3/O:5,27 strain YE14902 have lost the pYV plasmid from the first day of infection (24h p.i.) 
(Fig.5.6a) in both of the lethal and non-lethal doses.  The pYV plasmid presence in the 14902 
strain was also checked at 72h and 120h time points (Fig. 5.6b & 5.6c) to ensure if there are 
any of the 14902 strain cells that may still retain the pYV plasmid in the other infected 
Galleria larvae. Strain 14902 has lost the pYV plasmid in all time points during the 5 days of 
Galleria infection period.  Moreover, Y. enterocolitica strains YE8081, YE1203 and 
YE21202 have retained the pYV plasmid by both of the injected lethal and non-lethal doses 
during the 5 days period of the Galleria infection (Fig. 5.6). Figures 5.6a, 5.6b and 5.6c are 
showing the presence of pYV plasmid at 24h, 72h and 120h post infection respectively of         
Y. enterocolitica YE8081, YE1203 and YE21202 strains.  The Y. enterocolitica 16S rDNA 
gene was detected by PCR at 24h (Fig. 5.7a), 72h (Fig. 5.7b) and 120h (Fig. 5.7c) time 
points. The Y. enterocolitica 16S rDNA gene is confirming that these recovered bacteria are 
actually Y. enterocolitica. 
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5.5.2.1 Gel electrophoresis results of checking the stability of the pYV plasmid 
a- Gel image after 24h: 
 
 
 
 
 
b- Gel Images after 72h:  
 
 
 
 
c- Gel Image after 120h: 
 
 
 
 
Figure 5.6: Gel electrophoresis results of checking the stability of the yscP gene. Figure 5.6 
contains the three subfigures 5.6a, 5.6b and 5.6c.  Each sub figure represents a gel image of 
detecting the Y. enterocolitica yscP gene of the 4 tested Y. enterocolitica strains YE8081, 
YE1203, YE14902 and YE21202.   Subfigures 5.6a, 5.6b and 5.6c represents gel images of 
detecting the Y. enterocolitica yscP gene of the 4 tested Y. enterocolitica strains after 24h, 
72h and 120h of Galleria post infection respectively.  The lanes of each gel are labelled with 
numbers from 1-12 and each number represents a different. (–ve)= the PCR DNA template-
less negative control.  M= the 100bp DNA marker.         
 
 
 
500bp― 
M       1        2        3        4       5        6        7       8        9      10     11     12       -ve   
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5.5.2.2 Gel electrophoresis results for detecting the 16S rDNA gene:  
a- Gel image after 24h: 
 
 
 
 
b- Gel Images after 72h:  
 
 
 
 
c- Gel Image after 120h: 
 
 
 
 
Figure 5.7: Gel electrophoresis results for detecting the 16S rDNA gene. Figure 5.7 contains 
the three subfigures 5.7a, 5.7b and 5.7c.  Each sub figure represents a gel image of detecting 
the Y. enterocolitica 16SrDNA gene of the 4 tested Y. enterocolitica strains YE8081, 
YE1203, YE14902 and YE21202.   Subfigures 5.7a, 5.7b and 5.7c represent gel images of 
detecting the Y. enterocolitica 16SrDNA gene of the 4 tested Y. enterocolitica strains after 
24h, 72h and 120h of Galleria post infection respectively.  The lanes of each gel are labelled 
with numbers from 1-12 and each number represents a different sample. The broth cultures 
are used as positive controls of detecting the 16SrDNA gene in all tested strains. (–ve)= the 
PCR DNA template-less negative control.  M= the 100bp DNA marker.        
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5.7 Discussion  
In this chapter, the role of Y. enterocolitica pYV plasmid in modifying the Y. enterocolitica 
pathogenic biotypes was investigated in the insect infection model Galleria mellonella.  The 
main difference between the pathogenic biotypes and the non-pathogenic biotype is the 
presence of pYV in all pathogenic biotypes and absent from the non-pathogenic biotype 
(Reuter et al., 2012).   pYV plasmid is known as the major virulence factor in pathogenic       
Y. enterocolitica biotypes which encodes for the Ysc type three secretion system and Yop 
proteins (Hammer et al., 2007) and responsible in host immunomodulation (Ruiz-Bravo et 
al., 2003).  From previous results in this project it was observed that all pathogenic biotypes 
were showing less virulence than the non-pathogenic biotype in Galleria larvae. As a result, 
the pathogenic potential of three Y. enterocolitica derivative strains lacking the pYV plasmid 
(pYVˉ) was investigated to observe any difference in the pathogenic phenotype. The tested 
strains are the high pathogenic bioserotype 1B/O:8 strain 8081c, the low pathogenic 
bioserotype 4/O:3 strain 1203c and the low pathogenic bioserotype 3/O:5,27 strain 14902c.  
The pYV plasmid was removed from these strains by the continuous sub culturing on LB 
agar plates at the 37°C growing temperature in the absence of Ca
2+
.  We have checked on the 
loss of plasmid by sub culturing on the CRMOX agar (Bhaduri and Smith., 2011; Riley and 
Toma., 1989) and by targeting the yscP chromosomal gene which encodes for the YscP 
protein responsible for determining the needle length of the Ysc injectisome (Agrain et al., 
2005; Wood et al., 2008).  From the LD50 data of the pYV cured strains, it was found that all 
the pYVˉ Y. enterocolitica tested strains are showing an increase in virulence in the Galleria 
infected larvae at both incubation temperatures.  The pYVˉ high pathogenic derivative strain 
8081c has shown the minimum and a very slight increase in virulence only at the 37°C 
incubation temperature compared to the 8081 wild type pYV
+
 strain.  The 8081c derivative 
strain managed to kill only one larva with the highest 10
9
 dose at the 37°C incubation 
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temperature.  No difference in virulence was found at the 25°C incubation temperature by 
which the LD50 value was 7.6log10c.f.u/ml for both strains.  Previous work of this project has 
shown that the 8081 wild strain was completely avirulent to the Galleria larvae incubated at 
the 37°C incubation temperature.  The pYVˉ 1203c derivative strain has shown a small 
increase in virulence in the infected Galleria larvae at both 25°C and 37°C incubation 
temperatures but this increase was higher and more observable from the high pathogenic 
pYVˉ 8081c derivative strain.  The 1203c derivative strain has shown a decrease in the LD50 
values with a difference of 0.4log10 c.f.u/ml at 37°C incubation temperature and a difference 
of 0.5log10 c.f.u/ml at 25°C incubation temperature compared to the 1203 wild type strain 
LD50 values.  This decrease in LD50 values indicates a higher virulence profile of the 1203c 
derivative strain.  Furthermore, the pYVˉ low pathogenic 14902c derivative strain is showing 
a manifest high virulence ability compared to all the other tested pYV-cured strains.  
Although the wild type 14902 strain was the most virulent pathogenic strain in the Galleria 
larvae, the 14902c derivative strain shows an additional virulence ability to the infected 
Galleria larvae at both 25°C and 37°C incubation temperatures compared to the pYV
+
 wild 
type 14902 strain.  The LD50 value of the 14902c derivative strain was decreased 1.2log10 
c.f.u/ml and 1.3log10 c.f.u/ml at 25°C and 37°C incubation temperatures respectively 
compared to the wild type 14902 strain.   However, this experimentally noticed slight 
increase in virulence of Y. enterocolitica pYV-cured strains did not show significant 
statistical increase in virulence compared to the wild type strains.  This provides an evidence 
that Y. enterocolitica virulence doesn‟t depend only on the pYV plasmid but it utilizes a 
chromosomally encoded virulence factors as well for causing disease.   
The second part of this work included the investigation of the pYV plasmid stability during 
the life infection of the Galleria larvae.  The in vivo stability of the pYV plasmid during the 
life infection of Galleria larvae have been investigated with four pathogenic wild type strains.  
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Theses strains are the high pathogenic bioserotype 1B/O:8 strain 8081 and three low 
pathogenic strains 1203 (BT 4/O:3), 14902 (BT 3/O:5,27) and 21202 (BT 2/O:9).  The 
Galleria larvae were infected with lethal and non-lethal doses from each of the tested            
Y. enterocolitica wild type strains.  The injected strains were recovered from the infected 
Galleria larvae every 24 hours for 5 days.  The presence or the absence of the pYV plasmid 
was checked by PCR through targeting the yscP gene (Agrain et al., 2005; Wood et al., 
2008).   It have been observed that the 14902 had lost the pYV plasmid from the first day of 
infection while the other remaining strains retained the pYV plasmid.  This may indicates that 
the 14902 strain pathogenicity in infected Galleria depends on chromosomal virulence 
determinants rather than the virulence of the pYV plasmid.  On the other hand, the other 
strains kept the pYV plasmid during the 5 days incubation period which may indicates that 
these strains are using the pYV plasmid in addition to the chromosomal virulence factor for 
their pathogenesis in the infected Galleria larvae. It also can be concluded that the pYV 
absence in 14902 may play some role in increasing the pathogenicity of the low pathogenic 
14902 strain in the Galleria alternative infection model.   
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5.8 Conclusion  
 
This work shows that the pYVˉ Y. enterocolitica strains are showing similar virulence in the 
Galleria infected larvae.  However there is a slight increase in pathogenicity, depending on 
the bioserotype of the Y. enterocolitica pYVˉ tested strain, observed experimentally but 
statistically it is not significant.  It is well known that the pYV loss in Y. enterocolitica 
pathogenic strains leads to loss of virulence (Hammer et al., 2007).  However, the Galleria 
results are showing that loss of plasmid has increased the virulence of the tested Y. 
enterocolitica bioserotype 3/O:5,27 strain lacking the pYV plasmid.  Studies have provided 
evidence that Y. enterocolitica pYV-cured strains were capable of invading the mice infection 
model intestinal mucosa and were able to disseminate to the mesenteric lymph nodes. These 
studies also show that Y. enterocolitica pYV-cured strains were recovered from the 
mesenteric lymph nodes, the liver and the spleen of the infected gnotobiotic piglets animal 
model (Lian et al., 1987).  These results may support the pathogenic profile of                      
Y. enterocolitica pYV-cured strains in the infected Galleria larvae. The present results of 
monitoring the presence or the absence of the pYV plasmid during the Y. enterocolitica life 
infection in Galleria larvae have shown that Y. enterocolitica pathogenic strains maintain the    
pYV plasmid during Galleria infection with one exception, the bioserotype 3/O:5,27 strain 
14902.  The low pathogenic 14902 strain and the non-pathogenic 5303 strain were the most 
lethal strains to Galleria larvae.  As a result it can be concluded that the low pathogenic 
14902 strain, similar to the non-pathogenic 5303strain, causes pathogenesis in Galleria using 
chromosomal virulence determinants, but that a loss of pYV may help to exacerbate this 
effect. 
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6.1 Project Final Conclusion 
 
Y. enterocolitica is a zoonotic, food-borne pathogen associated with human infections and 
outbreaks worldwide. The main aim of this project is to provide a comparative study  of the 
pathogenesis of Y. enterocolitica high- ,low- and non-pathogenic biotypes. The human 
epithelial HEp-2 cell line and the emerging G. mellonella alternative insect infection model 
are used in this project to study the pathogenic potential of Y. enterocolitica high- ,low- and 
non-pathogenic biotypes.  Here, all the Y. enterocolitica high pathogenic, low pathogenic and 
non-pathogenic biotypes strains were able to invade the HEp-2 human epithelial cell line.  
The High pathogenic and low pathogenic Y. enterocolitica biotypes strains were efficiently 
able to invade HEp-2 epithelial cells to identical levels. The non-pathogenic biotype 1A strain 
has also shown invasive potential in this cell culture model but it was the least invasive 
biotype compared to the other Y. enterocolitica pathogenic biotypes.  Moreover,                   
Y. enterocolitica strains were pre-grown at 25°C and 37°C and at both pre-growing 
temperatures all the Y .enterocolitica strains were able to invade HEp-2 cell line in vitro. 
A diverse population of Y. enterocolitica strains encompassing different biotypes and 
serotypes and isolated from different biological origins,  were able to kill the Galleria insect 
model.  Killing of Galleria larvae was temperature-dependent and dose-dependent.  The 
median lethal doses (LD50) and the survival results showed that all Y. enterocolitica biotypes 
were more virulent to Galleria larvae incubated at 25°C and less virulent at the 37°C 
incubation.  Here Y. enterocolitica is showing a novel pathogenic potential in Galleria 
alternative infection by the high pathogenic biotype and the non-pathogenic biotype. The 
non-pathogenic biotype strains were the most lethal biotype in Galleria at all incubation 
conditions. The high pathogenic biotype strain was completely avirulent to Galleria at 37°C 
incubation temperature and weakly pathogenic at 25°C incubation temperature. Moreover, 
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the low pathogenic bioserotype 3/O:5,27 strain 14902 was the most virulent to Galleria 
between the pathogenic biotypes by which this serotype is always associated with animal 
infections and never isolated with human clinical cases. Both of the 25°C and 37°C pre-
grown Y. enterocolitica representative strains were very efficient to infect and kill the 
Galleria larvae.  Furthermore, the heat killed Y. enterocolitica (HKY) biotypes strains were 
completely avirulent to the Galleria larvae.  This result assumes that Galleria larvae were 
dying from living Y. enterocolitica bacterial cells and not from the dead ones.  Infection 
dynamics results revealed that all the tested low pathogenic biotypes strains show static 
growth kinetics in Galleria.  On the other hand, the non-pathogenic strain shows a big 
reduction in numbers during the Galleria infection.  This indicates that non-pathogenic 
biotype strain appears to trigger an immune response in the infected Galleria larvae. After 
that, the pYV role in modulating the lack of virulence of the pathogenic biotypes was 
investigated in Galleria host model. Curing the pYV plasmid from the pathogenic                
Y. enterocolitica showed  little to no effect on virulence in Galleria larvae. Moreover, the 
pYV plasmid stability of the pathogenic biotypes wild type strains (pYV
+
) in the infected 
Galleria larvae was investigated . During infection of Galleria larvae, pathogenic wild type 
strains retained their pYV plasmid during the infection period. However, the low pathogenic 
bioserotype 3/O:5,27 strain 14902 lost the pYV plasmid during the infection period by which 
this strain was the most virulent strain between the pathogenic strains.   
Finally, from the experimental work of this project it can be concluded that all                      
Y. enterocolitica biotypes show pathogenic potential to the infection models used.  In the 
mouse infection model, the high pathogenic biotype is able to kill mice, low pathogenic 
biotypes cause only a mild disease while the non-pathogenic biotype are completely 
avirulent.  However, the high pathogenic biotypes are rarely associated with human clinical 
cases while low pathogenic biotypes are the most isolated.  Moreover, the non-pathogenic 
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biotype is frequently isolated from healthy and infected humans but the pathogenicity of the 
non-pathogenic still confusing.  Here, all Y. enterocolitica biotypes were able to infect 
Galleria larvae insect infection model.  The non-pathogenic biotype was the most lethal to 
Galleria infection model followed by the other  pathogenic biotypes.  So it can be observed 
that all Y. enterocolitica biotypes are capable of causing disease, and that the severity of that 
disease is lineage specific dependant on the different hosts studied. Therefore it is should not 
refer to any of the Y. enterocolitica biotypes as a non-pathogenic biotype. 
 
6.2 Future Work 
In this project an extensive phenotypic work have been provided to investigate the pathogenic 
potential of all the Y. enterocolitica biotypes.  In addition, an experimental work at the  
molecular level was also provided to investigate the in vivo infection dynamics of                  
Y. enterocolitica strains in Galleria.  The molecular work also investigated the role of pYV 
plasmid in modulating the lack of virulence in the pathogenic biotypes because the pYV is 
the main virulence factor of Yersinia.  However, the virulence mechanisms causing the 
pathogenicity of  Y. enterocolitica biotype 1A in Galleria remains ambiguous.  I would like 
to suggest that future work should investigate Biotype 1A unique, putative virulence-
associated genes for their role during the infection of the Galleria insect host model.  Many 
techniques are provided in the research field to investigate gene functions and here I would 
like to propose an example of two of them that may be useful in the future work: 
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RNA sequencing (RNA-seq) 
One way to investigate the Y. enterocolitica virulence genes implicated in Galleria infection 
is to use the functional genomics approach which enables the study of global gene expression 
during host infection. RNA-seq technology is a technique used to sequence large 
transcriptomics content rapidly. RNA sequencing technique includes the next-generation 
sequencing techniques to provide a rapid sequencing output (Ozsolak and Milos, 2010). Since 
this project is providing a new pathogenicity phenotypes and potentials of Y. enterocolitica 
biotypes that no previous studies have encountered before, there is a need for a technique to 
study global gene expression for a large amount of genomes of different biotypes to reveal 
which genes are causing this new novel pathogenicity.  RNA-seq will allow the accurate 
identifications of all genes expressed by all the biotypes during live infection.   
 
Transposon directed insertion-site sequencing method (TraDIS) 
The other suggested approach is to assess a the function of wide range of genes by generating 
a large number of mutants using the transposon directed insertion-site sequencing method 
(TraDIS) (Langridge et al., 2009). TraDIS include the Signature Tag transposon Mutagenesis 
(STM) and the modern Illumina sequencing method making it a high-throughput technology.  
Knocked out genes that going to show an attenuated virulence strains may be suggested as 
the genes responsible for Y. enterocolitica pathogenesis.   
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